Trading Analysis Report: MELI¶

Analysis date: 2026-10-03
Rating: Underweight
Generated: 2026-10-04 18:58:32
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-opus-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 1696.56 USD Price As Of: 2026-10-02

MELI (MercadoLibre, Inc.): technical analysis report¶

Analysis date: 2026-10-03, a Saturday. The latest completed bar is Friday 2026-10-02. All prices are in USD.

Summary¶

The main trend is down. The weekly and daily SuperTrend are both DOWN. Price is below a falling 200-day average and below a 50-day average that has just started to fall. MACD is negative and below its signal line. OBV made a new 90-session low on 09-28.
The short term is stretched, but sellers haven't given up. The daily TD buy setup has reached 9, which is a reversal watch. RSI is 33.49, price is close to the lower Bollinger band, and 10-02 was an inside day on light volume. On the other side, RSI has never closed below 30 during this decline, volatility (ATR) is shrinking, and the first daily 9 (09-18) did not stop the slide.
There is still a floor on the higher timeframe. The monthly SuperTrend is still UP, with its stop at 1,549.51, almost exactly the May-2026 lowest close (1,546.81). The 1,546–1,600 zone is the key line.
The evidence argues against chasing either way. It is better to wait for a bounce into resistance at 1,745–1,860, or for a confirmed break below 1,668.44 and then 1,646.73.

1. Indicators chosen (8) and why¶

Indicator	Role	Why it fits MELI now
close_50_sma	Medium-term trend	It crossed above the 200 SMA on 09-08 and has now turned down; key resistance overhead
close_200_sma	Long-term trend	Falling all quarter; tells us whether a "death cross" (50 below 200) is coming
macd	Momentum	Shows whether momentum is above or below zero, divergences, and whether the drop is slowing (signal line and histogram come from the verified snapshot)
rsi	Momentum	How close to oversold, where bounces stall, and whether a divergence is forming
atr	Volatility	Sizing stops and positions in a stock that moves about 3% a day
obv	Volume	Tests whether the 2–3× volume surge was large holders selling
supertrend	Trend and stops (weekly/monthly/daily)	Gives direction on each timeframe plus concrete trailing-stop levels
td_9	Exhaustion (weekly/monthly/daily)	Tells us whether a 19-session slide is exhausted on each timeframe

Left out on purpose: stochrsi (repeats RSI), adx (SuperTrend already gives direction plus stops), z_score (RSI, Bollinger and TD already cover how stretched price is), mfi/vwma (OBV covers volume). The Bollinger bands and the 10-day EMA come from the verified snapshot as extra reference points.

2. Data check¶

Verified snapshot for 2026-10-02: open 1,693.75, high 1,709.36, low 1,679.02, close 1,696.56, volume 389,300.
Match: The indicator tool agrees exactly with the snapshot: 50 SMA 1,860.26, 200 SMA 1,837.61, MACD −50.37, RSI 33.49, ATR 55.27. There are no discrepancies.
Not in the snapshot: OBV, SuperTrend and TD-9. I checked the weekly (+3) and monthly (+1) TD counts by hand against closing prices, and they match. The SuperTrend distance percentages are consistent with the 1,696.56 close.

3. Price structure and context¶

The 1-year range: The data runs from a high of 2,428.00 intraday / 2,360.76 close on 2025-10-30 down to a low of 1,495.00 intraday on 2026-05-13 and a lowest close of 1,546.81 on 2026-05-15.
MELI now sits about 22% of the way up that range.
It is −28.1% from the 2025-10-30 close and −15.8% year to date (versus 2,014.26 on 2025-12-31).
The 2026 range: Since the gap down on 2026-02-25, MELI has traded between about 1,495 and 2,066.
The only close above 2,000 in that period was 2,006.58 on 09-02.
On 09-03 the stock opened at 2,025.00, spiked to 2,066.00 and closed at 1,991.06. That was a clear rejection at the top of the range, and it marked the peak.
Price is now about 35% of the way up this range.
How much of the summer rally is gone:
On closes (1,583.66 on 06-23 to 2,006.58 on 09-02), the September slide has given back about 73% of the rise.
On the intraday swing (1,495.00 on 05-13 to 2,066.00 on 09-03), it has given back about 65%. Price is below the 61.8% retracement level (about 1,713). The 78.6% level is about 1,617. These levels are my calculations, not tool outputs.
A clean staircase down:
Each bounce peaked lower: closes of 1,906.24 (09-10), 1,826.58 (09-22) and 1,728.53 (09-30).
Each dip went lower: closes of 1,876.33 (09-09), 1,787.39 (09-18), 1,712.41 (09-28) and 1,685.12 (10-01).
The bounces are shrinking: +2.19% from 09-18 to 09-22, then only +0.94% from 09-28 to 09-30.
Back to June prices: The 10-01 close (1,685.12) was the lowest since 06-29 (1,683.13). Its intraday low (1,668.44) was the lowest since 06-30 (1,657.01). The whole July–August rise has been erased.
The latest bar: 10-02 was an inside day: its range (1,679.02–1,709.36) sat entirely within 10-01's range (1,668.44–1,731.36).
Volume was 389,300 shares, the lightest since 09-11.
It reads as a pause, not a reversal candle.
The 10-01 range of 1,668.44 to 1,731.36 is the near-term decision box: a break out of either end is the next signal.

4. Moving averages¶

Price is below every average:
−2.79% versus the 10-day EMA (1,745.25).
−7.68% versus the 200 SMA (1,837.61).
−8.80% versus the 50 SMA (1,860.26).
There have been 14 closes in a row below the 200 SMA. They started on 09-15, when a −3.75% day (1,900.24 to 1,828.94) cut through both averages at once.
The bullish crossover failed: The 50 SMA crossed above the 200 SMA (a "golden cross") on 2026-09-08 (1,862.69 vs 1,859.50).
It happened while the 200 SMA was still falling, which makes it a weak signal.
Price closed at 1,926.25 that day and is down 11.9% since.
Both averages are now falling:
The 50 SMA peaked at 1,877.88 on 09-17 and has fallen 11 sessions in a row.
The 200 SMA has slid from 1,890.37 (08-04) to 1,837.61.
Death-cross watch (my estimate, not a tool output): A death cross is the 50 SMA falling below the 200 SMA. The gap between them is only 22.65 points.
If price just holds around 1,697, the 50 SMA drops about 2–5 points a day as late-July and early-August closes (about 1,800–1,940) leave its window.
The 200 SMA drops about 1.1–2.5 points a day as mid-December and early-January closes (about 1,916–2,187) leave its window.
On that arithmetic, the cross lands in about 13 sessions, around 2026-10-21. A rebound toward about 1,800 would push it well out; further weakness would bring it sooner.
Takeaway: The 1,813–1,860 band now has three layers of resistance stacked in it: the 20 SMA, the 200 SMA and the 50 SMA.

5. SuperTrend: the timeframes point bearish¶

The weekly reading carries the most weight, the monthly gives the bigger picture, and the daily is for timing.

Weekly: DOWN, stop at 2,061.81. The close is 17.72% below it, about 6.6 times the daily ATR.
No ordinary bounce will flip this, so any rally in the coming weeks goes against the main trend.
The stop sits next to the 09-03 rejection high (2,066.00).
Monthly: UP, stop at 1,549.51. The close is 9.49% above it.
The stop is effectively the May-2026 lowest close (1,546.81).
Until a monthly close below about 1,549.51, the long-term structure still reads as a pullback within a 2026 base. A close below it would turn all three timeframes bearish.
Daily: DOWN, stop at 1,860.01. The close is 8.79% below it.
The stop is almost exactly on the 50 SMA (1,860.26), which makes it the strongest resistance overhead.
The daily trend won't flip until a close above about 1,860.
A tension worth noting: The monthly SuperTrend is UP while the 200 SMA is falling. That fits a broad range or base rather than a clean long-term trend in either direction.

6. Momentum¶

MACD (from the snapshot): MACD line −50.37, signal line −35.38, histogram −14.99. - It has been below zero since 09-17, when it went from 0.20 to −5.61. The current −50.37 is the lowest reading in the 60-session lookback. - It gave an early warning that proved right: The MACD peak on 09-03 (41.22) was slightly below its 08-05 peak (42.32), while price made a higher closing high (2,006.58 vs 1,922.57). That is a mild bearish divergence. - The decline is slowing but hasn't turned. Daily changes in the MACD line were −6.37 (09-28), −3.56, −2.02, −4.55 and −2.10 (10-02). - The first good sign would be the histogram shrinking from −14.99. - Getting MACD back above its signal line would take a meaningful rally.

RSI: 33.49 now, with a low of 31.35 on 10-01. - No oversold reading in the whole decline. RSI has never closed below 30, so there has been no washout yet. - A clear bearish divergence at the top: - RSI highs fell: 68.74 (08-05), 64.13 (08-11), 64.97 (08-25), 62.22 (09-02). - Over the same dates, closes rose: 1,922.57, 1,940.00, 1,997.00, 2,006.58. - It is behaving like a downtrend: RSI has been below 50 every session since 09-09, and bounces stalled at 43.04 (09-16) and 43.52 (09-22). - No bullish divergence yet: On 10-01 the lower price low (1,685.12 vs 1,712.41) came with a lower RSI low (31.35 vs 32.55). - What to watch: - Above 43.5 would be the first higher high in RSI during this decline. - Above 50 would mean momentum has recovered. - Below 30 would be the first oversold reading, which could mean either a final flush or the decline speeding up.

7. Volatility¶

ATR 55.27, or 3.26% of price. - ATR has fallen from 70.25 (08-19) and 64.05 (09-15) even as price dropped. - That points to steady, grinding selling rather than panic. Washout lows usually come with daily ranges widening, and that hasn't happened. - Stop distances from 1,696.56: - 1× ATR = 55.27, 1.5× = 82.9, 2× = 110.5. - A 2× ATR stop for a long would be about 1,586.0; for a short, about 1,807.1. - Gaps can jump these stops. Event days have gapped well beyond the ATR: - 05-08 opened at 1,685.00 after a 1,870.01 close: −185, about 3.3× today's ATR. - 02-25 opened at 1,760.12 after 1,922.56: −162, about 2.9×.

Bollinger bands (from the snapshot): middle 1,813.33, upper 1,979.93, lower 1,646.73. - Price is about 50 points (about 0.9 ATR) above the lower band. On a 0–1 scale from lower to upper band, it sits at about 0.15. - The bands are wide, about 18% of the middle line, which reflects the September trend. - A close below 1,646.73 would mean the price is "riding the band", a sign the trend is speeding up. It would not be an automatic buy signal.

8. Volume and OBV¶

The selling has been confirmed by volume:
OBV peaked at 14,738,400 on 09-02, the same day as the closing high.
It fell to 11,221,000 on 09-28, the lowest in the 90-session lookback and below every reading since 07-06. All the buying volume built up in July and August has been given back.
It is 12,055,900 now.
Volume surged:
Sessions from 09-15 to 09-24 averaged about 909K shares, versus about 346K in July (07-06 to 07-31). That is roughly 2.6×.
The peak was 1,161,900 on 09-18, the September quarterly options-expiration Friday, so part of that day may be mechanical. But the heavy volume carried on for days afterwards.
Buyers who stepped in were overrun: The heavy-volume up days on 09-21 (1,064,900 shares) and 09-22 (923,800) were fully reversed between 09-23 and 09-28.
An early positive sign: On 10-01 price made a lower closing low (1,685.12 vs 1,712.41), but OBV stayed above its 09-28 low (11,666,600 vs 11,221,000).
That is a small bullish divergence over three sessions.
It is weak evidence, because the 10-02 uptick came on the lightest volume since 09-11.
A new OBV low below 11,221,000 would cancel it.

9. TD Sequential setup¶

The TD count tallies consecutive closes below the close four bars earlier; a count of 9 is a reversal watch.

Daily: 9 of 9, complete, with a caveat.
By my count from the closes, the condition has held for 19 sessions in a row, starting 09-08.
The first 9 printed on 09-18 at 1,787.39. It even met the stricter "perfected" rule (the bar-9 low of 1,785.22 went under the lows of bars 6 and 7).
Price has still fallen another 5.1% since then.
A count that keeps running past 9 shows the trend persisting, so the daily reversal signal deserves less weight.
Weekly: 3 of 9. There is no weekly exhaustion yet.
The earliest possible weekly 9 is the week ending 2026-11-13.
For the count to keep running, weekly closes must stay below 1,897.37 (week ending 10-09), 1,787.39 (10-16), 1,752.61 (10-23) and 1,696.56 (10-30).
Monthly: 1 of 9, and fragile. October's close so far (1,696.56) is only $0.83 below June's (1,697.39). Any October close above 1,697.39 erases it.
The weekly count (3 of 9) carries more weight than the daily 9. A short-term bounce is plausible, but there is no sign of exhaustion on a higher timeframe.

10. Key levels¶

These are reference prices from the data. I am not claiming they have been proven as support or resistance.

Resistance, nearest first: - 1,709.36: 10-02 high - 1,728.53–1,739.88: 09-30 close and high - 1,731.36: 10-01 high - 1,745.25: 10-day EMA - 1,752.61–1,759.11: 09-25 close and high - 1,813.33: 20 SMA (Bollinger middle) - 1,826.58–1,842.49: 09-22 close and high - 1,837.61: 200 SMA - 1,860.01–1,860.26: daily SuperTrend stop and 50 SMA - 1,979.93: upper Bollinger band - 2,006.58: 09-02 close - 2,061.81–2,066.00: weekly SuperTrend stop and 09-03 high

Support, nearest first: - 1,679.02: 10-02 low - 1,668.44: 10-01 low - 1,646.73: lower Bollinger band - About 1,617: 78.6% retracement (my calculation) - 1,593.21–1,599.52: 03-27 low and close - 1,566.00–1,583.66: 06-23 low and close - 1,549.51: monthly SuperTrend stop - 1,546.81: 05-15 close, the lowest close in the year of data - 1,495.00: 05-13 low, the lowest price in the year of data

11. Scenarios and triggers¶

A. The decline continues (favoured by the weekly and daily trend).
Trigger: a close below 1,668.44, then below 1,646.73.
Likely path: 1,593–1,600, then 1,566–1,584, then 1,546–1,550.
Confirmation would be OBV below 11,221,000, or RSI below 30 with ATR rising.
B. A relief bounce against the trend (conditions are ripe).
Trigger: a close above 1,731.36, ideally also above the 10-day EMA at 1,745.25, with RSI above 43.5 and the MACD histogram shrinking.
Targets: 1,813, then 1,837, then 1,860.
Expect sellers there unless volume and OBV expand.
C. The trend repairs (unlikely soon).
Trigger: a daily close above about 1,860. That would flip the daily SuperTrend, take back the 50 SMA and head off the death cross.
Flipping the weekly trend needs a move above 2,061.81.
D. The long-term regime breaks (a tail risk).
Trigger: a monthly close below 1,549.51, which would turn all three timeframes bearish.
The next reference below is 1,495.00.

Risk/reward for whoever makes the trade decision: - Shorting at about 1,697 has poor odds. - A stop above 1,731–1,745 risks about 0.6–0.9 ATR. - The first target, 1,646.73, is only about 0.9 ATR away, so roughly 1:1, in a stretched market. - Shorts that go with the trend look better on a bounce into 1,813–1,860, with a stop above about 1,875. That risks about 0.7–1.1 ATR against about 2.6–3.1 ATR of reward down to 1,668. - Buying against the trend needs the trigger first. - Entering around 1,745 with a stop under 1,668.44 risks about 1.4 ATR. - The reward is about 1.2–2.1 ATR up to 1,813–1,860. - That is marginal, so any position should be small. - A zone for longer-term buying: 1,546–1,600, where the monthly SuperTrend stop lines up with the March, May and June 2026 lows. The case fails on a monthly close below 1,549.51.

12. Event risk¶

Large, high-volume gap days in the price data:
2026-02-25: −8.05% on 2.38M shares.
2026-05-08: −12.70% on 2.33M.
2026-08-06: −4.82% on 1.20M.
A quarterly pattern: The spacing fits quarterly earnings, but these tools can't confirm the dates. If the pattern holds, the next one probably lands in late October or early November, close to the estimated death-cross window.
Sizing: Positions should be sized so that a gap of about 3 ATR is survivable.

13. What the data supports (the trade decision is left to the other agent)¶

The weight of evidence is bearish on the main trend and stretched in the short term. - Bearish: - Weekly and daily SuperTrend are DOWN. - The 09-08 golden cross failed. - The 50 and 200 SMAs are both falling and are converging toward a likely death cross. - MACD is below zero and falling. - RSI stays capped below 44 on bounces. - OBV made new lows on heavy volume. - Arguing against chasing lower at 1,697: - The daily TD 9 is complete. - RSI is in the low 30s. - Price is near the lower Bollinger band. - The latest bar is an inside day on light volume. - A small OBV divergence has appeared. - What has to happen first: The 1,668.44 / 1,731.36 range needs to resolve. The clearest setups are a bounce that fails at 1,745–1,860, or a breakdown below 1,646.73 that targets the 1,546–1,600 zone.

Key points at a glance¶

Area	Reading	What it means	Level or trigger to watch
Price	1,696.56 close (2026-10-02); inside day, 389.3K shares	Pause after the lowest close since 06-29	10-01 range: 1,668.44 / 1,731.36
Structure	Lower highs and lower lows since 09-03; about 65–73% of the summer rally erased	Clean downtrend; bounces getting weaker	A close above 1,728.53 breaks the lower-high pattern
10-day EMA	1,745.25 (−2.79%)	Nearest moving resistance	Taking it back is the first sign of a bounce
50 SMA	1,860.26, falling 11 sessions in a row (−8.80%)	Medium-term trend has turned down	Same level as the daily SuperTrend stop
200 SMA	1,837.61, falling (−7.68%); 14 closes below	Long-term trend is down	Death cross estimated around 10-21 if price stays flat (my estimate)
SuperTrend weekly	DOWN, stop 2,061.81 (−17.72%)	Main trend is bearish	A flip needs a move above 2,061.81
SuperTrend monthly	UP, stop 1,549.51 (+9.49%)	The 2026 base is still intact	A monthly close below 1,549.51 turns all timeframes bearish
SuperTrend daily	DOWN, stop 1,860.01 (−8.79%)	Timing still says down	A daily close above about 1,860 flips it
MACD	−50.37 / signal −35.38 / histogram −14.99	Bearish; the decline is slowing	Watch for the histogram to shrink
RSI	33.49 (low 31.35); below 50 since 09-09	Weak but not oversold; no bullish divergence	Above 43.5 = first improvement; below 30 = flush or acceleration
ATR	55.27 (3.26%), down from 70.25	Steady selling, no washout	2× ATR stops: about 1,586.0 long / about 1,807.1 short
Bollinger	1,646.73 / 1,813.33 / 1,979.93	Price in the lower part of the bands	A close below 1,646.73 means the trend is speeding up
OBV	12,055,900; 90-session low of 11,221,000 on 09-28	Selling confirmed; a small 3-day bullish divergence	A new low below 11.221M cancels the divergence
Volume	09-15 to 09-24 about 909K vs July about 346K	Heavy selling; now quieting down	A bounce needs volume to expand
TD-9 daily	9 of 9 complete; 19 qualifying sessions in a row	Reversal watch, but the first 9 (09-18) failed	Needs price confirmation
TD-9 weekly	3 of 9	No weekly exhaustion; earliest 9 is the week ending 11-13	Weekly closes need to stay below 1,897.37 / 1,787.39 / 1,752.61 / 1,696.56
TD-9 monthly	1 of 9 (October so far 1,696.56 vs June 1,697.39)	Fragile; a $0.83 margin	An October close above 1,697.39 erases it
Resistance	1,745 → 1,813 → 1,837 → 1,860 → 2,062	Layered resistance overhead	Best zone for trend-following shorts: 1,813–1,860
Support	1,668 → 1,647 → about 1,617 → 1,593–1,600 → 1,546–1,550 → 1,495	1,546–1,600 is the line on the higher timeframe	Breakdown trigger: below 1,668.44, then below 1,646.73
Event risk	Gaps on 02-25 (−8.05%), 05-08 (−12.70%), 08-06 (−4.82%)	Quarterly gap risk of about 3× ATR (earnings dates not confirmed)	Size for gaps ahead of late Oct / early Nov

Sentiment Analyst¶

Overall Sentiment: Mixed (Score: 4.7/10) Confidence: Low

Summary. The evidence shows a “good business, bad stock” standoff in MELI. Institutional headlines frame the fundamentals constructively: fintech credit growth, a profitability screen and a “better buy” comparison with Shopify. The only MELI price-action headline documents relative weakness, and the StockTwits board is dominated by tired, frustrated holders. The raw tag ratio (9 Bullish / 5 Bearish) looks mildly bullish, but one account supplied 5 of the 9 Bullish tags. Without that account, labeled sentiment is 4 Bullish vs. 5 Bearish.

The band is Mixed rather than Mildly Bullish because the bullish lean disappears once that one account is removed. It is Mixed rather than Mildly Bearish because constructive fundamental framing and active dip-buying offset the negative price action and tone. The score of 4.7 reflects a slight negative tilt. Confidence is low: Reddit was not collected, the news is headline-only, and the StockTwits sample is small and concentrated.

1. Source-by-source breakdown¶

News — Yahoo Finance, 7 headlines (headline-only: no article bodies, estimates, price targets or ratings provided)

MELI-specific (3): - Zacks, “MercadoLibre (MELI) Stock Falls Amid Market Uptick: What Investors Need to Know” — negative, price event. MELI fell in a session in which the broad market rose, so the weakness was specific to MELI rather than market-wide. - Zacks, “MercadoLibre's Credit Growth Strengthens Its Fintech Ecosystem” — positive, fundamental framing. Lending expansion is presented as reinforcing the fintech ecosystem. No loan-book, delinquency or provisioning figures are available, so the risk side of credit growth cannot be assessed. - Motley Fool, “MercadoLibre vs. Shopify: Which Stock Is a Better Buy in 2026?” — neutral-to-positive. MELI is framed as a buy candidate among quality e-commerce names; the article's verdict is not visible.

Probably MELI-inclusive (1): StockStory, “3 Profitable Stocks Worth Investigating” — mildly positive profitability framing. MELI's inclusion is implied by its presence in the MELI feed but not confirmed by the headline.

Peer / read-across (3): - 24/7 Wall St., “Nu Holdings Keeps Imploding: Goldman Sachs Reiterated Its Belief That NU Shares are Going to Double” — negative for the sector, but with sell-side support. A Latin American fintech peer is under sustained selling pressure while Goldman defends it. This suggests the regional fintech group, not only MELI, is out of favor this week. - Trefis, “Should You Buy eBay Stock For Its Cash?” and “Is eBay Stock Priced Right Against Its Peers?” — neutral for MELI. Both are eBay-focused, with MELI at most a peer comparator.

Net news read: two positive and one neutral-positive MELI-specific headlines vs. one negative. That is neutral-to-mildly-constructive on fundamentals and negative on price action. No hard company event appears in the window: no earnings release, guidance change, buyback authorization, M&A, rating change or insider-filing story. The flow is low-intensity and mostly evergreen or comparative.

Nothing in the feed explains the relative weakness on company-specific grounds, which points toward regional, sector or factor drivers. A StockTwits relay (@Good2go, 10-02: “Zacks prefers $TGT over $MELI in recent article”) suggests a second Zacks comparison in which MELI lost out. That article is not among the seven headlines, so it is unverified.

StockTwits — 29 most-recent messages (2026-09-28 to 2026-10-02), 17 unique accounts

Headline ratio: 9 Bullish (31%) / 5 Bearish (17%) / 15 unlabeled (52%). Among the 14 labeled posts that is 64/36. This is a mild bullish lean, short of the 70/30 “moderately bullish” marker, on a tiny labeled base.
Concentration: @thereisalwaysaway posted 9 of 29 messages (31%, seven of them on 09-29 alone) and 5 of the 9 Bullish tags (56%). Excluding that account, tags split 4 Bullish vs. 5 Bearish, so the bullish lean comes from one voice.
Tag quality: Of the 4 remaining Bullish tags, one relays a negative comparison (the Zacks TGT note) and one is exasperation (@Lets__Go: “this damn thing”). Of the 5 Bearish tags, two (@Undone_ai) are jabs at other users rather than arguments about the stock. Tags backed by an actual argument thin out to about 2 bullish (@darioras “Keep adding!”, @Kevm84 “it's an easy add”) vs. 3 bearish (@ArmLee, @DavyDaveCharts, @notamusedatall).

Content read of all 29 posts (analyst classification, labeled or not): - Bullish positioning or argument — 8 posts, 6 accounts. - Buying: @Spks (“Bought some yesterday”), @darioras, @Kevm84, @thereisalwaysaway (“I bought for first time... GREAT price per share”). - Long-dated options: @GraffGripANW cites Jan 2028 $3,000 calls at ~$5K per contract and says “someone bought 10 today”, while noting long-dated options (LEAPS) are “insanely expensive”. - Long-term views from the same user: calls the stock a “beach ball under water” (“See 3k next year”) and sees a “massive inverse head and shoulders” on a long timeframe. - Event-driven: @LTideas expects “a pop on Monday” from Brazil's elections. - Bearish argument or negative information — 6 posts, 5 accounts. - @ArmLee: “Chart suggests this is going to $1500.00”. - @DavyDaveCharts: the Latin America ETF $ILF has its “monthly MACD curling down and possible sweep on this HTF” (higher timeframe). - @notamusedatall: “IT'S OVER FOR MELI”, “Insiders selling at ANY price”, “death spiral”, “$100 DOLLAR STOCK”, “PROFITS TO FALL TO $0”. These claims are hyperbolic and unsupported; no insider filing appears in the evidence. - @ForestLiR8pdme: “$SE and $MELI are software stocks on the ai days and ai stocks on the software days”. In other words, MELI loses whichever group the market is favoring. - Plus the Zacks-prefers-TGT relay. - Holder frustration and management criticism — 9 posts, 3 accounts. - @thereisalwaysaway's seven-post buyback campaign: “DEAD money ($$$) for about a year”, “Management is failing the shareholders”, “missing in action”, and calls for a “massive share buyback” to push the stock “over $2,000”, “$2,200” and “$2,500 again”. - @BullcaseDan: “price is down YTD, even worst 1Y... trading back to 2024 levels but the company is hauling record number revenue”. - @Lets__Go: “this damn thing”. - Snark/meta — 2. @Undone_ai rebuts the buyback campaign: “Management doesn't owe yo anything. They need money to invest into efficient operation”. - Neutral/empty — 4.

Character: fatigue, not euphoria. Bulls argue, in effect, that the business is fine, the price is wrong and the stock is cheap; bears argue through charts and hyperbole rather than fundamental evidence.

Implied price context (retail claims, unverified): down YTD and over one year, back at 2024 levels, below roughly $2,000 (the buyback poster wants it “over $2,000 already”), and previously above $2,500.

Activity peaked on 09-29 (12 posts, 7 from one account) and 10-01 (9 posts). The final two posts (10-02) are the Zacks relay and a retail buy, so there is no late-window shift. No posts from 09-26/27 or 10-03 are in the sample.

Reddit — not collected. The feed returned “reddit skipped: disabled by sentiment_include_reddit config”. There is no read on r/wallstreetbets, r/stocks or r/investing; this is a data gap, not evidence of silence. In particular, the longer-horizon r/investing view on valuation and the buyback debate is missing.

2. Cross-source alignments and divergences¶

Alignment — relative weakness (most robust signal): The Zacks “Falls Amid Market Uptick” headline is corroborated by retail posts: “down YTD”, “worst 1Y”, “DEAD money”, the SE/MELI rotation quip and the TGT-over-MELI relay. Two independent sources agree the stock is lagging the market.
Alignment — fundamentals seen as intact: Zacks' credit-growth piece, the StockStory profitability screen and the Motley Fool comparison match retail's “record number revenue” claim and dip-buyers calling MELI an “easy add”.
Alignment — regional and sector pressure: “Nu Holdings Keeps Imploding” matches the $ILF monthly-MACD warning and the Brazil-election chatter. With no MELI-specific negative news in the feed, the weakness looks at least partly regional or sector-driven rather than specific to MELI.
Divergence — tags vs. content: Labels lean bullish (9:5), but the text is dominated by frustration. Many Bullish tags come from frustrated holders rather than people expecting near-term upside.
Divergence — institutional vs. retail mood: Institutional framing still treats MELI as a quality candidate while retail is worn out. This is the inverse of “retail chasing while institutions are cautious”.
No crowding on the long side: Bullish-tagged posts are only 31% of all messages, nowhere near the ≥90/10 over-extension zone. The board reads washed-out, which lowers the risk of a crowded long unwinding but does not by itself imply a reversal.
Retail-only debate — capital allocation: The buyback demand and its rebuttal exist only on StockTwits; nothing in the news feed indicates a repurchase.

3. Dominant narrative themes¶

Record fundamentals vs. dead-money stock — the core disconnect, voiced by holders and mirrored by constructive headlines sitting next to a negative price-action headline.
Capital-allocation frustration — buyback demands and “Management is failing the shareholders” rhetoric. This signals holder fatigue, not a change in the business.
Fintech credit as growth engine, Latin American fintech as overhang — Zacks praises credit growth while the Nu headline shows the market punishing the regional fintech group.
Brazil political event risk — a first-round vote with a Monday readout and a runoff “at the end of October” (per @LTideas).
Technical tug-of-war — inverse head-and-shoulders and $3,000 (bull) vs. $1,500 and the $ILF MACD rollover (bear); none verifiable from the data.
Relative-value benchmarking — MELI vs. SHOP, TGT preferred over MELI, eBay peer valuation. MELI is being compared rather than championed, typical of a “show-me” phase.

4. Catalysts and risks¶

Potential upside catalysts: - Brazil first-round readout — @LTideas expects Bolsonaro to outperform, which the poster says is “not baked into the company”, lifting Brazil-exposed names. Monday 2026-10-05 is the first post-vote session. This is opinion only; the outcome is unknown. - Capital return — a buyback would address the loudest retail grievance, but nothing in the evidence suggests one is planned. - Fintech re-rating — continued credit growth (Zacks) plus sell-side defense of the group (Goldman on NU) could help if Latin American fintech stabilizes. - Washed-out positioning — dip-buying and small long-dated call purchases (10 Jan 2028 $3,000 calls, roughly $50K of premium at the quoted ~$5K each) could support a contrarian case, but the evidence is anecdotal.

Downside risks: - Persistent relative underperformance — the only corroborated price signal is negative, and the AI-vs-software rotation quip suggests MELI keeps losing out. - Election gap risk in both directions — an outcome contrary to the poster's view could hit Brazil-exposed names on 10-05. The late-October runoff extends the volatility window. - Latin American fintech contagion — Nu “imploding” and the $ILF monthly MACD rolling over. - Credit quality — loan growth is framed positively, but no delinquency or provisioning data is in the evidence. - Capitulation — fatigued holders could sell if the bear target ($1,500) gains traction. The insider-selling claim is unverified, but a confirming filing would amplify it. - Unknown calendar — no earnings date, guidance or estimate revisions appear in the evidence; confirm externally.

What would shift this read: - Toward bullish: MELI outperforming the market on a positive Brazil reaction, a capital-return announcement, stabilization in NU/$ILF, or Bullish tags broadening beyond a single account. - Toward bearish: MELI lagging even on a positive Brazil reaction (confirming MELI-specific weakness), a confirmed insider-sale filing, credit-quality concerns surfacing in news, or price moving toward the bear-chart levels cited.

Data limitations: - Reddit was disabled, so one of three sources is missing. - News is headline-only, and 3 of 7 headlines are about peers. - StockTwits is limited to 29 messages (14 labeled), with one account supplying 31% of messages and 56% of Bullish tags. - There is no price, volume, options-flow or short-interest data; all price levels above are inferred from retail posts.

This is signal to weigh alongside fundamentals and technicals, not a price call.

5. Key sentiment signals¶

Signal	Direction	Source	Supporting evidence
Relative price weakness	Bearish	News (Zacks) + StockTwits	“Stock Falls Amid Market Uptick”; “down YTD, even worst 1Y”, “back to 2024 levels”, “DEAD money”
Fintech credit growth	Bullish (fundamental)	News (Zacks)	“Credit Growth Strengthens Its Fintech Ecosystem”; no figures available
Quality/profitability framing	Mildly bullish	News (StockStory, Motley Fool)	“3 Profitable Stocks Worth Investigating”; “MercadoLibre vs. Shopify: Which Stock Is a Better Buy in 2026?”
Peer comparison lost	Mildly bearish	StockTwits relay (unverified)	“Zacks prefers $TGT over $MELI”
Latin American fintech/regional pressure	Bearish (sector), sell-side support	News (24/7 Wall St.) + StockTwits	“Nu Holdings Keeps Imploding” + Goldman “double” call; $ILF “monthly MACD curling down”
Raw tag ratio	Mildly bullish	StockTwits	9 Bullish / 5 Bearish (64/36 of labeled; 31%/17% of all)
Ratio excluding dominant account	Neutral to mildly bearish	StockTwits	4 Bullish / 5 Bearish without @thereisalwaysaway
Dip-buying	Bullish	StockTwits	“Bought some yesterday”, “Keep adding!”, “easy add”, “I bought for first time”
Long-dated calls	Bullish (anecdotal)	StockTwits	Jan 2028 $3,000 calls ~$5K each, “someone bought 10 today”; “See 3k next year”
Holder frustration / buyback demands	Bearish tone from holders	StockTwits	“Management is failing the shareholders”, “massive share buyback” (7 posts, one account)
Technical calls	Split	StockTwits	“massive inverse head and shoulders” vs. “going to $1500.00”
Capitulation rhetoric	Bearish (low quality)	StockTwits	“IT'S OVER FOR MELI”, “death spiral”, “Insiders selling” (unverified), “$100 DOLLAR STOCK”
AI-vs-software rotation	Mildly bearish	StockTwits	“software stocks on the ai days and ai stocks on the software days”
Brazil election	Event risk in both directions	StockTwits	“pop on Monday”; “1^st round ballots will give a readout and 2^nd round at the end of October”
Reddit	No data	Reddit	Disabled by sentiment_include_reddit config

News Analyst¶

MELI (MercadoLibre, Inc.): news and macro research report¶

As of: Saturday, October 3, 2026 · Main window: Sept 26 – Oct 3, 2026, with September for context Instrument: MELI (NASDAQ/NMS), Consumer Cyclical / Internet Retail, plus its fintech arm Mercado Pago Scope: This covers news flow and macro only. The tools gave me no MELI price, fundamentals or analyst estimates, and the trade decision belongs to another agent.

1. Bottom line¶

This is a hard macro setup for a richly valued EM growth stock. The Fed raised rates on Sept 16, 2026. The 10Y Treasury reached 5.29% on Sept 30, its 2026 high. About 90% of September's rise in yields came from real yields, which hurts long-duration equities like MELI the most. The dollar rallied and Latin American currencies and credit sold off in the last week of September.
MELI is falling while the broad market rises. A Zacks headline from Oct 1–2 reads "MELI Stock Falls Amid Market Uptick", and the NASDAQ closed Oct 2 up 1.19% at 27,191, near its highs. That points to selling tied to Latin America or fintech specifically, not just broad risk-off.
The biggest risk sits right at the start of the week. Brazil's general election first round is Sunday Oct 4, and MELI's largest market is Brazil. (That date comes from Brazil's constitutional calendar, not from the tools.) Latin American corporate credit spreads widened 51bp in six sessions just before the vote.
Some offsets exist. Expectations of another Fed hike faded after a weak September jobs report (+29K payrolls, unemployment 4.2%). Brazil has cut rates by roughly 95bp since February. By my calculation, Q3 2026 results converted to USD get a meaningful currency boost: the real (BRL) was about 5% stronger than a year earlier and the peso (MXN) about 9% stronger.

Net read from my tools: the near-term skew is negative to neutral. Over the next roughly 3–4 weeks the stock faces a string of binary events: the Brazil vote, US CPI, the Brazil runoff, the FOMC and Q3 earnings.

2. MELI-specific news flow¶

I only had headlines, not article text, so the readings below interpret titles only.

Date range	Headline (source)	My read
Oct 1–2	"MercadoLibre (MELI) Stock Falls Amid Market Uptick" (Zacks)	Bearish: `MELI` fell on an up day for the market
Sept 26–Oct 3	"MercadoLibre's Credit Growth Strengthens Its Fintech Ecosystem" (Zacks)	Bullish: lending at Mercado Pago is a growth engine
Sept 26–Oct 3	"Nu Holdings Keeps Imploding: Goldman Sachs Reiterated…NU Shares Going to Double" (24/7 Wall St.)	Bearish read-across: Nu, the main Brazilian digital-bank peer, is in a steep drawdown even though Goldman stays bullish
September	"Nu Holdings Expands Lending: Can Credit Quality Hold Up?" (Zacks)	Caution: the market doubts Brazilian consumer credit quality, which also exposes `MELI`'s growing loan book
September	"MELI Stock Looks Rich Relative To Its Earnings" (Simply Wall St.)	Bearish: valuation concern makes `MELI` more sensitive to rates
September	"MELI Sees a More Significant Dip Than Broader Market" (Zacks)	Bearish: the underperformance has lasted at least a month
Sept–Oct	Comparison pieces against Shopify, Coupang, Chewy and Target (Motley Fool, Zacks); "3 Profitable Stocks Worth Investigating" (StockStory)	Neutral to mildly positive: the long-term growth story is still promoted
September	"Michael Burry keeps pointing at unloved stocks…" (TheStreet)	Appears in `MELI`'s feed; content unknown, so no direction inferred

What the news says overall: there were no hard company catalysts this week (no guidance, M&A or regulatory action surfaced). Three themes dominate: - Relative weakness: MELI is lagging the market. - Valuation: commentators call the stock rich. - Fintech credit: lending growth is a selling point, but Nu's slump shows how fast sentiment on Brazilian lenders can turn.

3. Global macro¶

3.1 Geopolitics and oil: the Iran war is re-escalating¶

A Yahoo Finance headline this week: "The Iran war is driving inflation higher — and it's not just because of oil." That suggests second-round effects beyond fuel.
WTI crude path:
$64.56 on Feb 4
About $93–98 by mid-March
Peak of $114.58 on Apr 7
Down to about $77 in early August
Back up to $107.02 on Sept 15
$96.16 on Sept 29
Daily swings are extreme: WTI went from $85.23 on Sept 25 to $99.37 on Sept 28, a 16.6% jump. Oil is still +53% since February.

3.2 US inflation: firm, not runaway¶

Headline CPI: +3.35% year over year in August (334.131 vs 323.291) and +0.40% month over month. The war shock shows in March (+0.87%), April (+0.64%) and May (+0.47%).
Core PCE: +3.0% year over year in August, +0.25% month over month, up from +0.13% in both June and July. The 3-month annualized rate is only about 2.0%, but August re-accelerated.
10Y breakeven inflation: steady at 2.36% (Oct 2). Long-run inflation expectations are not de-anchoring.

3.3 The Fed has turned to hiking¶

The target range's upper bound went from 3.75% to 4.00% on Sept 17, 2026, reversing the December 2025 cut. The effective rate moved from 3.63% to 3.88%.
On Oct 1 the 2Y yield was 4.78%, about 90bp above the effective fed funds rate. That means the market was still pricing more tightening.
On Oct 2, a jobs miss caused "Fed rate-hike expectations [to] fade", and stocks and tech rallied while yields eased. Moody's Mark Zandi also warned that higher rates are already damaging the economy.

3.4 The bond selloff is a real-rate shock¶

Measure	Aug 31	Peak	Oct 1	Change since Aug 31
10Y nominal	4.75%	5.29% (Sept 30)	5.24%	+49bp (+111bp year over year)
10Y real (TIPS)	2.44%	2.93% (Sept 30)	2.88%	+44bp
10Y breakeven	2.31%	n/a	2.36%	+5bp
2Y	4.34%	4.92% (Sept 28)	4.78%	+44bp
10Y minus 2Y	0.41%	low of 0.20% (Sept 21)	0.45% (Oct 2)	Curve steepened as long yields rose

The 10Y has climbed about 130bp from its 2026 low of 3.97% on Feb 27. At 5.29% it is above the October 2023 peak of about 5.0% (background knowledge), which makes it roughly the highest level since 2007.
Because the move is mostly real yields, it maximizes pressure on valuation multiples for high-growth names like MELI.

3.5 US labor and growth: low hiring, low firing, slowing¶

Payrolls: Sept +29K, Aug +133K, Jul −10K, a 3-month average of about 51K. Unemployment is 4.2%, up from 4.1%.
Initial jobless claims: 197K (week of Sept 26). Layoffs are not rising.
Real GDP: Q2 2026 about +2.2% annualized, Q1 about +2.5%, Q4 2025 about +0.2%.
University of Michigan sentiment: 51.7 in August, after a trough of 44.8 in May. Consumers remain gloomy.

3.6 Credit stress is growing while equity volatility stays calm¶

Measure	Recent low	Oct 1	Change
US high-yield credit spread (ICE BofA)	2.68% (Sept 22)	3.24%	+56bp in 7 sessions
Latin America corporate credit spread (ICE BofA)	1.90% (Sept 23)	2.41%	+51bp in 6 sessions; +18bp on Oct 1 alone
VIX	14.21 (Sept 22)	16.39	Only mildly higher
NASDAQ Composite	25,978 (Sept 16)	27,191 (Oct 2)	Near highs, led by AI and tech

Implication: credit is flashing stress that the stock market has not priced. Latin American credit is weakening in relative terms (+27% on a low base), consistent with pre-election hedging on top of the global rate shock. AI-heavy US tech is absorbing inflows, while EM and fintech names like MELI and Nu are being sold.

3.7 The dollar is up and Latin American currencies are under pressure¶

Broad USD index: 117.88 (Sept 9) to 120.33 (Sept 25), +2.1%.
USD/MXN: 16.86 (Sept 4) to 17.69 (Sept 25). The peso lost about 4.7% in three weeks.
USD/BRL: 5.08 (Sept 8) to 5.19 (Sept 25), the real down about 2%. The Aug–Sep range was about 5.07–5.24.
Fed currency data run only through Sept 25, so the pre-election week of Sept 28–Oct 2 is not visible yet.

3.8 Latin American interest rates are easing¶

Brazil: the overnight interbank rate (a proxy for the Selic policy rate) fell from 15.00% (Feb) to 14.06% (Aug average). That looks like steady 25bp cuts.
Risk: a Fed hike plus a weaker real could make Brazil's central bank slow or pause.
Mexico: the OECD call-money series eased from 6.21% to 5.09% over the year. Its level may differ from Banxico's headline rate; the direction is what matters.

4. How this reaches MELI¶

Valuation (strongly negative): real yields up 44bp in a month, combined with a stock already called rich, means multiples compress. This is the main headwind. If the Oct 2 relief rally extends and the 10Y falls back under about 5.0%, MELI is one of the names with the most to gain.
Currency translation (mixed):
Average Aug–Sep 2026 rates were BRL 5.14 vs 5.41 a year earlier (about +5.1% stronger) and MXN 17.10 vs 18.61 (about +8.8% stronger). That flatters Q3 results reported in USD.
The late-September weakening shrinks that boost for Q4 if it continues.
I had no data on Argentina's peso, historically a source of translation drag.
Fintech and credit (two-sided):
Positive: Brazil's rate cuts lower funding costs, and lending growth is a selling point (Zacks).
Negative: Nu's slump, wider Latin American credit spreads and doubts about Brazilian consumer credit point to a higher risk premium on loan books and closer scrutiny of MELI's credit margins and bad loans in Q3.
Brazil politics (binary): the first round is Oct 4 and a runoff, if needed, is Oct 25 (calendar knowledge, not tool-confirmed). Investors will focus on fiscal credibility. A market-friendly result could reverse the recent spread widening and real weakness. A contested or fiscally worrying one could push USD/BRL above its 5.24 August high.
Oil (secondary): Brazil is a net oil exporter, which cushions its trade balance somewhat. But the oil-driven Fed tightening and strong dollar effect currently dominates.

5. Catalyst calendar¶

Date	Event	Why it matters for MELI
Sun Oct 4	Brazil general election, 1^st round [calendar knowledge]	Opening-gap risk on Monday Oct 5
Mon Oct 5	First trading reaction; Fed currency data for Sept 28–Oct 2 released	Confirms or rejects pre-election currency stress
~mid-Oct	US September CPI [approximate date]	A hot print could revive hike pricing and push the 10Y back toward 5.3%
Oct 25	Brazil runoff, if needed [calendar knowledge]	Second political event
Oct 27–28	FOMC [Fed's published calendar]	Hike or hold after the Sept 16 hike
Late Oct / early Nov	`MELI` Q3 2026 earnings [date not confirmed by tools]	Currency boost against credit-quality and margin scrutiny
Ongoing	Iran war and oil headlines	Inflation, then Fed, then real yields

6. Scenarios and levels to watch¶

These are considerations for the desk, not trade calls.

Relief scenario: a market-friendly Brazil result, fading Fed hike pricing and oil de-escalation. Signals: USD/BRL back to about 5.08–5.10, Latin American credit spreads below about 2.2%, 10Y below 5.0%. MELI's underperformance could then reverse sharply, which is a squeeze risk for anyone short MELI against the NASDAQ.
Stress scenario: a fiscally worrying Brazil outcome, hot CPI or oil above $107. Signals: USD/BRL above 5.24, Latin American credit spreads above 2.5%, US high-yield spreads above 3.5%, 10Y above 5.29% and real yields above 2.93%. In that case MELI likely keeps derating.
Positioning: event risk is concentrated in the next 72 hours and again in late October. With the VIX at 16 against widening spreads, equity volatility looks cheap relative to credit, so defined-risk structures or reduced size into Oct 4–5 fit what the data shows.

7. Data gaps¶

Prediction markets: all three queries (Brazil election, Fed rate cut, recession 2026) were withheld for this date. I have no market-implied odds.
MELI news: headlines only, no article bodies, no MELI price or volume data. The July–August news window was unavailable, so I have no Q2 earnings coverage.
Unavailable series: Argentine peso and inflation, Brazil long-term yields, Brazil CPI, S&P 500.
Not tool-confirmed: Brazil election details and candidates, the FOMC calendar and MELI's earnings date all come from general background knowledge.

8. Summary table¶

Theme	Key data / evidence	Direction for MELI	What to watch
MELI relative performance	Fell on an up day (Oct 1–2) while NASDAQ +1.19% to 27,191; September underperformance	🔴 Negative	Whether it decouples from the NASDAQ after the Brazil vote
Valuation	"Looks rich relative to earnings" (Simply Wall St.)	🔴 Negative given current rates	Moves in real yields
Fintech / credit	Lending growth praised (Zacks); Nu "imploding"; credit-quality doubts	🟡 Mixed	Q3 credit margins and bad loans; Nu stabilizing
Fed policy	Hiked to 3.75–4.00% (Sept 17); effective rate 3.88%; 2Y 90bp above it	🔴 Negative	Sept CPI; Oct 27–28 FOMC
Hike expectations	Faded Oct 2 after +29K payrolls and 4.2% unemployment; Zandi warning	🟢 Positive (relief)	Whether the relief carries into October data
Treasury yields	10Y 5.24% (peak 5.29%, highest since about 2007); +111bp year over year	🔴 Strongly negative	5.0% pivot; 5.29% breakout level
Real yields	10Y TIPS 2.88% (+44bp in September); breakevens flat at 2.36%	🔴 Strongly negative	Above 2.93% means more multiple compression
Oil / Iran war	WTI $96 (peak $107 Sept 15; $114.58 Apr 7); 16% daily swings	🔴 Negative (via inflation and the Fed)	Above $107 hawkish; below $85 relief
US inflation	CPI 3.35% y/y (Aug, +0.40% m/m); core PCE 3.0% y/y	🔴 Negative	Mid-October CPI release
US growth / labor	Q2 GDP about 2.2% annualized; claims 197K; sentiment 51.7	🟡 Neutral	Slowdown supports a peak-rates story
Credit spreads	US high-yield 3.24% (+56bp); Latin America corporate 2.41% (+51bp in 6 days)	🔴 Negative	Latin America above 2.5% stress; below 2.2% relief
Equity volatility	VIX 16.39, low relative to credit	⚠️ Complacency risk	Equity volatility catching up with credit
US dollar	Broad index +2.1% since Sept 9 to 120.33	🔴 Negative	Dollar trend after the FOMC
Brazilian real	5.19 (−2% in September); Q3 average about 5% stronger year over year	🟡 Q3 boost, recent weakness	5.24 break (bearish) or 5.08 (relief)
Mexican peso	17.69 (−4.7% in 3 weeks); Q3 average about 8.8% stronger year over year	🟡 Q3 boost, recent weakness	Back below 17.2 means stabilizing
Brazil rates	Interbank 15.0% to 14.06% (about −95bp since Feb)	🟢 Positive (funding costs, demand)	Whether Brazil's central bank pauses after the Fed hike
Brazil election	1^st round Oct 4; runoff Oct 25 [calendar]	⚠️ Binary, high impact	Monday Oct 5 moves in the real, Brazilian stocks and `MELI`
Q3 earnings	Late Oct / early Nov [unconfirmed]; currency boost computed	🟡 Mixed	Growth helped by FX against credit and margin quality
Net assessment	Macro headwinds and event risk outweigh the offsets	🔴/🟡 Near-term negative to neutral; binary	Election → CPI → FOMC → earnings sequence

Fundamentals Analyst¶

MELI (MercadoLibre, Inc.): Fundamental Analysis Report¶

As of 2026-10-03. Exchange: NASDAQ (NMS). Sector: Consumer Cyclical / Internet Retail. Latest reported period: Q2 2026 (quarter ended 2026-06-30). Source: SEC EDGAR, using values as filed by 2026-10-03. Figures are USD millions unless noted.

1. Summary¶

MELI's revenue growth is speeding up, but it is earning less on each dollar of sales.

Revenue growth has picked up for four straight quarters. It went from +33.8% YoY in Q2'25 to +49.8% in Q2'26. Trailing-twelve-month (TTM) revenue is $35.2B, up 46%.
Profits are moving the other way. Operating income fell 19.9% YoY in Q1'26 and 17.2% in Q2'26. Operating margin dropped from 12.2% to 6.7%. TTM EPS is $36.77, below FY2025's $39.40.
Gross margin fell to 40.9% in Q2'26, down 4.67 points YoY. That is the 5^th straight quarter of YoY decline, and the drop is getting bigger.
The balance sheet is growing faster than revenue and carrying more debt relative to equity. Total assets rose 56% YoY to $51.4B. Liabilities/equity has risen five quarters in a row to 5.56x. The current ratio (current assets ÷ current liabilities) is 1.12x, the lowest since at least 2022.
Reported cash flow looks very strong, but it overstates what shareholders actually earn. TTM operating cash flow (OCF) is $13.9B and free cash flow (FCF) is $12.4B. For a lender, these numbers are inflated by how loans and customer funds are accounted for (see §7).
There are early signs margins may be bottoming. In Q2'26, operating income rose 11.8% from Q1'26 and operating margin held at about 6.7–6.9%. Q3'26 faces an easier comparison (Q3'25 margin was 9.8%), so it is the key test.

2. Data limits and method (read first)¶

Item	Status	What it means
Profile and valuation data (market cap, P/E, 52-week range)	Withheld for this date	Price-based metrics need quote data from another source; per-share inputs are in §8
Insider transactions	Withheld (the feed has no filing dates)	No insider signal available
New filings in the past week	None; latest is the Q2'26 10-Q	Fundamentals did not change this week; Q3'26 is not yet reported
"Revenue" line	Changes definition from 2023	Before 2023, the tool's Revenue row equals gross profit plus cost of revenue (e.g., FY2020: 1,709 + 2,265 = 3,974). From 2023 on it doesn't: it reports a narrower revenue figure (Q2'26: $7,055M). This report uses gross profit + cost of revenue as total revenue. That matches MELI's reported FY2024 total of $20,777M. The left-out portion is most likely interest income from Mercado Pago lending (my inference)
Q4'24 and Q4'25	Missing from the quarterly data	Calculated as full year minus first nine months (marked *)
Cash flow	Reported as year-to-date totals	Individual quarters calculated by subtraction
FY2022–23 annual figures	Appear restated in later filings	FY2022 quarters sum to $10,537M vs $10,780M in the annual figure; growth rates for those years are approximate

3. Company profile¶

MercadoLibre is Latin America's largest e-commerce and fintech business, mainly in Brazil, Mexico and Argentina. - Commerce: the online marketplace, Mercado Envíos logistics, advertising, and goods it sells directly itself (first-party, or "1P", retail). - Fintech (Mercado Pago): payments, consumer and merchant loans, credit cards, and asset management.

Financially, MELI now looks more like a lender than a retailer: liabilities are 85% of assets, and credit appears to be its fastest-growing revenue source.

Background not from the tools: founder Marcos Galperin was due to hand the CEO role to Ariel Szarfsztejn in January 2026, per a 2025 announcement. Please verify.

4. Income statement: quarterly trend¶

Quarter	Total revenue	YoY	Gross profit	Gross margin	Operating income	Operating margin	Net income	Net margin	Diluted EPS
Q2'24	5,073	+41.5%	2,365	46.6%	726	14.3%	531	10.5%	10.48
Q3'24	5,312	+35.3%	2,439	45.9%	557	10.5%	397	7.5%	7.83
Q4'24*	6,059	+37.4%	2,749	45.4%	820	13.5%	639	10.5%	~12.60
Q1'25	5,935	+37.0%	2,771	46.7%	763	12.9%	494	8.3%	9.74
Q2'25	6,790	+33.8%	3,094	45.6%	825	12.2%	523	7.7%	10.31
Q3'25	7,409	+39.5%	3,209	43.3%	724	9.8%	421	5.7%	8.32
Q4'25*	8,759	+44.6%	3,784	43.2%	889	10.1%	559	6.4%	~11.03
Q1'26	8,845	+49.0%	3,862	43.7%	611	6.9%	417	4.7%	8.23
Q2'26	10,169	+49.8%	4,159	40.9%	683	6.7%	466	4.6%	9.19

YoY growth by line

Metric	Q2'25	Q3'25	Q4'25*	Q1'26	Q2'26
Revenue	+33.8%	+39.5%	+44.6%	+49.0%	+49.8%
Gross profit	+30.8%	+31.6%	+37.7%	+39.4%	+34.4%
Operating expenses (gross profit − operating income)	+38.4%	+32.0%	+50.1%	+61.9%	+53.2%
Operating income	+13.6%	+30.0%	+8.4%	−19.9%	−17.2%
Net income	−1.5%	+6.0%	−12.5%	−15.6%	−10.9%

Findings

The revenue speed-up is real, not a side effect of my revenue definition. The tool's narrower revenue line shows the same pattern: +27.6% in Q2'25 rising to +46.9% in Q2'26. Q1'26 revenue ($8,845M) was even slightly higher than Q4'25 ($8,759M), which is normally the strongest quarter; Q1'25 fell 2% from Q4'24. I can't separate out currency effects with these tools.
Revenue is shifting toward credit. The gap between total and narrower revenue (likely mostly interest income from lending) was about $3,114M in Q2'26. That is up 56.7% YoY and now about 30.6% of revenue, up from 25.8% in Q2'24.
Where the margin went.
Q2'26: operating margin fell 5.43 points YoY. Gross margin explains 4.67 points; operating expenses growing faster than revenue explain 0.76.
Q1'26: operating margin fell 5.95 points, split 3.03 from gross margin and 2.93 from operating expenses.
In Q2, cost of revenue grew 62.6% against revenue growth of 49.8%, so the pressure has moved from operating expenses into cost of revenue.
Likely causes (consistent with the data, but the tools don't break them out):
- shipping subsidies;
- more lower-margin 1P sales;
- the cost of funding loans;
- upfront loan-loss provisions under CECL, the US accounting rule that books expected losses when a loan is made. Fast loan growth therefore depresses near-term margins, and margins can recover when growth slows.
Quarter-on-quarter, things steadied.
From Q1'26 to Q2'26, revenue rose 15.0%, operating income 11.8% and EPS 11.7%.
Operating margin barely moved (6.9% to 6.7%). Operating expenses fell 2.58 points as a share of revenue, offsetting a 2.76-point gross margin decline.
Items below operating income softened the blow. Net income was 68% of operating income in Q2'26, up from 63% in Q2'25, so EPS fell less than operating income.
Margins are far below their peak. Quarterly operating margin reached about 20% in Q3'23, and gross margin was 50.2% for FY2023 (7.5 points above the current TTM level). That leaves room for recovery, but some of the decline may be permanent if competition is the cause.

5. Financial history: annual¶

FY	Total revenue	YoY	Gross margin	Operating income	Operating margin	Net income	Diluted EPS	OCF	Capex	FCF
2018	1,440	+18.3%	48.4%	−69	−4.8%	−37	−0.82	231	93	138
2019	2,296	+59.4%	48.0%	−153	−6.7%	−172	−3.71	451	137	314
2020	3,974	+73.1%	43.0%	128	3.2%	−1	−0.08	1,182	247	935
2021	7,069	+77.9%	42.5%	441	6.2%	83	1.67	965	573	392
2022	10,780	+52.5%	48.2%	1,069	9.9%	482	9.53	2,940	454	2,486
2023	15,107	+40.1%	50.2%	2,207	14.6%	987	19.46	5,140	509	4,631
2024	20,777	+37.5%	46.1%	2,631	12.7%	1,911	37.69	7,918	860	7,058
2025	28,893	+39.1%	44.5%	3,201	11.1%	1,997	39.40	12,116	1,343	10,773
TTM to Q2'26	35,182	+46.0%	42.7%	2,907	8.3%	1,863	36.77	13,905	1,496	12,409

The history falls into three phases: 1. 2017–2019, first investment period: operating losses of $69M (2018) and $153M (2019). It was funded by a roughly $1.9B equity raise in Q1'19, which lifted equity from $337M to $2,214M (financing inflow that quarter: $1,975M). 2. 2020–2023, margins expand: operating margin rose from 3.2% to 14.6%, and EPS went from −$0.08 to $19.46. Operating income dropped to $335M in Q4'23 from $785M in Q3'23; at the time this was attributed to a one-off Brazilian state tax charge (DIFAL). 3. 2024–2026, second investment period: operating margin went 12.7%, then 11.1%, then 8.3% TTM, while growth picked up again. FY2025 EPS grew only 4.5%, after roughly doubling in both 2023 and 2024. TTM EPS is now down 9.2% YoY (operating income −2.0%, net income −9.3%).

Compound annual growth: revenue about 48.7% a year over 2020–25 and 38.9% over 2022–25; EPS about 60.5% a year over 2022–25.

Takeaway: MELI has done this before: it gave up margin to buy growth, then expanded margins sharply. This time margins stay positive, but the balance sheet is much more dependent on lending.

6. Balance sheet¶

Date	Total assets	Current assets	Cash	Total liabilities	Current liabilities	Equity	Current ratio	Liabilities / equity	Equity / assets
2023-12-31	17,612	14,260	2,556	14,541	11,263	3,071	1.27x	4.73x	17.4%
2024-12-31	25,196	20,142	2,635	20,845	16,603	4,351	1.21x	4.79x	17.3%
2025-03-31	27,682	21,740	2,977	22,678	18,065	5,004	1.20x	4.53x	18.1%
2025-06-30	32,948	26,062	3,008	27,235	21,750	5,713	1.20x	4.77x	17.3%
2025-09-30	36,691	28,795	2,582	30,473	24,522	6,218	1.17x	4.90x	16.9%
2025-12-31	42,667	33,573	3,670	35,919	28,633	6,748	1.17x	5.32x	15.8%
2026-03-31	46,934	37,123	3,677	39,653	31,969	7,281	1.16x	5.45x	15.5%
2026-06-30	51,356	40,782	3,649	43,522	36,372	7,834	1.12x	5.56x	15.3%

Findings

Assets are growing faster than revenue.
Total assets were up 55.9% YoY in Q2'26 and up 69.3% in FY2025, when revenue grew 39.1%.
The growth is driven by lending, and probably also by currency translation.
Quarterly asset growth slowed to about 9–10% in the first half of 2026, from 19% in Q2'25 and 16% in Q4'25. If that means slower loan growth, the upfront provision drag on margins could ease.
Leverage is rising. Liabilities/equity has gone up five quarters in a row, from 4.53x to 5.56x, and equity fell from 18.1% to 15.3% of assets. That level is moderate for a lender, but the direction matters if loan quality worsens.
Liquidity is tighter.
The current ratio of 1.12x is the lowest in the series (1.28x in 2022).
Working capital fell $744M from Q1'26 to $4,410M, because current liabilities grew 13.8% that quarter against 9.9% for current assets.
Short-term liabilities rose to 83.6% of all liabilities, from 79.7% at the end of 2025. Long-term liabilities fell $534M in Q2, possibly debt moving closer to maturity.
Cash is a small share of obligations. Cash of $3.65B is flat on the quarter and up 21% YoY, but it covers only about 10% of current liabilities (13.8% a year ago). The tools don't break out loans receivable, investments or debt, so I can't compute net debt or bad-loan levels.
Equity is moving with currencies, not just profits.
Over the last twelve months, equity grew $2,121M while net income was $1,863M, so about $258M came from other items, most likely currency gains.
In FY2024 it went the other way: equity grew $1,280M on $1,911M of net income, about $631M lower, consistent with a weaker Brazilian real and/or share buybacks.
Book value is therefore sensitive to currency moves.
The share count is flat at about 50.7M diluted shares (net income ÷ EPS) and has barely moved since Q1'24. There is no dilution and no meaningful net buyback, so EPS moves in line with net income.

7. Cash flow¶

Period	OCF	Capex	FCF (OCF − capex)	Investing cash flow	Financing cash flow
Q1'25	1,031	272	759	−1,842	+465
Q2'25	2,917	287	2,630	−1,225	+613
Q3'25	2,959	357	2,602	−1,111	+444
Q4'25*	5,209	427	4,782	−2,001	+1,382
Q1'26	2,075	271	1,804	−1,471	+473
Q2'26	3,662	441	3,221	−2,691	+630
1H26 vs 1H25	5,737 vs 3,948 (+45.3%)	712 vs 559 (+27.4%)	5,025 vs 3,389 (+48.3%)	−4,162 vs −3,067	+1,103 vs +1,078
FY2024 / FY2025	7,918 / 12,116	860 / 1,343	7,058 / 10,773	−8,287 / −6,179	+1,959 / +2,904

Findings

Reported cash generation is very strong. TTM OCF is $13.9B (up 64% YoY) and TTM FCF is $12.4B (up 68%).
Reported FCF is not money shareholders could take out. OCF is about 7.5x net income on a TTM basis (6.1x in FY2025). For a lender, that gap usually comes from three things:
loan-loss provisions are non-cash, so they get added back to OCF;
money that customers hold in their accounts flows in as operating cash;
new lending is counted under investing, which was −$7.3B TTM.

A stricter measure, OCF plus investing cash flow, was $1.58B in 1H26 vs $0.88B in 1H25. That is improving, but much smaller than the headline. 3. Most of the cash doesn't show up as ordinary cash. - In FY2025, operating, investing and financing flows added up to +$8.84B, yet cash on the balance sheet rose only $1.04B. That is a gap of about $7.8B (about $1.5B in FY2024 and $2.7B in 1H26). - Most of the cash generated likely sits in restricted cash or customer-fund accounts, or was offset by currency moves, so it is not freely available. This should be checked against restricted cash in the 10-K. 4. Capex was $1.50B TTM, about 4.3% of revenue. Q2'26 capex of $441M was up 54% YoY, consistent with building out logistics and technology. If the tool's capex figure leaves out capitalized software, real capex is higher. 5. Growth is funded with borrowing and deposits, not new shares. Financing cash flow has been positive every year since 2024 (+$2.9B in FY2025).

Metric	TTM to Q2'26	FY2025	FY2024
Return on equity (average equity)	27.5%	36.0%	51.5%
Return on assets (average assets)	4.4%	5.9%	8.9%
Revenue ÷ average assets	0.83x	0.85x	0.97x
Average assets ÷ average equity	6.2x	6.1x	5.8x

Return on equity is falling because net margin is shrinking and revenue per dollar of assets is lower. Rising leverage only partly offsets this.

Per-share inputs (about 50.7M diluted shares) - EPS: TTM $36.77; FY2025 $39.40; Q2'26 annualized (×4) $36.76. - Book value per share $154.5; TTM revenue per share $694; TTM OCF per share $274.

Valuation formulas (my tools have no share price) - P/E (TTM) = price ÷ 36.77 - Price/book = price ÷ 154.5 - Price/sales = price ÷ 694 - Market cap ≈ price × 50.7M - Example at a hypothetical $2,000 per share: about 54x TTM earnings, 12.9x book value, 2.9x sales. - Don't use a headline FCF yield, for the reasons in §7.

FY2026 EPS math - First-half 2026 EPS was $17.42, down 13.1% from $20.05 in 1H25. - If the second half matches 2H25 ($19.35), FY2026 EPS would be about $36.77, down 6.7%. - Matching FY2025's $39.40 would need second-half EPS of $21.98, up 13.6% YoY.

9. Insider activity¶

Not available. The data was withheld for this date because the feed has no filing dates. There is no insider buying or selling signal to report; Form 4 filings with filing dates would need to be checked separately.

10. Catalysts and what to watch¶

Q3'26 results (quarter ended 2026-09-30). MELI usually reports in late October or early November; the tools don't confirm the exact date.

The comparison is easier than in the first half. Q3'25 had operating income of $724M, a 9.8% operating margin and EPS of $8.32, versus a 12.2% margin in Q2'25.

Q3'26 scenario (revenue +45%, about $10.7B)	Operating margin	Implied operating income	vs Q3'25
Margins keep falling	6.0%	~$645M	−11%
Margin stays at Q2'26 level	6.7%	~$720M	about flat
Margins turn up	7.5%	~$806M	+11%

Good signs - Operating margin of about 7.5% or more with revenue growth of 40% or more, which would be the first YoY rise in operating income in three quarters. - Gross margin holding at about 41% or higher. - Operating expenses keep falling as a share of revenue.

Warning signs - Operating margin below about 6–6.5%, or gross margin below 40%, despite the easier comparison. - Liabilities/equity heading toward 6x. - Current ratio below 1.10x.

What these tools can't show: loan quality (bad-loan rates, provisions), growth excluding currency effects, and debt maturities. These will decide whether margins can recover.

11. Bull vs bear case¶

Bull case (supported by the data)	Bear case (supported by the data)
Revenue growing about 50% YoY on a $35B base; gross profit up 34–39%	Operating income down 17–20% YoY for two quarters; TTM EPS below FY2025
Record operating and free cash flow; return on equity still about 27.5%	Gross margin down 4.67 points YoY, and the decline is getting bigger
Has rebuilt margins after a past investment period (−6.7% in 2019 to 14.6% in 2023)	Leverage up five quarters in a row; current ratio at a series low; more short-term funding
Q2'26 steadied quarter-on-quarter; easier comparisons from Q3'26	Reported FCF overstated by lending accounting; about $7.8B of FY2025 cash flow not visible as ordinary cash
No share dilution; book value up 37% YoY	A lending-heavy balance sheet is exposed to Latin American economic and currency swings

Overall: mixed. Earnings are falling while the business grows very fast, so Q3'26 needs to show margins stabilizing. If margins hold at Q2'26 levels, YoY operating income should turn flat to positive. If margins fall again despite the easier comparison, the earnings decline continues. The trade decision is left to the decision agent.

12. Key metrics summary¶

Category	Metric	Latest value	Comparison	Signal
Growth	Total revenue, Q2'26	$10,169M	$6,790M in Q2'25 (+49.8%)	🟢 Faster growth 4 quarters running
Growth	TTM revenue	$35,182M	$24,096M (+46.0%)	🟢
Growth	Likely credit/interest income, Q2'26	~$3,114M (30.6% of revenue)	+56.7% YoY	🟡 Fastest-growing piece; more credit risk
Profitability	Gross margin, Q2'26	40.9%	45.6% a year ago (−4.67 pts)	🔴 Decline getting bigger
Profitability	Operating margin, Q2'26	6.7%	12.2% a year ago (−5.43 pts)	🔴
Profitability	Operating income, Q2'26	$683M	−17.2% YoY; +11.8% vs Q1'26	🟡 Steadier quarter-on-quarter
Profitability	Net income / EPS, Q2'26	$466M / $9.19	$523M / $10.31 (−10.9%)	🔴 Third straight YoY decline
Earnings	TTM EPS	$36.77	FY2025 $39.40; prior-year TTM $40.48 (−9.2%)	🔴
Returns	Return on equity (TTM)	27.5%	36.0% FY2025; 51.5% FY2024	🟡 High but falling
Balance sheet	Total assets	$51,356M	+55.9% YoY	🟡 Lending-driven growth
Balance sheet	Liabilities / equity	5.56x	4.77x a year ago; up 5 quarters running	🔴 Rising leverage
Liquidity	Current ratio	1.12x	1.20x a year ago; 1.28x in 2022	🔴 Lowest in series
Liquidity	Cash and equivalents	$3,649M	+21.3% YoY	🟢
Capital	Equity / book value per share	$7,834M / ~$154.5	+37.1% YoY	🟢 (sensitive to currencies)
Cash flow	TTM OCF / FCF	$13.9B / $12.4B	+64% / +68% YoY	🟢 Headline; 🟡 overstated (§7)
Cash flow	OCF + investing cash flow, 1H26	$1,575M	$881M in 1H25	🟢 Improving, much smaller than headline
Cash flow	TTM capex	$1,496M (4.3% of revenue)	+37% YoY	🟡 Investment phase
Shares	Diluted shares	~50.7M	Flat since 2024	🟢 No dilution
Insider	Transactions	Withheld	—	⚪ No signal
Valuation	P/E, price/sales, price/book	Needs share price	P/E = price ÷ 36.77; P/B = price ÷ 154.5; P/S = price ÷ 694	⚪ For the decision agent
Catalyst	Q3'26 results (late Oct/early Nov, estimated)	Comparison: operating income $724M, margin 9.8%, EPS $8.32	Margin ≥7.5% = turning up; ≤6% = still falling	⚠️ Key event

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for MELI: Opening Argument

The bear hasn't spoken yet, so I'll lay out my case and answer the objections I expect.

My thesis: MELI is a business in a deliberate investment trough, priced as if the trough were permanent. The pressures that crushed the multiple (rates, regional risk, an election) are starting to turn.

The disconnect this debate turns on¶

Over the past year, MercadoLibre's trailing revenue grew 46% and trailing gross profit grew 36%. Over the same stretch the stock fell 28% from its October 30, 2025 closing high of $2,360.76. The business got much bigger while the multiple got much smaller.

My math at $1,696.56, using about 50.7M diluted shares (flat since 2024):

	At the Oct-2025 high	Today
Price / trailing revenue	~4.6–5.0x	~2.4x
Price / trailing gross profit	~10–11x	~5.7x
Trailing P/E	~58x	~46x
Market cap	~$120B	~$86B

The ranges depend on whether you use trailing figures through Q2'25 or Q3'25.

When the market paid ~58x, the latest quarterly growth it had seen was 34–40%. Today it's 49.8%. You are being offered a faster-growing MercadoLibre at roughly half the price per dollar of gross profit.

1. Growth is accelerating, at $35 billion of scale¶

Revenue growth has sped up for four straight quarters: 33.8% → 39.5% → 44.6% → 49.0% → 49.8%, on a $35.2B trailing base.
This is not an accounting artifact. The narrower revenue line shows the same pattern (+27.6% → +46.9%).
Seasonality was broken. Q1'26 revenue was higher than Q4'25, which is normally the peak quarter.
Mercado Pago is a second engine. The credit-related line was about $3.1B in Q2, up 56.7%, and is now about 31% of revenue. That's why Zacks is running "Credit Growth Strengthens Its Fintech Ecosystem."

Currency helped somewhat, and I'll concede that. But on competition: companies losing share to Shopee, Temu or Amazon don't accelerate to 50% growth. They slow down. MELI's moat is the whole stack: - the marketplace - its own logistics network - payments - credit underwritten on its own transaction data - advertising

A rival has to rebuild all five to compete on equal terms, and the revenue line says nobody has.

2. Margins: the bear's best card, and why I'd rather own it than fear it¶

The compression is real: - Operating margin fell from 12.2% to 6.7%. - Gross margin is down 4.67 points. - Operating income is down 17% year on year. - Trailing EPS ($36.77) is below FY2025's $39.40.

But look at what the fundamentals report names as the likely causes: - shipping subsidies - more first-party (1P) retail - funding costs - loan-loss provisions booked upfront under CECL accounting

Each of these is a choice to buy growth, not a sign that demand is breaking. CECL matters most. It books expected lifetime losses on the day a loan is written, so a fast-growing loan book makes current earnings look worse than the loans' real economics.

Three reasons the trough is likely now:

The provisioning drag is easing. Total assets grew about 9–10% per quarter in 1H26, down from 19% in Q2'25 and 16% in Q4'25. A slower-growing loan book means a smaller upfront hit.
The sequential decline has stopped. In Q2:
operating income rose 11.8% from Q1
operating expenses fell 2.58 points as a share of revenue
operating margin has held around 6.7–6.9% for two quarters
Q3 has the easiest comparison of this cycle. Q3'25 had a 9.8% margin, $724M of operating income and $8.32 EPS.
Simply holding Q2's margin on ~45% growth keeps operating income flat year on year.
At the 64–68% conversion from operating income to net income seen over the past year, that's roughly $9.10–9.66 EPS, up 9–16%. That would end three straight quarters of year-on-year EPS declines.
Q3 also gets a currency boost: the Brazilian real averaged about 5% stronger and the Mexican peso about 9% stronger year on year in Aug–Sep.

We've seen this before: - MELI ran an operating margin of −6.7% in 2019 to fund growth, then reached 14.6% by 2023. - EPS went from −$3.71 to $19.46 to $37.69 in 2024. - This cycle is gentler. Margins never went negative, and return on equity is still 27.5% at the trough.

So what is the 46x P/E really pricing? Here is my illustrative math:

Scenario	EPS	P/E at today's price
Margin back to FY2025's 11.1% (not the 14.6% peak), on today's revenue	~$49	~34x
Margin back to FY2024's 12.7%, on today's revenue	~$56	~30x
Either margin, plus one more year of 30% growth (well below today's ~50%)	~$64–73	~23–26x

46x is a multiple on trough earnings of a business still growing at elite rates. That is not the same as expensive.

3. Balance sheet and cash: I'll concede the right things¶

Headline free cash flow ($12.4B) overstates the cash shareholders could actually take out. Lending and customer-fund accounting inflate it, so I won't lean on it. A stricter measure, operating plus investing cash flow, rose to $1.58B in 1H26 from $0.88B, up 79%.
Liabilities of 5.56x equity sound alarming if you think of MELI as a retailer. It now has a fintech balance sheet. Equity is 15.3% of assets, a thicker cushion than a typical bank holds.
There has been no dilution. The share count has stayed flat while book value grew 37% year on year. In 2019, growth needed a roughly $1.9B equity raise; this cycle is self-funded.

The legitimate open question is credit quality. The packet has no delinquency data, and Nu's slide shows how fast sentiment can turn. Q3 will answer it. Meanwhile Brazil has eased rates by roughly 95bp since February, which lowers Mercado Pago's funding costs and takes pressure off borrowers.

4. So why is the stock falling? Rates, region and an election, not the business¶

The news flow has no company-specific bad news: no guidance cut, no regulatory action, no M&A. What the data does show: - The 10-year Treasury yield hit 5.29%, the highest since about 2007. - About 90% of September's rise came from real yields, which hurts long-duration growth stocks the most. - The Fed hiked in mid-September and the dollar rallied 2.1%. - Latin American corporate credit spreads widened 51bp in six sessions before the election. - Nu's slump dragged the whole regional fintech group down with it.

That is a discount-rate and regional-risk story, and those reverse. The first cracks are showing: - September payrolls were +29K, the three-month average is about 51K, and unemployment is 4.2%. - Rate-hike expectations faded on October 2. - 10-year inflation breakevens are stable at 2.36%.

The macro report's own conclusion: if the 10-year yield falls back under about 5%, MELI is among the names with the most to gain.

Brazil votes today, and I won't pretend to know the result. But a lot of pre-vote hedging is already in the price: wider spreads, a weaker real, and MELI's lowest close since June earlier this week. In 2022, the last polarized Brazilian election year, MELI grew revenue about 50% and lifted operating margin from 6.2% to 9.9%. The business doesn't run on the electoral calendar.

5. The chart: I'll grant the trend, but I'll take the location¶

The bear will point to: - weekly and daily SuperTrend both pointing down - a failed golden cross - a likely death cross around October 21

Fair enough; this isn't a momentum buy. But a death cross is just arithmetic on a decline that has already happened. For an investor, where the price sits matters more:

The monthly SuperTrend is still up. Its stop at 1,549.51 sits right on May's lowest close (1,546.81). The technical report itself calls 1,546–1,600 "a zone for longer-term buying."
Short-term exhaustion signals are piling up:
the daily TD 9 buy setup is complete
RSI is 33.5
price is near the lower Bollinger band
ATR fell from 70 to 55, which points to orderly selling rather than panic
the latest bar was an inside day on light volume
OBV held above its September 28 low even as price made a lower low
The risk/reward is lopsided:
Downside is about 9% to the monthly stop, or 12% to May's intraday low.
Upside is about 18% just to retest the September 2 close, and 39% to revisit last October's high.
The gap reactions are getting smaller. Of the last three earnings-type gap days (−8.05%, −12.70%, −4.82%), the most recent was the mildest.

Sentiment points the same way. Retail is posting "DEAD money," "IT'S OVER" and "$100 DOLLAR STOCK," and only 31% of posts are bullish. That looks washed out, not crowded. Meanwhile, institutional framing stays constructive. The sample is small and confidence is low, I'll grant that. But "good business, bad stock" setups tend to resolve in the business's favor.

How I'd own it, and what proves me wrong¶

I'd build the position in stages: 1. A starter position now, or after Monday's election reaction. 2. Add in the 1,546–1,600 zone. 3. Add again if price reclaims 1,731–1,745.

Size each piece so it survives a gap of about 3× ATR. The election runoff, CPI, the FOMC meeting and Q3 earnings all land in the next four to five weeks.

I'm wrong if: - Q3 operating margin comes in below about 6%, or gross margin below 40%, against the easiest comparison of the cycle - Q3 credit metrics show real deterioration - a month closes below 1,549.51

Bear, here's what you need to explain. This platform grows revenue about 50% and gross profit about 34%. It earns a 27.5% return on equity at trough margins and hasn't diluted shareholders. From 2019 to 2024 it turned an investment phase into soaring earnings. Why should it trade under 6x gross profit, about half what the market paid eleven months ago for a slower-growing version of the same company? "Rates are high" and "the chart is down" describe the last quarter. They don't describe the next five years. Bull Analyst: # Bull Rebuttal: MELI Has Climbed Out of This Exact Trough Before

Bear, that's the strongest case against MELI I've seen. I re-ran your arithmetic and nearly all of it checks out, so I won't fight your numbers. I'll fight three conclusions you built on them, because each one breaks down on data from this same packet:

that a gross-margin recovery would be unprecedented, because the opex lever is already spent;
that my CECL mechanism failed its test in Q2;
that Q3 seasonality points to another leg down.

Then I'll fix my one-sided scenario table, which was a fair hit. Your downside needs as many things to go wrong as my upside needs to go right.

Two structural points below come from MELI's filings, not this packet: where MELI books loan-loss provisions, and how its Brazilian credit is funded. Both can be checked in the Q2 10-Q.

1. "We've never seen a gross-margin trough." We have. It was 2021.¶

You wrote: "We've seen an operating-expense trough before. This is a gross-margin trough." Compare like with like, annual against trailing:

	FY2021	TTM to Q2'26
Gross margin	42.5%	42.7%
Operating margin	6.2%	8.3% (Q2 alone: 6.7%)
Operating income per $1 of gross profit	14.7¢	19.4¢ (Q2 alone: 16.4¢)

Today's P&L closely resembles 2021's and is slightly better on every line. Here's what followed: - 2022: gross margin jumped 5.7 points to 48.2%. Operating margin reached 9.9%. - 2023: gross margin reached 50.2% and operating margin 14.6%. Operating income per dollar of gross profit hit 29.1¢, double 2021's. - Operating margin gained 8.4 points from 2021 to 2023, and 7.7 of them came from gross margin. Opex barely moved, from 36.3% to 35.6% of revenue.

Your "19 of 21 points came from opex" compares 2019 directly with 2023 and skips the years in between. Gross margin fell 5.5 points from 2019 to 2021, then recovered 7.7 points in two years. The lever you say is untested did most of the work in the last recovery. You also said a recovery would have to reverse five straight quarters of declines. In 2022, MELI reversed three straight years of gross-margin decline in a single year.

You even cited it yourself: "Gross margin rose from 42.5% to 48.2% that year; today it's falling." It was falling in 2021 too, from 43.0% to 42.5%. The recovery came the year after the trough, during a polarized Brazilian election and a Fed hiking cycle.

The road back doesn't require any record either: - Your 44.5% gross-margin hurdle isn't a record. It's FY2025's gross margin. - Put gross margin back at Q1'26's 43.7%, one quarter ago, and opex at FY2024–25's 33.4%. That gives a 10.3% operating margin. MELI reported both numbers within the last year.

You called this trough "harsher where it counts." What counts for owners is operating income. The 2019 trough was −6.7%. This one is +6.7%, with a 27.5% ROE.

On "bought" growth: - Negative incremental margins are what investment years look like. 2019's were negative too, and 2023's incremental operating margin was 26%. - Paying to defend share holds growth steady. It doesn't push the narrower revenue line, which likely excludes credit income, from +27.6% to +46.9%. That's MELI taking share with the logistics and payments stack it owns. - You're right that credit income softens seasonality. The narrower line is the cleaner signal.

2. The CECL test: you graded it on the wrong line¶

MELI books its provision for doubtful accounts as an operating expense, not in cost of revenue. The gross line carries shipping, 1P product costs and funding costs. So the right test is whether the opex drag eased when balance-sheet growth slowed. It did, in the quarter you picked: - Assets added per $1 of revenue: $0.78 in Q2'25 against $0.43 in Q2'26, the lowest since Q1'25. - YoY asset growth: 69.5% in Q1'26, then 55.9% in Q2'26. - Your Q1-vs-Q1 comparison picks the one quarter where the growth rates matched. - On the YoY basis that drives YoY margins, balance-sheet growth slowed 14 points in a single quarter. - The opex drag on YoY operating margin fell from 2.93 points in Q1 to 0.76 in Q2. Opex also fell 2.58 points as a share of revenue from Q1. That could be provisions easing or plain leverage on a 15% revenue jump. Either way, it's what the bottom of a trough looks like.

One of your two "seasonal" examples, Q3'24, was an opex event. Opex jumped 3.1 points of revenue while gross margin slipped only 0.7. That's a provisioning spike, on the line where provisions sit.

So the open problem is the gross line. I expect it to stabilize for three reasons: - Funding costs. These sit in cost of revenue. A loan book in reais is funded in reais, mostly at rates linked to the interbank rate, which is about 95bp below February. The ICE LatAm index you cite measures spreads on dollar bonds. - Lapping. The YoY decline stepped up in Q3'25, from −1.0 to −2.6 points, so from Q3'26 that drop is in the comparison base. If gross margin merely holds Q2's 40.9%, the YoY decline roughly halves, to −2.4 points. - Mix. Faster-growing 1P puts the cost of goods above the gross line, and credit puts its funding costs there. A blended ratio that moves with mix doesn't prove worse unit economics, and neither of us can see segment margins in this packet.

I'll concede the number that bothers me most: Q2's 2.76-point drop in gross margin from Q1. That's why my 40% tripwire stays exactly where it is.

3. Your Q3 pattern rests on two years with two different causes¶

2023: Q3 was the year's peak, at roughly a 20% operating margin against 14.6% for the full year.
2024: the drop came from opex, the provisioning spike above.
2025: the drop came from gross margin, the step-down above.

Three years, three different stories. That's a run of specific investment steps, not a calendar effect. Even your own seasonal model shows the YoY gross-margin decline no longer widening: - Your 40.2% case is −3.1 points YoY. - Your 38.6% case is −4.7 points, matching Q2.

That's because Q3'26 laps Q3'25's own 2.3-point drop.

On EPS, you used Q3'25's 58% conversion of operating income to net income, the lowest in the quarterly series. - The last two quarters converted at 68%, and the trailing average is 64%. - At 64%, flat operating income gives about $9.10 of EPS, up 9%. - Flat after −20% and −17% isn't a failure to turn. It is the turn. Stocks move on whether the trend is improving, not just on its level.

4. Valuation: fixing my table, and showing what yours assumes¶

You were right that my table only pointed up. Here's one that doesn't. Price is the multiple times EPS over the next four quarters (Q3'26–Q2'27). I use the trailing 64% conversion, 50.7M shares, and your own multiples: 40x ("still a growth premium") and 35x.

Scenario	Revenue growth	Op margin	EPS	Multiple	Price	vs $1,696.56
Bear: margins fall again and growth halves	+25%	6.0%	~$33	35x	~$1,170	−31%
No margin recovery at all	+35%	6.7%	~$40	40x	~$1,610	−5%
Base: half of 2022's margin gain	+35%	8.5%	~$51	40x	~$2,040	+20%
Bull: roughly a 2022 repeat	+40%	10.3%	~$64	40x	~$2,570	+51%

Revenue growth of 35% is 15 points below today's and assumes the currency tailwind fades, as you argued. Each 5 turns of multiple moves the price about 12%.

Two things fall out of this: - With zero margin recovery and growth slowing to 35%, the stock is roughly flat at your own 40x. - Your −13% and −24% valuation rows hold EPS flat at $36.77. - At today's 6.7% margin, flat EPS needs revenue growth to fall to about 24%, half today's rate. - So your downside needs margins stuck, growth halved and the multiple compressed. That's three things going wrong at once, the mirror of what you charged my upside with.

On earnings yield versus TIPS: at FY2025's 11.1% margin on today's revenue, EPS is about $49. That's a 2.9% earnings yield, matching TIPS with zero growth assumed. A test that ignores growth would have ruled MELI out in 2021, at EPS of $1.67. EPS rose 5.7x the following year.

On "you're making the October-2025 buyers' argument": they paid 58x for near-peak margins, about 12% trailing. You're being offered 46x on trough margins. A high P/E on trough earnings is the opposite trade from a high P/E on peak earnings.

5. Credit, the balance sheet and "pick one framing"¶

Credit quality: conceded, there's no delinquency data.
CECL books expected lifetime losses when loans are written, so the P&L already carries the book as written.
A deteriorating book shows up first in provisions. Q2 opex, where they sit, fell as a share of revenue.
Q3 tests this.
Nu: it's a pure-play digital lender, and Goldman still expects its shares to double. MELI's credit is about 31% of revenue and is underwritten on its own commerce data. The read-across is sentiment.
Framing: MELI is both, so price it as a sum of the parts.
The leverage lens applies to the balance sheet that funds credit.
The earnings lens also covers commerce, ads and payments, which need far less equity per dollar of revenue.
Pricing the whole company at a bank's price-to-book ignores that.
I'll adopt your concern as a tripwire: if liabilities/equity reaches 6x or the current ratio falls below 1.10x, I cut.
Buybacks: the "loud retail demands" are seven posts from the same account you discounted when it tagged posts bullish. Reinvesting at a 27.5% trough ROE beats buying back stock. Book value grew 37% in a year, with no dilution.

6. "It's not rates": then it's region and election, two-thirds of my thesis¶

I named three forces: rates, region and election. Your NASDAQ comparison shows region and election doing the work: - Latin American corporate spreads widened 51bp in six sessions. - The peso fell 4.7%, and Nu kept sliding. - All of it came in the run-up to today's vote, with no MELI-specific negative event.

That's investors cutting regional risk ahead of a binary event, not a verdict on the business. The NASDAQ rally is AI-led. The macro report's own read is that AI tech is absorbing inflows while emerging-market fintech gets sold.

Your "first live test" was one session, the Friday before a Brazilian election weekend, and nobody adds Brazil risk into that. You said one payroll print isn't a pivot. One pre-election Friday isn't a test.

I'll concede that rates aren't a reliable near-term catalyst. I don't need them; the thesis rests on the earnings base.

7. Timing: we agree on the next move¶

You're right that there's been no capitulation, the first TD 9 failed and the bounces are shrinking. I'm not calling a V-bottom. But your preferred trade, shorting a failed bounce at 1,813–1,860, assumes a 7–10% rally first. We agree on the next move. We disagree about what comes after it.

You asked why pay for the answer before seeing it. I'm only paying for part of it, and you'd pay more for yours: - My starter is a quarter of the position. Half goes in at 1,546–1,600, which the technical report calls the longer-term buying zone. The last quarter waits for Q3. - One of your mind-changers is a daily close above about 1,860, 9.6% above today. The stock moved −8%, −12.7% and −4.8% on its last three earnings-type gap days. If Q3 lands well, it won't drift up to your entry; it can gap up instead. - Our tripwires are only about 1–1.5 points of margin apart. - Operating margin: 6% for me, 7.5% for you. - Gross margin: 40% for me, 41% for you. - If Q3 simply holds Q2's 6.7%, I'm adding while you're still waiting.

Revised plan¶

Starter (~25%) after Monday's election reaction, not before.
Main tranche (~50%) in the 1,546–1,600 zone.
Final tranche (~25%) when either of these happens:
Q3 confirms: operating margin of at least 6.7%, operating income flat to up YoY, and gross margin of at least 40%.
A daily close above 1,745 with RSI above 43.5.
Size each piece for a −13% gap, the worst this year, rather than 3× ATR. You were right on that.

I'm wrong, and I'll cut, if: - Q3 operating margin comes in below 6%, or gross margin below 40%; - credit metrics show real deterioration; - liabilities/equity reaches 6x, or the current ratio falls below 1.10x; - a month closes below 1,549.51.

Closing¶

You counted my concessions, so here are yours: - an exceptional franchise; - real growth; - no distress and no dilution; - real squeeze risk; - no short at this price.

We aren't debating the business. We're debating whether this trough is really a trough.

So here's my question. The last time MELI's gross margin was 42.5% and its operating margin was about 6%, operating margin reached 14.6% two years later. Operating income per dollar of gross profit doubled. What's different this time that makes that playbook impossible, and why should today's price assume it is? Bull Analyst: # Bull Rebuttal: Drop the Analogy. At $1,697, a Floor Is Enough.

Bear, that was your strongest round, and most of it checks out. Here is what I concede:

Gross margin hasn't stopped falling. Nothing in the packet says otherwise, and Q2's 40.9% is the dataset low.
I oversold CECL. With provisions in opex, it sits in the smaller part of Q2's compression: 0.76 of 5.43 points. "CECL matters most" was wrong.
None of my three gross-margin stabilizers has shown up in the level yet. That covers funding costs, lapping and mix.
My 2021 TIPS example was wrong. Real 10-year yields were negative that year.
My base case needs a fast step-up, to about 9% operating margin from Q4'26. Fair hit.
Being 75% invested before Q3 was too much. The revised plan in §6 fixes it.

None of this changes my call. Your closing question, "what shows gross margin has stopped falling?", tests for a re-rating. This price doesn't need a re-rating. It needs a floor.

So I'm dropping 2021 entirely. Using only this packet, I'll argue three things: 1. The floor is forming on the operating line. 2. At today's price, "no recovery" is already priced at your own multiple. 3. The September selloff came after the market had absorbed the Q2 print you're building on.

1. You asked me to name a line that stopped. Here are five.¶

This table compares Q1 to Q2 this year with the same seasonal step last year.

	2025: Q1 → Q2	2026: Q1 → Q2
Revenue, quarter on quarter	+14.4%	+15.0%
Operating income per $1 of gross profit (your metric)	27.5¢ → 26.7¢ (down)	15.8¢ → 16.4¢ (up)
Operating margin	12.9% → 12.2% (−0.7)	6.9% → 6.7% (−0.2)
Opex as % of revenue	33.8% → 33.4% (−0.4)	36.8% → 34.2% (−2.6)

The five lines:

Operating income per dollar of gross profit rose. That's your own metric. Last year it fell from Q1 to Q2.
Operating margin held within 0.2 points. Last year's seasonal slip was 0.7.
The opex ratio recovered by more than revenue growth explains.
Last year a revenue step of the same size improved the opex ratio by 0.4 points.
The other ~2.2 points this year are Q1's spike reversing, in the line where provisions sit.
At 34.2%, opex is back within about a point of 2025's 33.1–33.8%. That half of the problem has mostly closed.
The year-on-year declines are narrowing. Operating income went from −19.9% to −17.2%, and EPS from −15.5% to −10.9%.
Revenue per dollar of assets is flattening. It fell 0.12 over 2025 (0.97x to 0.85x), and only 0.02 in the six months since (0.83x).

Gross margin is the line that hasn't stopped. Two things about its shape matter:

It's falling in steps, not on a slope. The sequence is 45.6%, 43.3%, 43.2%, 43.7%, 40.9%: two drops with a three-quarter plateau between them. Steps fit discrete choices better than steady erosion. Examples would be a shipping threshold, a 1P push or a credit ramp. That's an inference, not proof.
In Q2 it moved almost one-for-one against opex. Gross margin fell 2.76 points and the opex ratio fell 2.58. When two lines offset like that, judge the quarter by the line that nets them. Operating margin moved 0.2.

One note on your cycle table. The "2021 bottom" of 42.5% is a full-year average, and an annual average always has at least one quarter at or below it. Setting our worst quarter against their average is the same calendar mixing you flagged in me.

2. Drop the analogy: "no recovery" is already in the price¶

No recovery doesn't mean flat earnings. Freeze operating margin at Q2's 6.7%, the row you weight most heavily. Here is operating income year on year:

Quarter	Laps a margin of	Operating income YoY at 6.7%
Q3'26 (revenue +45%)	9.8%	about flat
Q4'26 (+40–45%)	10.1%	−4% to −8%
Q1'27 (+35%)	6.9%	+31%
Q2'27 (+35%)	6.7%	+35%

You're right that the turn stalls in Q4. After that, the compression is in the base and earnings grow with revenue. The decline ends without any recovery at all.

Your "three flat years" mixes calendars. You list FY24, FY25 and FY26 on a fiscal basis. Your fourth point is my forward-twelve-month figure through mid-2027, which still includes two 2026 quarters that are lapping higher margins.

On your own fiscal calendar, frozen margins give FY2027 EPS of about $48. The assumptions: - 45% revenue growth in 2H26 and 35% in 2027 - your accepted 64% conversion of operating income to net income - 50.7M shares

That's about 30% above FY2026.

Now price it at your multiple. $1,696.56 ÷ $48.5 = 35.0x. That's your bear-row multiple, the level where you said the earnings yield merely matches TIPS. - With slower growth (40% in 2H26, 30% in 2027), EPS is about $45.8, or 37x. - At my buying zone of about $1,575, it's 32.5x. That's a 3.1% earnings yield, above the 2.88% TIPS yield, with no margin recovery. It passes your own test.

Why FY2027 and not FY2026. In five weeks, three quarters of FY2026 will be reported. 35–40x is a forward multiple. Applied to a year that's 75% reported, it's really a trailing multiple.

A year out. Keep margins frozen another year, and the following four quarters' EPS is about $52 at 30% growth. At your 35x, that's about $1,830, +8%. The no-recovery row loses money over a year only if the multiple drops below about 32.5x or growth falls below about 20%.

So your downside can't be "margins don't recover." It has to be "margins keep falling." Flat EPS through 2027 needs operating margin near 5%, another 1.6 points down. That's a testable call, and my exit sits at 6%.

The floor does need gross margin to hold around 40–41%. Opex has less than a point left before its record low, so it can't absorb much more. That's exactly why my gross-margin tripwire is 40%.

3. My weights, since you asked¶

Expected values (EV) use the scenario returns from my table.

	Bear	No recovery	Base	Bull	EV at $1,697	EV at $1,575
Your weights	30%	40%	20%	10%	−2%	+5%
My weights	20%	35%	30%	15%	+6%	+14%

Why I put the bear row at 20%. It needs three things at once, the same charge you made against my upside:
25% revenue growth, when MELI hasn't grown slower than 37.5% in any year since 2018
another step down in margin
multiple compression
Your −2% is the EV of buying everything today. That isn't my plan. Even on your weights, the tranche I buy in the zone has a positive EV.
A fill in the zone doesn't shift the odds against me. It happens one of two ways:
on macro weakness before Q3, which says nothing about margins
after a Q3 that clears my tripwires If price gets there because Q3 broke a tripwire, I'm selling, not buying.
Your table assumes holding through the bear row. My exits trigger on its first symptom: operating margin below 6%.

4. The September selloff came after the market had absorbed Q2¶

Your case rests on the Q2 print. The market had already priced it: - Aug 6: a −4.82% gap, the day we've both treated as the Q2 reaction. That reaction included the 40.9% gross margin and the −17.2% drop in operating income. - Aug 11: a close of 1,940, above the pre-print 1,922.57. - Sept 2: a close of 2,006.58, the highest since February's gap.

The 15.5% fall since then came with no new company numbers and no company event in the news flow. What did move: - the dollar index, +2.1% (Sept 9–25) - the peso, −4.7% (Sept 4–25), and the real, −2% - the Fed, which hiked in mid-September - 10-year real yields, up 44bp in the month - and only after all that, Latin American corporate spreads, up 51bp into the election

You're right that corporate spreads moved last. But MELI earns in reais and pesos and reports in dollars, so currency is its direct channel, and currency moved first. MELI didn't fall ahead of the region; it fell with the dollar.

On rates, you've merged two things I kept separate: - Explanation: rates and the dollar explain the decline. The heaviest selling, Sept 15–24, brackets the Fed hike. - Catalyst: I said I don't need rates to reverse for the thesis to work.

As for the NASDAQ, the macro report already says why it rose. AI-heavy US tech absorbed the inflows, and it carries little EM currency risk. EM fintech was sold.

5. Balance sheet, reinvested capital and Nu¶

The tripwires are deadlines by design.
Your countdown gives them two to four quarters: the Q3, Q4 and Q1 prints. That's exactly when the trough thesis has to prove itself.
If loan growth doesn't slow enough to bend those lines, the "investment phase is ending" thesis is wrong, and I should be out.
The honest risk is Q4. Liabilities/equity jumped 0.42 in Q4'25 alone. If that repeats, I'm out in February, and I'd rather be stopped by my own rule than argue with it.
For the record, the 2026 increases so far are +0.13 and +0.11.
Return on reinvested capital always looks near zero 18 months into a lending build-out.
Losses are booked when a loan is written; interest arrives over its life.
The $3.5B of equity added since 2024 supports $14.4B more annual revenue than FY2024, including a credit line growing 57%.
Whether that revenue earns 6.7% or 11% is what Q3 starts to answer. It isn't evidence the capital was wasted.
Sum of the parts: agreed, it was a framing. This round's valuation is a plain P/E on consolidated earnings.
Nu: same households, granted. That's why credit sits in my tripwires rather than my assumptions.

6. Floor test versus recovery test, and the revised plan¶

You said my Q3 trigger describes the no-recovery row. Correct, and deliberate. §2 shows that today's price already reflects that row on next year's earnings, so confirming it confirms the floor.

Your test is gross margin up and operating margin at 7.5% or more. That's a recovery test. By the time it passes, you're buying the base case at a base-case price. The last three event days moved the stock 5–13%.

So I'll use both tests and cap what I hold before the answer:

Starter (25%) after Monday's election reaction.
Zone tranche (25%) in 1,546–1,600, allowed before Q3.
Floor tranche (25%) after Q3, if all of these hold:
operating margin of at least 6.7%
gross margin of at least 40%
operating income flat to up year on year
Recovery tranche (25%) on your conditions: gross margin above 40.9% with operating margin of 7.5% or more on 40%+ growth, or a daily close above about 1,860.

Maximum exposure before Q3 is now 50%, down from 75%. A −13% gap on that half costs about 6.5% of the planned position.

The exits are unchanged: - Q3 operating margin below 6%, or gross margin below 40% - disclosed credit deterioration - liabilities/equity at 6x, or a current ratio below 1.10x - a monthly close below 1,549.51

Closing¶

You said I'm paying 46x for an analogy. I'm not. I'm paying about 35x next year's earnings for a floor, with no margin recovery assumed. I'm holding back half the position until Q3 shows whether that floor holds, and your conditions trigger the last quarter.

The business underneath hasn't changed: - revenue up 50%, at $35B of scale - credit revenue up 57% - gross profit dollars up 34% - Q1 revenue above Q4 - no dilution, and book value up 37% - the stricter cash-flow measure up 79% - a 27.5% ROE at the trough

So here's my question. With operating margin anywhere from 6% to 6.7%, MELI trades at 35–39x next year's earnings. That's inside the 35–40x band you've used all debate. Your downside needs operating margin below 6%, the exact level where I've said I'm out. What's your bear case that doesn't run through my exit? Bull Analyst: # Bull Final: You Fixed My Rules. You Didn't Break the Trade.

Bear, that was your sharpest round, and I re-ran every number. Your arithmetic holds. Where you attacked my plan, you found four real flaws, and §5 fixes each one. Where you attacked the trade, your own numbers make my case once they're measured over the right time horizon.

What I concede: - Lines 1–4 of my "five lines" were mostly one fact: the opex reversal. - "No recovery" is a forecast. So is "the trend continues." §3 asks which one the evidence supports. - My balance-sheet stops were a countdown. A fixed trigger level sitting on a trend line fires on drift. - Three of my rules were badly specified: - My credit trigger had no number. - My buying zone overlapped my exit. - My starter had no direction. - Trough ROE is about 24–25%, annualizing the first half, not 27.5%. - Q3 is close. Your mildest case lands at 5.9%, a tenth of a point below my exit.

1. Your closing question: the payoff doesn't wait for May 2027¶

You date the payoff to the Q1'27 report, when reported operating income first jumps. Markets don't wait for a comparison to print. They price the next twelve months.

On the growth path you accepted last round (45% in 2H26, 35% in 2027), with margins frozen at Q2's 6.7%, that forward window turns well before May:

Report	Market's forward year	Operating income growth, no recovery
Q3'26 (Nov)	Q4'26–Q3'27 vs trailing	+22%
Q4'26 (Feb)	FY2027 vs FY2026	+34% (EPS +30%, ~$37.3 → ~$48.5)

FY2026's EPS decline is already in every model. By February the market is pricing 2027.

The Q4 report is the one where you say my balance-sheet rules sell me. It is also the report where the forward year shows 30% EPS growth with no margin recovery. A rule that sells at that moment is a bad rule. You've shown me I wrote one, and §5 replaces it.

2. You priced a 30% grower as if the clock had stopped¶

Your §7 compared my scenario expected values (+6%, +5%) with annual Treasury yields. But my table valued each scenario on today's forward earnings. Those numbers measure how mispriced the stock is today; they contain no year of compounding. So your −2% means "about 2% overvalued today on your weights." It does not mean "−2% over a year."

Here is the same exercise rolled forward a year: - at your 35x; - on the growth path from your own year-out math (35%, then 30%); - with 64% of operating income reaching net income, and a flat share count.

I put my bear row at 30x, harsher than you did.

Scenario, a year out	Growth	Op margin	Multiple	Price	12-month return
My bear row	25%, then 20%	6.0%	30x	$1,199	−29%
Your bear case inside my rules	35%, then 30%	6.0%	35x	$1,637	−4%
Floor, no recovery	35%, then 30%	6.7%	35x	$1,828	+8%
Your "change my mind" bar	35%, then 30%	7.5%	35x	$2,046	+21%
My base	35%, then 30%	8.5%	35x	$2,319	+37%
My bull	40%, then 30%	10.3%	35x	$2,914	+72%

Rows two and three are numbers you used last round.

The weighted return clears Treasuries even on your weights. Using my four scenarios (bear, floor, base, bull):
your weights (30/40/20/10) give about +9% over twelve months;
mine (20/35/30/15) give about +19%;
the 10-year pays 5.24%.
Your TIPS test makes the same mistake. A 2.9% earnings yield on earnings that grow 30% next year, with no recovery, is not a 2.9% return.
You'll say growth isn't free, because the capital added since 2024 has earned about nothing so far. It bought $5.4B more annual gross profit, up 57%. Whether that converts into earnings is exactly what Q3 tests, and what my exits watch.

3. The evidence outside opex, and my Q3 number¶

Since four of my lines were really one, here are lines that aren't opex:

Your own correction to line 5 cuts my way. On your same-quarter method, annualized revenue per dollar of average assets:
fell 0.11 year on year in Q1 (0.90x → 0.79x);
fell 0.07 in Q2 (0.90x → 0.83x).

The decline narrowed by more than a third in one quarter. Quarter on quarter it rose 0.04, while last year's Q1→Q2 move was flat. - Growth needs less balance sheet. Assets added per dollar of revenue were $0.46 in 1H26, against $0.61 in 1H25. That's down a quarter. - The opex lever isn't spent. Your "0.8 points above the record low" is the calendar error you just conceded. You compared Q2'26's 34.2% with the annual 33.4% for FY2024–25. - The same quarter two years ago, Q2'24, ran 32.3%. - Q4'24 ran 31.8%.

I conceded that point too fast last round. It was the same calendar mistake, made in your favor. - The one line that is opex is the credit line. Loan-loss provisions sit there. By your own logic, a deteriorating loan book forces reserves to be re-estimated across the whole portfolio, which pushes opex up. In Q2, opex as a share of revenue fell 2.6 points. A year earlier, the Q1→Q2 dip was 0.4 points.

Gross margin hasn't stopped falling, and I still concede that. But your "mildest Q3" is a composite: 2024's gross-margin move attached to 2025's opex move. Neither year printed that quarter. And one of the two Q3 drops had a known, one-time cause. - Outside the packet, verifiable in the 2025 earnings calls: in mid-2025 MELI cut Brazil's free-shipping minimum from R$79 to R$19, so Q3'25 was the first full quarter at the new level. - That explains Q3'25's 2.3-point gross-margin step, and that step is now in the year-ago comparison. - The other drop, Q3'24, was the opex spike we both read as provisioning.

Here is my Q3 forecast, stated so you can grade it:

	Gross margin	Opex ratio	Operating margin
Your mildest case	40.2% (seasonal −0.7)	~34.3% (Q2 + 0.1)	5.9%
My case	40.2% (same slip, no new step)	~33.5% (top of 2025's Q2–Q4 range)	6.7%

I'll take your gross-margin slip as given. The whole bet comes down to about 0.8 points of opex, on a line that ran between 33.1% and 33.5% for three straight quarters last year. That's close, and I won't pretend otherwise. It's exactly why no more than half the position goes in before the print.

4. Your entry price fails your own test¶

You'd buy at about $1,400 "provided Q3 holds 6.7%." There are two ways to get that price: - After a 6.7% Q3: by your own §7 rule, a post-Q3 fill means "the market rejecting" the floor. You'd be buying that rejection at 29x. - Before Q3: it takes a 17.5% fall through two levels: - the monthly SuperTrend stop (1,549.51); - May's low (1,495).

That would put all three SuperTrends (daily, weekly, monthly) in downtrends. A fall that size most likely comes with the real past 5.24 and wide credit spreads. That is the macro-driven fill you warned me about, and you'd be taking it without Q3 in hand.

In practice, then, your plan either buys at about $1,870 after a strong Q3 or doesn't buy at all. - Waiting costs more than the first 10%. A year out, my base case returns +24% from $1,870 and +37% from here. Confirmation costs about a third of the base case. - If margins only hold at the floor, your $1,870 entry loses about 2% while mine makes 8%.

5. Four fixes to the plan¶

(a) Balance-sheet levels become a size cap, not an exit. Both ratios drift with the business model and the calendar: - Current ratio: in Q2, long-term liabilities fell $534M while current liabilities rose $4.4B. The fundamentals report reads this as debt moving closer to maturity. If so, that reclassification explains about 0.017 of the current ratio's 0.040 drop. - Leverage: Q4'25's +0.42 jump was the holiday quarter. In Q1'25, leverage fell 0.26 from its year-end level. (It didn't fall in Q1'26; I grant that.)

New rule: - Liabilities/equity at 6.0x, or a current ratio below 1.10x, cuts me to 25% and stops all adds. - It becomes a full exit if paired with either of these: - a credit trigger from (b); - the stricter cash measure (operating plus investing cash flow, +$1.58B in 1H26) turning negative over a half-year.

That loosens one rule, and I'll own it. Here's what tightens:

(b) A credit trigger with numbers. Full exit on either: - an opex spike: a Q3 opex ratio at or above 35.7%, a 1.5-point jump from Q2 and the Q3'24 pattern, even if operating margin clears 6%; - delinquencies: a 15–90-day delinquency ratio in MELI's Q3 release up more than a point year on year. (This figure comes from the release, not the packet.)

© The zone no longer overlaps the exit. It's now 1,566–1,600, from the June low to the March close. That sits above the 1,549.51 monthly stop.

(d) The starter and the zone have direction. - Starter: only if Monday closes above 1,668.44. A break below that level starts the technical report's downside path, so I'd skip the starter and wait. - Zone: only if USD/BRL is under 5.24 and LatAm corporate spreads are under 2.5%, the macro report's stress lines. If the zone fills because of a Brazil-specific shock, that money waits for Q3. That answers your independence objection with a filter rather than a hope.

Final plan: MELI, BUY in stages¶

Tranche	Size	Condition
Starter	25%	Monday (Oct 5) closes above 1,668.44
Zone	25%	1,566–1,600, with USD/BRL < 5.24 and LatAm spreads < 2.5%
Floor	25%	After Q3: op margin ≥ 6.7%, gross margin ≥ 40%, op income flat to up YoY, credit triggers clean
Recovery	25%	Your test: gross margin > 40.9% and op margin ≥ 7.5% on 40%+ growth, or a daily close above ~1,860

Full exit on any of:
Q3 operating margin below 6.0%;
Q3 gross margin below 40%;
either credit trigger;
a monthly close below 1,549.51.
Size cap (cut back to 25%): liabilities/equity at 6.0x or a current ratio below 1.10x. This becomes a full exit if paired with a credit trigger or a negative half-year of operating plus investing cash flow.
Maximum exposure before Q3: 50%. One −13% gap costs 6.5% of the planned position.

Closing¶

Four rounds ago we were arguing about whether this is a trough. Now we're arguing about 0.8 points of Q3 opex, and whether to own the first half of a position before the print. That's how far the bear case has narrowed.

What hasn't narrowed is the business: - revenue up 50% on a $35B base, with growth accelerating four quarters running; - credit revenue up 57%, and gross profit up 34%, which is $1.07B more in a single quarter; - no dilution, and book value up 37%; - the stricter cash measure up 79%; - a 24–25% ROE in its worst-margin quarters; - a price of 35x next year's earnings with no margin recovery, and 32.5x in the zone.

You showed that the market paid 55x trailing earnings for this thesis in early September. Then a macro shock, not an earnings print, took 15% off. That discount is the opportunity, not the verdict.

You asked why I'd buy a floor that pays off only after my rules sell me. It doesn't pay off that late. The forward year shows +30% EPS growth at the very Q4 report you named, and the rule that would have sold me there is gone. What's left is a defined bet: half a position on a close call about Q3 opex. Your own year-out case inside my rules is −4%. The floor is +8%. The recovery you say you need to see is worth +21%.

You've put Q3 at 5.9%; I've put it at 6.7%. If it prints 6.7%, with opex back near 33.5%, are you still trimming? Bull Analyst: # Bull Final: Q3 Is Closer Than I Said. The Floor Print Is Still the Buy.

Bear, that was the strongest round of the debate. I re-ran it and it holds. Concessions first, because several of them change my plan:

On Q3, you have the better point forecast. My 6.7% needed opex dollars up about 3.5% from Q2. Both Q3s in the data ran a higher opex ratio than their Q2s, by +3.1 and +0.1 points.
My starter filter sat at the bottom of the box, so it was already met. That isn't a filter.
My zone filter kept the idiosyncratic fills, and those are the ones that carry information about margins and credit.
My pre-Q3 loss figure assumed one fill price. About −16% on deployed capital was the right number.
The delinquency trigger is diluted by growth. You're right, so it's out.

I won't concede that any of this makes a floor print a pass. That is now the one place our plans really differ, and your own numbers support me there. Brazil votes today, and nothing below requires guessing the result.

1. Your question: what in the data says opex growth slows?¶

What the data has for me: - The ratio's own history. - Opex was 33.4% of revenue in both FY2024 and FY2025, the figure you cited in your opening. - Every 2025 quarter landed between 33.1% and 33.8%. - Q1'26 broke out at 36.8%, then gave back about 70% of the jump (2.6 of 3.7 points) in one quarter. - Your "95 cents" is mostly gross margin. - At FY2024's margins, trailing operating income would be about $1.55B higher. About $1.2B of that gap is gross margin and about $0.35B is opex. - All but about $50M of the opex piece is the Q1 spike. Across the other three trailing quarters combined, on $26B of revenue, opex ran only about $50M above its FY2024 ratio. - The only other spike in the data. After Q3'24's spike, opex dollars grew 2.5% and then 4.1% over the next two quarters. Q2'26 was the first quarter after this spike (+6.9%). Q3 is the second. - Your "trend" is a level. - Your 34.3% carries Q2's +0.8-point YoY gap forward unchanged. - The actual trend was the gap narrowing from +2.9 to +0.8 in one quarter. Carry that forward and Q3 lands near 32%. - My 33.5% assumed the narrowing finishes, not that it continues. - "A point a year" depends on which quarter you pick. Q2s rose (32.3%, 33.4%, 34.2%). Q3s fell (35.4%, 33.5%). Full years were flat.

What the data has against me: both Q3s ran above their Q2s. That's real, so here is the whole grid instead of my single point.

Q3'26 operating margin, with gross margin at your 40.2% in every cell

Revenue growth ↓ / Opex dollars vs Q2 →	+4.1% (2^nd quarter after the last spike)	+6.9% (Q2'26 pace)	+9.5% (Q3'25 pace)
+45.0% (my model, +5.6% QoQ)	6.5%	5.6%	4.8%
+46.7% (average of the last two Q3s, +6.9% QoQ)	6.9%	6.0%	5.2%
+49.8% (Q3'25's seasonal pace; growth holds)	7.6%	6.7%	5.9%

What the grid says: - Five of nine cells clear my 6.0% exit, one barely. The median is 6.0%, exactly my exit. My 6.7% sat in the upper third, and you were right to call it out. - Repeat Q3'25 on both lines (bottom right) and you get your 5.9%. - Revenue matters as much as opex. Your 5.6% stacks my own revenue haircut on Q2's opex pace. Give revenue Q3'25's seasonal lift and the same opex pace prints 6.7%, as you noted yourself. - A gross-margin step the size of 2025's (−2.3 points) trips my gross-margin exit in every cell. That risk sits on top of the grid.

Q3 is a coin flip around my exit. I'll size it as one rather than defend a point forecast.

2. CECL timing: the local inputs mostly held¶

Agreed, Q3's loan-loss allowance is set on September 30. Here's what changed for a Brazilian or Mexican borrower since June 30: - Rates: Brazil's policy rate kept falling. The interbank rate went from 15.00% in February to 14.06% on the August average. - Currencies: on Aug–Sep averages, the real and the peso were about 5% and 9% stronger than a year earlier. - Spreads: by your own citation, LatAm corporate spreads hit their period low, 1.90%, on Sept 23. The 51bp widening came in the last six sessions, in dollar bonds, which you agreed aren't MELI's funding. - What the models use: CECL models typically re-estimate on local forecasts such as unemployment, policy rates and growth. A US rate hike and one week of dollar-bond spreads aren't those inputs.

So I expect September's allowance to look more like June's than you do. If I'm wrong, it shows up in the provision line, which is now a gate in my plan (§4).

3. The real disagreement is the floor print¶

After the fixes in §4, I hold at most 25% before Q3. Most of my position waits, like yours. Where we differ is what to do if Q3 holds. Your treatment of that case has four problems.

a. Your trigger catches the bull row, not the base row. - You buy only on an operating margin of 7.5%+ with gross margin above 40.9%. You'd need that in the quarter that printed the year's lowest margin in both 2024 and 2025. - My base row averages 8.5% over four quarters and builds through the year. It doesn't need Q3 to jump 0.8 points. - On that path your test fails in November, and you buy later, well above "+10%". - Your cost-of-waiting math is right for the bull row and too cheap for the base row.

b. Your bear row doesn't survive a floor print. - It needs forward-year revenue up 25%. After a +45% Q3, that means about 20% growth for each of the next three quarters. - That is below every quarter in this packet (low: 33.8%) and every year after 2018 (low: 37.5%). - A Q3 that holds Q2's operating income on 45% growth breaks both of the row's conditions.

c. So price the floor print honestly. Take either of our weights and update them harshly for a print that clears the floor test: move a third of the recovery weight into the floor row, and only halve the bear row. Here are the returns a year out, buying at the cap from §4:

Weights after a floor print	Bear	Floor	Base	Bull	Expected return
Yours, bear row halved	15%	65%	13%	7%	about +11%
Mine, bear row halved	10%	60%	20%	10%	about +16.5%
Yours, bear row removed	0%	80%	13%	7%	about +16%
Mine, bear row removed	0%	70%	20%	10%	about +20%

The rows come from my round-four table: bear −29%, floor +8%, base +37%, bull +72%. At a 6.7% print the cap equals today's price, so those returns apply directly. At lower prints the cap falls with the margin, which only helps the recovery rows.

Cash pays about 4.5%. Your "+8%, about three points over cash" is the worst row that survives the print, not the expected outcome.

d. The floor row's multiple. - You're right that $1,828 is 45.5x the trailing earnings MELI would just have reported. - It is also 35x forward earnings, on EPS growing 30%. That's a price-to-growth ratio (PEG) near 1.2. - The de-rating from 58x to 46x happened while EPS fell 9%. In the floor row, EPS rises 30%.

4. The fixes¶

The starter (25%) moves to the top of the box.
It triggers on a daily close above 1,731.36, the technical report's own bounce trigger.
Before Q3, it's stopped on a close back below 1,668.44. That costs about 1% of the plan.
If a print gap jumps the stop, the loss is about 3–4% of the plan. Your −16% on deployed capital is now about 4% of the plan.
If a floor print gaps up 10%, the price cap stops me chasing it. Capturing that gap is the starter's whole job.
No zone buying before Q3. The fills you described wait for the print.
The floor test becomes Q3 operating income at or above Q2's $683M.
That's about 6.2–6.4% margin, depending on revenue.
It's lower than my old test (operating income flat YoY), and I'm saying so.
It's also harder than it looks: Q3 operating income fell from Q2 in both years we can see, by 23% and 12%.
On the grid, four cells add, one holds and four exit.
The price adjusts to the print.
I pay at most 35x FY2027 EPS frozen at the printed margin, on the 45%/35% revenue path you accepted.
That's about $1,595 at 6.3%, $1,697 at 6.7% and $1,773 at 7.0%.
I never buy below the 1,549.51 monthly stop.
If a floor print gaps down anyway, as May's and August's deteriorating prints did, the cap just means I pay less.
Your provision test becomes my credit gate. I measure it against credit revenue so that mix alone can't fail it. No floor tranche unless provisions are flat or down on that basis.
The 35.7% opex trigger stays as an exit. It's redundant at a 40.2% gross margin by design. It exists for the quarter where a gross-margin beat hides a provision spike.
Balance-sheet lines (current ratio below 1.10x, or liabilities/equity at 6.0x) mean no adds beyond the starter. They trigger a full exit if the provision gate also fails. Since the starter is all I hold before Q3, the cap now binds where it should: on the adds.

You said I was closer to selling than to adding. Under the old plan, yes. Under this one, my add line sits mid-grid, my exit sits below it, and my price moves with the print.

Final plan: MELI, BUY in stages¶

Tranche	Size	Condition
Starter	25%	Before Q3: a daily close above 1,731.36. Stop: a close below 1,668.44. If it never triggers, it joins the floor tranche.
Floor	50%	After Q3, all of: operating income ≥ $683M; gross margin ≥ 40%; provisions flat or down vs credit revenue; balance-sheet lines inside limits. Price: between 1,549.51 and 35x FY2027 EPS frozen at the printed margin.
Recovery	25%	Your test: gross margin > 40.9% and operating margin ≥ 7.5% on 40%+ growth, or a daily close above ~1,860.

Full exit on any of: - Q3 operating margin below 6.0% - Q3 gross margin below 40% - Q3 opex ratio at or above 35.7% - a balance-sheet break combined with a failed provision gate - a monthly close below 1,549.51

Q3 print	My plan	Yours
Recovery: op margin ≥ 7.5%, GM > 40.9%	Add the floor and recovery tranches	Buy after the gap
Floor: op income ≥ $683M, gates pass	Add 50% at or below the cap; above it, the starter rides the gap	Cash; trim a pop
In between: op margin ≥ 6.0%, op income < $683M	Hold the starter; no adds	Cash
Miss: op margin < 6.0% or GM < 40%	Exit, costing about 3–4% of the plan	Cash

We'd behave almost the same in three of those four rows. The fourth, the floor print, is worth about +11% to +20% a year out on the weights above, against about 4.5% in cash.

Closing¶

In my opening I priced a recovery. This round I priced none, conceded Q3 to a coin flip, cut my pre-print exposure to a quarter and let your multiple set my entry price. The trade still clears, because the business underneath hasn't changed: - Growth: revenue up 49.8% in Q2 on a $35B trailing base. Growth has accelerated four quarters running, and Q1 revenue beat the Q4 holiday quarter. - Credit and gross profit: credit revenue up 57%, and gross profit up $1.07B year on year in a single quarter. - The moat: a five-layer stack (marketplace, logistics, payments, credit and ads) that a rival must rebuild to compete on equal terms. - Capital: no dilution, book value up 37%, the stricter cash measure up 79%, and a 24–25% ROE in its worst-margin quarters. - Price: the stock is down 15% since September 2 on the dollar and the peso, not on a print. It trades at about 35x next year's earnings with no recovery assumed.

You've said a 6.7% print would move you from trim to hold. Here's the question that decides the rest. After a Q3 that holds Q2's $683M of operating income on 45% growth, your bear row needs the next three quarters to grow about 20%. What weight does it get then? And if it isn't 30%, why isn't a floor print at 35x a buy?

Bear Researcher¶

Bear Analyst: # Bear Case for MELI: Revenue Is Not Earnings

Bull, that's a well-built case, so I'll start with what I accept. MercadoLibre is an exceptional franchise. The revenue growth is real, and it shows up in the narrower revenue line too. Nothing on the balance sheet says distress, and there has been no dilution.

My argument isn't that MELI is a bad company. It's that at $1,696.56 you're asking investors to pay up front for a margin recovery the data hasn't started to show, and in several places argues against. Your whole case hangs on one word: trough. I don't think we're there, and I'll use your own numbers to show it.

1. The "half price" comes from the metric you picked¶

You moved the valuation onto revenue and gross profit. I understand why: on the measures shareholders actually own, most of the discount disappears.

	Oct-2025 high	Today	Change
Price / trailing gross profit	~10–11x	~5.7x	−43% to −47%
Market cap / trailing operating income	~38–40x	~30x	−23% to −27%
Trailing P/E	~58x	~46x	−21%
Operating income per $1 of gross profit (Q2'25 → Q2'26)	26.7¢	16.4¢	−38%

The stock fell 28%, but trailing EPS also fell about 9–10%, from roughly $40.5–41.0 to $36.77. On earnings, the multiple compressed about 20%. That's a modest de-rating for a year in which the 10-year yield rose about 111bp. A halved price per dollar of gross profit means little when each dollar of gross profit produces 38% less operating income.

The growth path that justified 46x is also gone: - EPS roughly doubled in 2023 and again in 2024. - It grew 4.5% in 2025. - It is down 9% on a trailing basis.

Anchoring to last October's high doesn't help either. Buyers then paid 58x for "record growth plus a fintech engine." They got three straight quarters of falling EPS and a 28% loss. You're making their argument at a lower price, on lower earnings.

Two numbers are missing from your table: - About 11x book value ($154.5 per share). - A 2.17% earnings yield, below the 2.88% yield on 10-year TIPS. Investors are being paid less than the inflation-protected risk-free rate to bet that earnings recover.

2. This growth is being bought, and the price keeps rising¶

Look at what the extra revenue earned: - Q2'26 vs Q2'25: +$3.38B revenue and +$1.07B gross profit, a 31.5% incremental gross margin against 45.6% a year earlier. Operating income fell $142M. - Q1'26 vs Q1'25: +$2.91B revenue, −$152M operating income. - First half of 2026: about $6.3B more revenue and about $294M less operating income.

That's negative incremental margin, the opposite of operating leverage. And under the "acceleration," the profit lines are weakening: - Gross profit growth slowed from 39.4% to 34.4% in Q2 while revenue growth sped up. - Cost of revenue grew 62.6% against revenue growth of 49.8%. - Operating expenses grew 62% in Q1 and 53% in Q2.

On competition: you say companies losing share don't accelerate to 50%. Companies paying to defend share do exactly that. Accelerating revenue, a collapsing gross margin and negative incremental margin are what subsidized growth looks like. Neither of us can measure market share from this packet. We can measure unit economics, and a real moat lets you grow without giving back 4.67 points of gross margin in a year. A rival doesn't need to rebuild all five layers to force that. A cross-border discounter only has to attack price and shipping.

Two things also flatter the top line: - Currency. You conceded it helped. In August–September the real averaged about 5% stronger and the peso about 9% stronger than a year earlier. That tailwind is shrinking. In September the dollar rose 2.1%, the peso lost about 4.7% in three weeks and the real about 2%. - "Broken seasonality." Q1 revenue beating Q4 is partly what you'd expect when about 31% of revenue is likely credit income. Interest accrues regardless of the holiday calendar. So this shows the mix shifting toward the riskiest line, not a stronger marketplace.

3. The trough isn't in, and your mechanism failed its own test¶

a. This cycle is harsher where it counts. Q2'26 gross margin of 40.9% is the lowest annual or quarterly figure in the entire dataset. It's below every year back to 2018, including the 2019 loss year (48.0%). That breaks your precedent: - 2019 was an operating-expense problem. Operating expenses were 54.7% of revenue. By 2023 they were 35.6%, which accounts for about 19 of the 21 points of margin recovery. - That lever has already been pulled. Today operating expenses are 34.2% of revenue, close to their historical low of 33.4% in both FY2024 and FY2025. - Getting back to your 11.1% scenario takes one of two things: - operating expenses at 29.8% of revenue, lower than ever recorded; or - with expenses at the record-low 33.4%, gross margin back to about 44.5%. - That gross-margin recovery would reverse five straight quarters of year-on-year declines, the latest the steepest: −1.0, −2.6, −2.2, −3.0 and −4.7 points.

We've seen an operating-expense trough before. This is a gross-margin trough, which means the unit economics themselves have worsened.

b. Your CECL story failed its own test in Q2. Use your own proxy, total assets: - There is no real slowdown on a like-for-like basis. Q1'26 asset growth was 10.0%, essentially the same as Q1'25's 9.9%. The slowdown only appears against the two fastest quarters, Q2'25 and Q4'25. The first half of 2026 still annualizes to about 45%. - Slower growth didn't bring relief. Q2'26 asset growth was half the Q2'25 pace (9.4% vs 19.0%). If upfront provisioning on a fast-growing book were the main drag, Q2 should have improved. Instead gross margin posted its worst year-on-year decline of the cycle (−4.67 points) and fell 2.76 points from Q1. - Neither explanation is a trough. Either provisions per loan are rising, which means credit is deteriorating, or the compression is structural: shipping subsidies, 1P mix, funding costs.

c. The "stabilization" was a gross-margin drop hidden by a one-quarter offset. - Operating margin didn't hold; it slipped from 6.9% to 6.7%. - Underneath, gross margin fell 2.76 points from Q1. - That was masked by operating expenses falling 2.58 points as a share of revenue, on a 15% sequential revenue jump. - You can't count on that offset every quarter while gross margin keeps falling.

d. The "easy" Q3 comparison is at least partly seasonal. In each of the last two years, Q3 operating income fell from Q2 even though revenue grew: - 2024: down 23%, from $726M to $557M. - 2025: down 12%, from $825M to $724M.

Apply that to Q2'26's $683M: - Operating income: about $525–600M, down 17–28% year on year. That would be a fourth straight decline, not a turning point. - Operating margin: roughly 5%, below your own 6% tripwire. - Gross margin: it fell 0.7 and 2.3 points from Q2 to Q3 in those years. From 40.9%, that gives 38.6–40.2%, right at your 40% tripwire, and through it if Q3 repeats 2025.

Two years isn't a law. But your base case assumes the opposite pattern without explaining why. And even your own math has operating income flat. Your "EPS up 9–16%" assumes 64–68% of operating income turns into net income. Q3'25's figure was 58%. At that rate your scenario gives about $8.25, roughly flat against last year's $8.32. Even in your base case, the operating business doesn't turn.

e. The "trough" P/E. Your normalized EPS of $49–56 depends on the gross-margin recovery in (a), and even then the stock trades at 30–34x. Your 23–26x case needs three things to go right at once: - full margin recovery; - another year of 30% growth; - no further multiple compression.

Notice also that all three rows of your scenario table point up. None shows the downside.

4. The second engine carries the risk, and the balance sheet shows it¶

Credit: - You're asked to pay for a line nobody can inspect. The credit-related line is about $3.1B a quarter, up 56.7%, and about 31% of revenue, up from 25.8% two years ago. You concede there's no delinquency data. So the bull case asks investors to pay 46x earnings and 11x book while the fastest-growing, riskiest revenue line has invisible credit quality. - The market is already punishing the closest peer. Headlines: "Nu Holdings Keeps Imploding," and Zacks asking "Can Credit Quality Hold Up?" - CECL cuts both ways. It looks forward, so wider spreads, a weaker real and election uncertainty raise expected loss rates even if loan growth slows. - Funding costs aren't falling the way you suggest. You cite about 95bp of Selic cuts, but the policy rate is still around 14%. Brazil's central bank may pause after a Fed hike and a weaker real. Meanwhile Latin American corporate spreads rose 51bp in six sessions, 18bp on Oct 1 alone. That spread is closer to MELI's cost of new funding than the overnight rate.

Balance sheet: pick one framing. When leverage comes up, MELI is a fintech with "a thicker cushion than a typical bank." When valuation comes up, it's a platform worth 46x earnings. - If it's a lender, 11x book would be extraordinary for any lender. And the right benchmark for Latin American consumer and merchant credit isn't "a typical bank." - If it's a platform, look at the trends: - Liabilities/equity has risen five quarters in a row, from 4.53x to 5.56x. - Equity/assets has fallen from 18.1% to 15.3%. - The current ratio of 1.12x is the lowest in the series. - Short-term liabilities are 83.6% of the total, up from 79.7% at year-end. - Cash covers about 10% of current liabilities, down from 13.8%. - Returns are falling despite more leverage. Return on equity went from 51.5% to 36.0% to 27.5%. Over the same period, average assets over average equity rose from 5.8x to 6.2x. - "Self-funded" means funded by liabilities. - Financing inflows have been positive every year since 2024, including +$2.9B in FY2025. - In FY2025, cash flows added up to +$8.84B, yet balance-sheet cash rose just $1.04B. - Management isn't buying back stock despite loud retail demands, which suggests the cash isn't free to return.

5. "It's just rates" doesn't fit the data¶

If this were mainly a discount-rate story, long-duration US tech would be falling too. Since mid-September, through the Fed hike, the NASDAQ is up about 5% while MELI is down about 7%. The selling is aimed at Latin American consumer credit, which is MELI's business, not outside noise. September's MELI-specific headlines say the same: "Looks Rich Relative To Its Earnings" and "Sees a More Significant Dip Than Broader Market."

The first live test of your reversal thesis has already happened: - On Oct 1, MELI fell 2.5% while the market rose (Zacks: "Stock Falls Amid Market Uptick"). - On Oct 2, rate-hike expectations faded and the NASDAQ rose 1.19%. MELI managed +0.68%, on its lightest volume since Sept 11.

The stock you say has the most to gain from falling yields didn't show it.

Rates aren't clearly turning, either: - The Fed just hiked, and the 2-year yield sits about 90bp above the effective fed funds rate. - Core PCE re-accelerated in August, and CPI rose 0.40% on the month. - WTI is near $96 after a 16.6% single-session jump in late September.

One +29K payroll print isn't a pivot. And if yields fall because the US economy is slowing, that isn't obviously good for emerging-market credit.

On the election: the business doesn't run on the electoral calendar, but the currency, funding spreads and the multiple do. - The Oct 25 runoff stretches the risk window. - A fiscally worrying result could push USD/BRL past 5.24. That would hit USD revenue, book value (which moves with currencies) and the central bank's room to cut. - Your 2022 analogy cuts against you. Gross margin rose from 42.5% to 48.2% that year; today it's falling. And 2022 was a Fed-hiking year in which strong operating results didn't protect growth multiples.

6. Chart and sentiment: buying near support doesn't help if support breaks¶

You grant the trend, so let me take the "exhaustion" signals: - There's no washout yet. RSI has never closed below 30 in this decline, and ATR is shrinking. The technical report says it directly: washout lows usually come with widening ranges, "and that hasn't happened." Orderly selling looks like distribution, not capitulation. - The TD 9 has already failed once. The first daily 9, on Sept 18, was perfected, and price fell another 5.1%. The count has now run 19 sessions. The weekly count is only 3, and the earliest weekly 9 is mid-November. - The OBV divergence is thin. OBV hit a 90-session low on Sept 28 after about 2.6x normal volume. The 3-session divergence rests on the lightest-volume day in three weeks. - Each bounce is weaker. Closing highs went from 1,906 to 1,827 to 1,729, and the bounces shrank from +2.19% to +0.94%. - The calendar is crowded. The estimated death cross around Oct 21 lands just ahead of the runoff, the FOMC and earnings.

Your risk/reward treats the monthly stop as a floor. It's a stop. - All three big event gaps this year were down, the largest −12.7%. - One more like that takes the stock to about $1,481. That's below May's $1,495 low and below your monthly stop, in a single session. - Your +18% target sits above four layers of resistance: 1,745, 1,813, 1,837 and 1,860. Your +39% target also needs the weekly SuperTrend at 2,062.

Even the technical report you cite says the evidence "argues against chasing either way." It calls even a triggered buy near 1,745 "marginal." It puts the longer-term buying zone at 1,546–1,600, 6–9% below your starter price. Your plan buys now, buys lower and buys higher. That's not a plan; it's a commitment.

Sentiment isn't washed out: - The sample is thin. It's 29 posts from 17 accounts, with low confidence and no Reddit data. One account supplied 56% of the bullish tags; without it, the split is 4 bullish to 5 bearish. - The dip-buyers haven't quit. Holders are still "adding," calling it an "easy add" and buying $3,000 LEAPS. That's fatigue, not capitulation; bottoms come when the dip-buyers give up. - The "constructive institutional framing" is thin too. It's evergreen comparison pieces, not ratings or estimate changes.

7. What the downside looks like, and my position¶

Scenario	Implied price	vs today
EPS flat at $36.77 (where FY26 lands if 2H26 matches 2H25), multiple drifts to 40x, still a growth premium	~$1,470	−13%
One May-style −12.7% earnings gap	~$1,481	−13%
EPS flat at 35x, where the earnings yield would only match today's 2.88% real 10-year yield	~$1,287	−24%

All three land below the worst case you laid out. Even matching FY2025 EPS requires second-half EPS up 13.6% year on year, against the seasonal pattern above.

My call: don't start a MELI position here, and holders should trim into strength. - I'm not arguing for a short at 1,697; the technicals put that trade near 1:1. The better bear trade is selling a failed bounce into the 1,813–1,860 resistance band. - Squeeze risk is real. A market-friendly Brazil result with the 10-year back under 5% could produce a sharp relief rally.

What would change my mind: - Q3 gross margin of about 41% or better and operating margin of 7.5% or better on 40%+ growth, breaking the seasonal pattern. - Disclosed credit metrics that hold steady, and liabilities/equity that stops climbing. - MELI outperforming the NASDAQ after the Brazil vote. - A daily close above about 1,860, which would flip the daily trend and head off the death cross.

Bull, you asked why MELI should trade under 6x gross profit. Because gross profit isn't what shareholders own: - Each dollar of it now produces 16 cents of operating income instead of 27. - Last quarter's extra $3.4B of revenue came with $142M less operating income. - Gross margin is at a dataset low, and the operating-expense lever that rescued the 2019 cycle has already been pulled. - Nobody can see the credit engine's loan quality, and the stock yields less than the real risk-free rate.

Count your own concessions: - currency helped; - headline FCF is overstated; - there's no delinquency data; - the trend is down; - it's not a momentum buy; - the sentiment sample is thin.

That's a lot of "I'll grant that" for a buy-now call. Your tripwires of a 40% gross margin and a 6% operating margin sit right where Q3 seasonality points. The thesis gets tested in about five weeks. Why pay for the answer before you see it? Bear Analyst: # Bear Rebuttal: In 2021 the Decline Was Ending. This One Is Speeding Up.

Bull, that's a sharp rebuttal. Your arithmetic checks out, and you caught a real mistake, so I'll start there.

What I concede: - MELI books its provision for doubtful accounts in operating expenses, not in cost of revenue. I tested your CECL mechanism on the wrong line. - The ICE LatAm index tracks spreads on dollar bonds, not funding costs in reais. - 58% was the low end for converting operating income to net income. I'll use your 64%. - The buyback posts came from one account. I'm dropping that point.

Each of these corrections makes your trough thesis weaker, not stronger: - Your 2021 analog describes a decline that was ending. Today's decline is accelerating. - Moving provisions into opex shrinks CECL to the smaller part of the problem. - Read your valuation table on the calendar the market actually uses, and your "no recovery" row lands about where mine did.

1. What's different from 2021 is the direction¶

You compared trailing 2026 with full-year 2021. Compare the shape of the two cycles instead. The figures are annual gross-margin changes.

	First year of decline	Second year	What came next
Last cycle	2020: −5.0 pts	2021: −0.5 pts	2022: +5.7 pts
This cycle	2024: −4.1 pts	2025: −1.6 pts	2026: another −3.6 pts (FY25's 44.5% to Q2's 40.9%)

In 2021, gross margin was flattening into a bottom. It fell only half a point that year, and the recovery followed.
This cycle already had its 2021 moment, in 2025. The decline slowed to 1.6 points. Anyone who called that the bottom has since watched gross margin fall another 3.6 points.
The quarterly declines are getting bigger. Year on year they run −1.0, −2.6, −2.2, −3.0 and −4.7 points. The latest is the steepest.
Your "slightly better on every line" relies on the trailing 42.7%. That average still includes three quarters above 43%. The current quarter, at 40.9%, is 1.6 points below the 2021 bottom.

So, to your closing question: I never said the playbook is impossible. I said nothing in the data shows it has started. At 46x trailing earnings, the price already treats it as under way.

2. With provisions in opex, CECL explains the small part of the problem¶

In round one you said "CECL matters most." With provisions in opex, here is how Q2's 5.43-point fall in operating margin splits: - Gross margin: 4.67 points, or 86%. By your own correction, CECL has nothing to do with this part. - Operating expenses: 0.76 points, or 14%. This is the most CECL could explain, and the line also carries marketing, technology and G&A.

The mechanism you said would end the trough can explain at most one-seventh of the latest quarter's compression. Even that seventh doesn't clearly show relief:

Even on your own proxy, the balance sheet didn't slow in Q2.
Assets grew 10.0% in Q1 and 9.4% in Q2.
In dollars, Q2 added more than Q1: $4.42B against $4.27B.
The 14-point drop in year-on-year asset growth comes from lapping Q2'25's 19% jump. It doesn't reflect anything MELI did differently this year.
What changed was revenue, which rose 15% from Q1. That is operating leverage, not provisioning relief.
Q2's opex ratio of 34.2% is still above every quarter of 2025 (33.1–33.8%).
It only looks good next to Q1's 36.8%, the highest of the nine quarters in the packet.
Total assets aren't the loan book anyway. They include customer funds and cash, and the packet doesn't break out loans. What they do show isn't encouraging:
Assets are still growing faster than revenue, 55.9% against 49.8%.
Revenue per dollar of assets keeps falling: 0.97x, then 0.85x, then 0.83x.
You cited the 10-Q for where provisions sit, but not for how large they were. That one number would settle this.

CECL also isn't booked once and then forgotten: - The allowance on the whole loan book is re-estimated every quarter against the economic outlook. - Wider regional spreads, a weaker real, an election runoff and Nu's slide all argue for building reserves on loans already written. - "The P&L already carries the book" holds only if the outlook stays the same, and it is changing.

Your own diagnosis of Q3'24 makes my case. Opex rose 3.1 points of revenue in a single quarter, which you called a provisioning spike. That is a precedent for exactly the risk I'm flagging for Q3'26.

3. The gross line: none of your three stabilizers shows up in the data¶

Funding costs: - Brazil's rate-cutting cycle was already under way in Q2, and gross margin still fell 2.76 points from Q1. - A 95bp cut from roughly 15% makes each real borrowed only about 6% cheaper. Meanwhile, credit revenue grew 57%. - Funding linked to the interbank rate reprices quickly in both directions. If Brazil's central bank pauses after the Fed hike and the weaker real, the relief stops at once.

Lapping: - Lapping changes the comparison, not the level. - "Merely holding 40.9%" would set a floor below every annual figure in the dataset. - Even holding there requires breaking the pattern of the past two years, when gross margin fell from Q2 to Q3 by 0.7 and 2.3 points.

Mix: If mix explains the decline, the decline is structural, because 1P and credit are the fastest-growing lines. Mix also undercuts your share-gain argument: - 1P sales are booked at the full sale price. (MELI reports product sales separately in its filings; that split isn't in this packet.) - Shifting volume into 1P therefore adds the whole ticket price to revenue instead of a commission. Revenue speeds up, but gross profit doesn't keep pace. - That is exactly what Q2 showed: narrower revenue rose 46.9%, while gross-profit growth slowed from 39.4% to 34.4%. - Without GMV, which neither of us has, the acceleration you call share gains can't be told apart from 1P mix.

"Three years, three stories": Fine, call it a run of investment steps. - MELI took a step that lowered margins in Q3 of both 2024 and 2025. - Your own thesis is that MELI is in a deliberate investment phase, and companies in investment phases keep making investments. - Nothing in the packet says management has declared this phase over.

The broader pattern points the same way. In both 2024 and 2025, operating margin in Q3 and Q4 came in below Q2: - 2024: 14.3% in Q2, then 10.5% and 13.5%. - 2025: 12.2% in Q2, then 9.8% and 10.1%.

4. The "turn" lasts one quarter¶

Q3: at 64% conversion, flat Q3 operating income gives about $9.10 of EPS, up 9%.
But that assumes the margin stays flat on the quarter.
The year-on-year "turn" comes from the comparison base dropping 2.4 points, from 12.2% in Q2'25 to 9.8% in Q3'25.
That base has been public for nearly a year. An easy comparison that everyone can see isn't a catalyst.
Q4 laps 10.1%.
At Q2's margin and 40–45% growth, Q4 operating income falls about 4–8% year on year.
Q4 margins also came in below Q2's in both prior years.
FY2026:
Hold Q2's margin through the second half, with 45% growth, and EPS lands around $37–38.5 at 64–68% conversion.
That is below FY2025's $39.40 either way.
It would be the first annual EPS decline since 2019.

5. Your valuation table, read on the market's calendar¶

Your no-recovery row says −5%. Mine said −13%. It's the same business measured on different clocks: - Yours applies 40x to EPS through Q2'27, which won't be fully reported until about August 2027. - Mine used FY2026, the next annual number the market will see. At Q2's margin and about 45% growth, that comes to about $37.

So my "flat EPS" row needs no slowdown in growth at all. It only needs Q2's margin to persist. Your claim that it needs growth to halve mixes my calendar-year anchor with your forward one.

Three more problems with the table: - Today's price is already 42x your own no-recovery forward EPS of $40.17. - On that path, EPS runs $37.69 (FY24), $39.40 (FY25), about $37 (FY26) and about $40 (mid-2027). That's three years of essentially flat earnings. - Will the market pay 40x for that? At 35x, the multiple in your bear row, the stock is worth about $1,406, which is −17%. - Your base case needs a fast jump in margins. - With your 35% growth assumption, and Q3 holding at 6.7%, Q4'26 through Q2'27 must average about 9.0% to reach 8.5% for the year. - That's 2.3 points of improvement within one to three quarters, while gross margin is still falling. - You gave no probabilities. - Your base case returns +20% on earnings that arrive over about ten months. Your bear case loses 31%. - Suppose I weight the rows 30/40/20/10 across bear, no recovery, base and bull. I think that's fair while gross margin is still falling. On those weights, your own table returns about −2%. - Give me your weights.

On TIPS: - Your 2.9% "normalized" earnings yield already assumes margins recover 4.4 points, to 11.1%. - Even if I grant that recovery, the stock pays the real risk-free rate with no premium for Latin American consumer credit and currency risk. - The test wouldn't have ruled MELI out in 2021, as you claimed. Ten-year TIPS yielded below zero all that year, at roughly −1% (this is from outside the packet). A roughly 0.1% earnings yield passed easily. - The test bites now because real yields are 2.88%.

On the October-2025 buyers: - Trailing operating margin then was about 12%. That was already about 2.5 points below 2023's 14.6%, and well into what the fundamentals report calls the second investment period. - They heard the same "margins will recover" pitch, at 58x earnings. - Since then the stock is down 28%. Trailing margin has fallen to 8.3%, and the latest quarter came in at 6.7%. - "Trough" was the pitch then, too.

6. Balance sheet: your new tripwires are already on schedule¶

Current ratio: 1.12x, against your 1.10x trigger. It fell 0.04 in Q2 alone. One more quarter like that trips your exit, possibly in the very Q3 report you're waiting for.
Liabilities/equity: 5.56x, against your 6x trigger. It has risen 1.03 over five quarters, about 0.2 a quarter. At that pace it hits 6x in about two quarters. Even at the slower recent pace of about 0.12 a quarter, it gets there in about four.
When a trend line runs straight into your exit, you've built a countdown, not a safeguard.

On "reinvesting at a 27.5% ROE": That's the average return on all equity, and it's falling. Look at the return on the new money instead: - Since the end of 2024, equity is up $3.5B (+80%), and total assets have more than doubled. - Yet trailing net income of $1,863M is below FY2024's $1,911M. - So far, the return on the capital reinvested since 2024 is roughly zero.

On sum of the parts: it needs segment margins, which you agree neither of us has. "It's both a platform and a lender" is a framing, not a valuation.

On Nu: - Nu also underwrites using its own customer data. - It lends to the same Brazilian households, in the same interest-rate environment. - The read-across is to the borrowers themselves, not just to sentiment. - Goldman's "double" call hasn't stopped Nu's slide.

7. Regional and election risk don't clear on Monday¶

You've dropped rates as a catalyst. That was a third of your round-one thesis, along with the macro report's line about MELI having the most to gain if yields fall.
For MELI, Latin America isn't a passing shock. It's where the company does business. The event calendar is crowded:
US CPI in mid-October
Brazil's runoff on Oct 25
the FOMC on Oct 27–28
Q3 earnings, probably in late October or early November
The timing doesn't fit your "pre-election de-risking" story.
More than half of MELI's fall from the Sept 2 close had happened by Sept 22, when it closed at 1,826.58, about 9% lower.
The heaviest selling ran from Sept 15 to 24, at about 2.6x July's volume. Latin American corporate spreads were at their low, 1.90%, on Sept 23.
The peso was softening, I grant that. But regional credit, the thing you say was being de-risked, was at its calmest.
MELI fell first; regional credit followed.

8. Timing: we don't agree on the next move¶

I didn't forecast a bounce. I said to sell one if it fails at 1,813–1,860. The technical report favors further decline on both the weekly and daily trends.
On that path, you're 75% invested before Q3 reports.
Half your position sits within about 3% of your own exit line, a monthly close below 1,549.51.
That half is exposed to a month of drift plus a possible −13% gap.
"Only paying for part of the answer" holds only if the stock bounces first.
Your Q3 "confirmation" doesn't test your base case.
Your trigger is an operating margin of at least 6.7%, flat operating income and gross margin of at least 40%.
That describes your own no-recovery row, the one that loses 5%.
A real trough test would be gross margin rising above 40.9% and operating margin rising above Q2's.
On the risk of missing a gap up: I'll accept it.
All three event gaps this year were down.
The 2022 recovery played out over a full year.
Missing the first 10% of a real recovery is cheap insurance against catching another −13% gap.

My position¶

MELI: don't start a new position, and holders should trim into strength. The tactical trade is to sell a failed bounce into 1,813–1,860 with a stop above about 1,875. I'm not shorting at 1,697.

What would change my mind: - Q3 gross margin above Q2's 40.9% (ideally 41% or more) and operating margin of 7.5% or better, on 40%+ growth. - A provision line in the 10-Q that is flat or down as a share of revenue. - The current ratio and liabilities/equity stop deteriorating. - MELI outperforms the NASDAQ through the runoff. - A daily close above about 1,860.

Closing¶

You said we're debating whether this trough is really a trough. Agreed. A trough is where things stop getting worse, so name the line that has stopped: - Gross margin: down year on year for five straight quarters, the latest decline the steepest. The current quarter is below the 2021 bottom. - Operating income: down year on year for two straight quarters. - EPS: down year on year for three straight quarters. FY2026 is on track for the first annual decline since 2019. - Return on equity: 51.5%, then 36.0%, then 27.5%. - Balance sheet: liabilities/equity up five quarters in a row, and the current ratio at a series low.

On margins and earnings, every improvement is quarter-on-quarter only. Operating income rose 11.8% on 15% more revenue, and opex came down from a Q1 spike.

So here's my question for you. What in the data, not in the 2021 chart, shows that gross margin has stopped falling? Until something does, you're paying 46 times earnings for an analogy. And the last time this cycle looked like 2021, in 2025, gross margin went on to fall another 3.6 points. Bear Analyst: # Bear Rebuttal: Your Floor Needs the One Line You Conceded Hasn't Stopped

Bull, this round moved the debate forward. We've dropped 2021, and your arithmetic checks out again. Here is what I accept:

My 2021 comparison mixed calendars. I set Q2'26's 40.9% against 2021's full-year average. That's the same mistake I flagged in you.
Your frozen-margin math is right. At 6.7%, with 45% growth in 2H26 and 35% in 2027, FY2027 EPS is about $48.5. Today's price is 35x that.
September's slide tracked the dollar and the peso. Regional credit did move last, but you're right that currencies moved first.
Capping pre-Q3 exposure at 50% is a real improvement.

Fixing my calendar error doesn't change the direction. On a like-for-like twelve-month basis, gross margin has fallen 1.8 points in six months (FY2025's 44.5% to 42.7% trailing). In all of 2021 it fell 0.5 points. If Q3 merely holds Q2's 40.9%, trailing gross margin drops to about 42.1%, below 2021's 42.5%.

Now the problem. Two sentences from your round:

"Gross margin hasn't stopped falling. Nothing in the packet says otherwise."

"The floor does need gross margin to hold around 40–41%."

Together they are the whole debate. Last round's "trough" is this round's "floor," and the requirement is the same: the line that's falling has to stop, starting with the next print.

1. "No recovery" is a forecast, not the default¶

You call a frozen 6.7% margin the "no recovery" row, as if nothing has to change for it to happen. Something does. The do-nothing case is the trend:

Gross margin has fallen year on year for five straight quarters: −1.0, −2.6, −2.2, −3.0 and −4.7 points. The latest decline is the steepest.
Opex has little room left to cushion it. It sits 0.8 points above its record low, as you concede. After that, every further point of gross margin lands on operating margin.

Freezing margin at 6.7% is a forecast that the trend breaks this quarter. You've made that forecast since round one; only the label has softened.

2. Your five lines are one line, counted several times¶

Lines 1–3 are the same fact: opex fell from 36.8% to 34.2% of revenue. - Operating income per dollar of gross profit is one minus opex per dollar of gross profit. It rose because opex fell. - Operating margin held because opex fell. - And line 3 is simply that opex fell.

Line 4 is that reversal again, year on year. - Opex explained 2.93 points of Q1's margin decline and only 0.76 points of Q2's. - EPS improved more than operating income because of items below the operating line: 68% of operating income reached net income, against 63% a year earlier.

Line 5 compares a twelve-month change with a six-month change in an overlapping average. Compare each quarter with the same quarter a year earlier instead. Annualized revenue per dollar of average assets fell from 0.90x to 0.83x.

Your best line, operating income per dollar of gross profit, across nine quarters: 30.7¢, 22.8¢, 29.8¢, 27.5¢, 26.7¢, 22.6¢, 23.5¢, 15.8¢, 16.4¢. - That's the second-lowest of the nine, and six cents below the next-worst quarter. - A 0.6¢ move off the series low isn't a floor.

The lines you didn't list moved the other way in the same quarter: - Gross profit growth slowed from 39.4% to 34.4%. - The year-on-year gross-margin decline widened from −3.0 to −4.7 points. - Cost of revenue grew 62.6%, against revenue growth of 49.8%.

If Q1's spike was provisions reversing, provisions are volatile, not falling. - Opex hit 36.8% of revenue in Q1'26, the highest in nine quarters. - It jumped 3.1 points in a single quarter in Q3'24.

In Q2, opex absorbed 2.58 points of gross margin's 2.76-point drop. It has only 0.8 points of that cushion left.

3. The "steps" are a seasonal plateau on a steepening slope¶

Q1 lifts gross margin seasonally, and this year's lift was weaker.
Q4'24 to Q1'25: +1.3 points.
Q4'25 to Q1'26: +0.5 points.
So your "plateau" (43.3%, 43.2%, 43.7%) leans on a smaller seasonal boost than last year's.
Year on year, there was no plateau. The plateau quarters were −2.6, −2.2 and −3.0 points, then −4.7. That's a slope, and it's getting steeper.
If the steps are management choices, as you infer, they tend to repeat.
Last year's first step landed in Q3, the quarter about to report.
Shipping subsidies and 1P are how a marketplace defends share against cross-border discounters, and choices made under that pressure come back.
You've called this a deliberate investment phase. Nothing in the packet says it's over.
If it's mix instead, mix is a slope too. The credit line went from 25.8% to 30.6% of revenue in two years, and it's still growing faster than the total.

4. The mildest version of the last two Q3s trips your exit¶

In both investment-phase years, both lines moved against margin from Q2 to Q3:

Q2 → Q3	Gross margin	Opex ratio	Operating margin
2024	−0.7	+3.1	−3.8
2025	−2.3	+0.1	−2.4
Q3'26, mildest of each	−0.7	+0.1	6.7% → 5.9%

Take the gentlest move of each line and Q3 operating margin is 5.9%, below your 6% exit.
Operating income would be about $633M.
That's down roughly 13% on "the easiest comparison of the cycle."
Your flat-Q3 case needs both lines to hold Q2's level. That didn't happen in either of the last two Q3s.
2023 is your counterexample, but it was a margin-expansion year. The two years that resemble this one went the other way.

5. Your question: a bear case that doesn't run through your exit¶

Here's one. Q3 prints a 6.0% operating margin on a 40% gross margin. - Operating income is about $645M, down 11% year on year on the easiest comparison of the cycle. - Neither margin tripwire fires. - You hold up to half a position and don't add.

Now price FY2027 at 35x, the multiple you used for your own floor:

FY2027 EPS at 35x	45% (2H26) / 35% (2027) growth	40% / 30% growth
Operating margin 6.7%	$48.5 → $1,697 (0%)	$45.8 → $1,603 (−6%)
Operating margin 6.0%	$43.4 → $1,519 (−10%)	$41.0 → $1,435 (−15%)

All four cells sit inside your hold rules, and none is positive. Your floor case is the top-left cell: zero.
None needs growth to halve. The worst cell uses 30% growth in 2027, your own "slower growth" case.
The top of your band is the weakest margin.
You wrote that at 6% to 6.7% margins, MELI trades at "35–39x next year's earnings."
The 39x end of that range is the 6% margin.
My bear case is simply that a 6%-margin company posting its first annual EPS decline since 2019 doesn't hold the top of the band.
Why 35x rather than 40x? Because 35x is what you used for your own floor. Every earnings-type gap this year was down, and the trailing multiple has gone from 58x to 46x.
On your "a year out" method, it still loses. At a 6.0% margin, forward EPS is about $46.8. At 35x that's $1,637, about −4% after a year.

The path that does run through your exit is worse than your rules suggest:

The exit fires after the gap. You read Q3 when the market does. All three earnings-type gaps this year were down: −8.05%, −12.70% and −4.82%.
Your credit tripwire has no threshold. "Disclosed credit deterioration," measured how? A tripwire that isn't defined can't fire.
Credit trouble would show up in opex, the line all five of your lines depend on.
Q3'24, your own example of a provisioning spike, added 3.1 points of opex in one quarter.
Repeat that with gross margin flat, and Q3 operating margin is about 3.6%.
Outside the packet, and from memory, so worth checking: the stock fell by a mid-teens percentage the day after that print.

6. Your exits are on pace to fire before your floor pays off¶

Your table shows when the floor starts paying off: Q1'27, with operating income up 31%, reported around May 2027. Two reports come first:

Q3, around November.
Q4, around late February. Your own table has operating income down 4–8% year on year there. FY2026 EPS lands near $37, the first annual decline since 2019.

Now run your balance-sheet tripwires on last year's pattern:

	Today	Trigger	Room left	Recent quarterly changes
Current ratio	1.121x	below 1.10x	0.021	−0.010, −0.005, −0.024, −0.002, −0.011, −0.040 (avg −0.015)
Liabilities/equity	5.56x	6.0x	0.44	2025's Q3 and Q4: +0.13, +0.42

The current ratio can trip you in Q3.
In two of the last six quarters it fell by more than your trigger allows, including Q3'25.
If Q3'26 repeats Q3'25, it's 1.097x and you're out on the Q3 report.
At the six-quarter average, it crosses 1.10x on the Q4 balance sheet.
Leverage can trip you in Q4. Repeat 2025's second half and liabilities/equity reaches 6.1x on the Q4 balance sheet.

You said you'd rather be stopped by your own rule than argue with it. Fair enough. But then the floor pays off one quarter after your rules are on pace to sell you. This isn't a floor trade. It's a bet that gross margin, the current ratio and leverage all stop deteriorating within two quarters.

7. A floor is enough to break even, not to buy¶

Start with your own numbers:

Case	Expected return	Comparison
Your floor, a year out (margins frozen, 30% growth, 35x holds)	+8%	10-year Treasury yields 5.24%
Your plan on your own weights	about +6%	2-year Treasury pays 4.78%
Your zone tranche on my weights	about +5%	roughly what the 10-year pays

That's about 3 points of premium at best for a stock that moves about 3.3% a day (its average true range) and gapped −13% this year.
The TIPS test barely clears, and only at your zone price.
At today's price, FY2027's earnings yield is 2.86%, against 2.88% for TIPS.
At $1,575 it passes by about 20bp.
Those are earnings that won't be fully reported for roughly 17 months, with Latin American credit and currency risk attached.

A floor priced at full value isn't a margin of safety. It's the absence of one.

The zone tranche has two more problems: - The fill isn't independent of the bear scenario. You said a pre-Q3 fill on macro weakness "says nothing about margins." But you also called currency MELI's "direct channel." A fill on a weaker real and peso and wider spreads means: - lower dollar revenue; - a CECL outlook that argues for building reserves; - less room for Brazil's central bank to cut. - A post-Q3 fill is the market rejecting your thesis. If the stock reaches $1,575 after a Q3 that confirms your floor, the market has just told you it won't pay 35x for one.

Your "27.5% ROE at the trough" isn't the trough. - Annualize Q1 and Q2 and it's 24–25%. - Even with frozen margins, trailing ROE falls to roughly 24–25% by year-end. Equity compounds about $550M a quarter while earnings stand still.

8. September, and your starter¶

I'll take the correction on September and keep the conclusion. - After the Q2 print, the market bid MELI up to 2,006.58 on Sept 2, about 55x trailing EPS. That was the market pricing your trough thesis. - One macro shock then took 15% off it in a month, with no company news. - OBV gave back all of July and August's accumulation (14.74M to 11.22M), on volume running 2.6x July's. The buyers who priced the trough have left. - You don't need rates or the dollar to reverse, but the thesis can't absorb them getting worse. Three tests likely land before Q3 reports: - mid-October CPI; - the Oct 25 runoff; - the Oct 27–28 FOMC. - September's Nu headline, "Can Credit Quality Hold Up?", isn't only sentiment. It's information about the same Brazilian borrowers behind MELI's fastest-growing line.

Your starter has no direction. Brazil votes today, and neither of us knows the result. You'll buy "after Monday's election reaction," but which way? The Oct 1 range, 1,668.44 to 1,731.36, decides it. - A break below 1,668.44 starts the technical report's downside path: 1,593–1,600, then 1,566–1,584, then 1,546–1,550. Your starter would buy the first leg of that path and your zone tranche the last. - Your buying zone overlaps your exit. Its bottom (1,546) sits below your monthly-close exit (1,549.51). An October close at 1,547 is both a buy and a sell in the same plan. - The weekly chart says waiting is cheap. The weekly TD count is 3 of 9, so the earliest weekly exhaustion signal is the week ending Nov 13, after Q3 reports.

On missing a gap up: suppose Q3 passes my test and the stock jumps 10% from here, to about $1,870. - Your base case ($2,040) is still 9% higher. - Your bull case ($2,570) is still 37% higher. - Confirmation costs the first 10%, not the base case.

My position¶

MELI: don't start a new position; holders should trim into strength. The tactical trade is still to short a failed bounce into 1,813–1,860, with a stop above about 1,875. I wouldn't short at 1,697.

What would change my mind: - Q3 breaks the trend, not just holds it: gross margin above 40.9% (ideally 41% or more) and operating margin of 7.5% or better, on 40%+ growth. - The balance sheet stops deteriorating: current ratio at or above 1.12x, and liabilities/equity up less than 0.1. - Provisions in the 10-Q flat or down as a share of revenue. - Price: around $1,400, roughly 29x frozen-margin FY2027 EPS and a 3.5% earnings yield. At that price I'd own the floor without needing a recovery, provided Q3 holds 6.7%. - Relative strength: MELI outperforming the NASDAQ through the runoff, or a daily close above about 1,860.

Closing¶

What your floor needs, against what the data shows:

Your floor needs	Latest data
Gross margin to stop near 40.9%	Down year on year five quarters running; latest −4.7 points, the steepest
Opex to stay near 34%	Hit 36.8% in Q1; rose from Q2 to Q3 in both investment years
Current ratio at or above 1.10x	1.12x, down 0.04 last quarter
Liabilities/equity below 6x	5.56x, up five quarters running
35x to hold through falling FY2026 EPS	Trailing multiple down from 58x to 46x in eleven months

You asked for a bear case that doesn't run through your exit. Inside your hold rules, at your own multiple, the outcomes run from flat to −15%. Outside them, your exit books the gap rather than preventing it. And the mildest version of the last two Q3s puts operating margin at 5.9%.

So here's my question. Your floor starts paying off in Q1'27. On last year's pattern, your current-ratio and leverage exits fire with the Q4 report, one quarter earlier. Why buy a floor that pays off only after your own rules are on pace to sell you? Bear Analyst: # Bear Final: Half a Position on 0.8 Points of Opex, and the Data Leans the Other Way

Bull, that was a strong close. I re-ran every line, and the arithmetic holds. Here is what I concede:

The clock. In round three, two of my three comparisons set today's valuation gap against a twelve-month Treasury yield. That was a mismatch. Your rolled-forward table is the right frame, and I'll argue inside it. The third comparison, your floor at +8% a year out, was already a twelve-month number.
The opex calendar error. "0.8 points above the record low" compared a quarter with annual averages. That's the same mistake I already conceded on gross margin. Quarterly opex has run lower: 32.3% in Q2'24 and 31.8% in Q4'24.
Shipping. Your free-shipping fact is outside the packet. If the filings confirm it, it fairly explains Q3'25's gross-margin step.
Your forward-window math checks out: +22% at the Q3 report and +34% at Q4, with margins frozen.
The plan fixes are real. The zone no longer overlaps your exit, the credit trigger has numbers and the starter has a condition.

You've reduced the trade to one line: your 33.5% Q3 opex ratio against my 34.3%. You said "that's close, and I won't pretend otherwise." Agreed, so let's look at which way close leans.

1. Your Q3 needs opex to fall from Q2. It rose in both years we can see.¶

	Revenue, QoQ	Opex dollars, QoQ	Opex ratio change
Q2 → Q3, 2024	+4.7%	+14.8%	+3.1 pts
Q2 → Q3, 2025	+9.1%	+9.5%	+0.1 pts
Q1 → Q2, 2026 (your "floor" quarter)	+15.0%	+6.9%	−2.6 pts
Your Q3'26 (revenue +45% YoY)	+5.6%	+3.5%	−0.7 pts
My mildest Q3'26	+5.6%	+6.0%	+0.1 pts

In both Q3s we can see, opex grew faster than revenue from Q2 to Q3. Your forecast needs it to grow at about 60% of revenue's pace.
At your own +45%, a 33.5% ratio needs opex dollars up only about 3.5% from Q2.
That's half of Q2's own pace.
Only one quarter in the data grew opex more slowly: Q4'24, the quarter right after a spike.
Keep your 40.2% gross margin and grow opex at a historical pace instead:
at Q2's pace, operating margin is 5.6%;
at last Q3's pace, it's 4.8%.
Both are below your exit.
My 34.3% isn't a composite. It's Q2's year-on-year trend carried forward one quarter.
The opex ratio was up 2.9 points YoY in Q1 and 0.8 in Q2.
Q3'25 ran 33.5%. Add Q2's +0.8 and you get 34.3%.
Your 33.5% needs that YoY increase to disappear. Opex has grown faster than revenue YoY in four of the last five quarters.
The composite you objected to was gentler than either real Q3.
MELI's actual operating-margin moves from Q2 to Q3 were −3.8 points (2024) and −2.4 (2025).
Applied to 6.7%, those give 2.9% and 4.3%.
My 5.9% was the most generous reading of that history.

To be fair, if revenue holds near Q2's +50% instead of the +45% you modeled, opex at Q2's pace gets you to about 6.7%. So your number needs either opex growth to halve, or revenue to beat your own assumption while the currency tailwind narrowed through September. Two things push the other way:

CECL timing. You moved provisions into opex.
Q2's loan-loss allowance was set against the June 30 outlook.
Q3's is set against September 30. Since June the Fed has hiked, the peso and real have weakened, LatAm spreads have widened, and the market is asking whether Nu's credit quality can hold.
Brazil's rate cuts help, but most of what moved, moved against reserves.
The base rate.
Both Q2→Q3 transitions in the data carried a margin hit of more than 2 points: opex +3.1 in 2024, gross margin −2.3 in 2025.
You've called each of them one-time. That's two "one-time" hits in two years, on the exact transition you're forecasting, in what you've called a deliberate investment phase.
Across all eight quarterly transitions, there were four moves of more than 2 points against margin. Your forecast assumes none, plus a 0.7-point improvement.

2. The lever you found is two years old and moving away from you¶

Like for like, the opex ratio is rising. Q2 ran 32.3% in 2024, 33.4% in 2025 and 34.2% in 2026. That's about a point a year.
Q4'24's 31.8% is the holiday quarter, the seasonal low. Comparing Q2 with it is the calendar mismatch in reverse. The two Q3s ran 35.4% and 33.5%, so your forecast repeats the best Q3 in the data.
The floor has probably risen with credit. This is my inference: provisions sit in opex and scale with the loan book, and credit has gone from 25.8% to 30.6% of revenue in two years.
You said the new capital bought $5.4B of gross profit. Here's where that profit went:
Since FY2024, annual gross profit is up about $5.4B and opex is up about $5.2B. That's 95 cents of every new gross-profit dollar.
Operating income rose $276M, and net income fell $48M.
Over the same stretch, liabilities grew $22.7B and equity $3.5B.
Your two non-opex lines are both revenue ratios.
Revenue per dollar of assets is still falling year on year, just more slowly.
Assets per dollar of revenue fell because revenue jumped 49%. In dollars, the balance sheet added 12% more in 1H26 than in 1H25 ($8.7B vs $7.8B).

Your Q3 bet is that opex stops eating gross profit in the quarter whose allowance is set on September 30.

3. Shipping explains Q3'25. It doesn't explain your own forecast.¶

Q2'26 was a new step.
Q1'26 already carried the full shipping cut, yet gross margin still fell 2.8 points from Q1 to Q2.
The same step last year was −1.1.
That leaves 1.7 points of new erosion after shipping was in the base, and nobody has explained it.
Your own Q3 forecast is down 3.1 points YoY on a base that already includes shipping.
40.2% against Q3'25's 43.3% means three points of gross margin vanish in a year for reasons unrelated to free shipping.
Whether it's credit funding or 1P mix, it isn't shipping, and it's still running.
Lapping changes the comparison, not the level.
A threshold cut from R$79 to R$19 doesn't roll off. It's a permanent price cut on every small basket.
That's what defending share against cross-border discounters looks like, which was my round-one point.
Your base row needs gross margin near 42% at 33.5% opex. Your Q3 forecast is 40.2%.
Your gross-margin forecast sits 0.2 points above your exit. Any new step bigger than that trips it, and Q2's new step was 1.7 points.

4. The clock: conceded. Without recovery, your table roughly matches cash.¶

The floor row assumes no de-rating at all.
A year out, $1,828 is 45.5x the trailing earnings MELI would just have reported. That's today's trailing multiple, unchanged.
It holds after twelve months proving margins won't recover, and after FY2026 posts the first annual EPS decline since 2019.
Over the last eleven months, the trailing multiple fell from 58x to 46x.
Strip out the recovery rows and your table earns less than cash.
The no-recovery branch is your bear row, the 6% row and the floor.
Across both our weightings, however the 6% outcomes are split, that branch returns between −8% and +4%. That's below the roughly 4–5% cash pays in every split.
On the mapping you used, it's −5% on your weights and −8% on mine.
"A floor is enough" holds only for the floor row by itself. That row returns +8%, about three points over cash, and only if 35x holds on earnings that end in mid-2028.
So your excess return lives entirely in recovery. On either set of weights, the recovery rows average +49%. That's the thing you said in round three you no longer needed.
Recovery is exactly what Q3 starts to reveal. Both our plans treat Q3 as the sorting event; it's why you hold back half. If Q3 does sort the branches:
Cost of waiting: paying 10% more cuts the recovery branch from +49% to +35%. On your weights that costs about 6 points (45% × 14).
Benefit of waiting: holding cash through the no-recovery branch earns about 4.5% instead of −5%. That saves about 5.5 points (55% × ~10).
Net: waiting costs about a point on your own weights and gains about 4.5 on mine.
Your "a third of the base case" counted only the branch where waiting costs me.
Your $1,870 comparison doesn't apply to my plan. I only buy at $1,870 if Q3 clears 7.5% with gross margin rising. On a floor print I don't buy at all, so I don't lose 2%; I earn the cash rate.
The forward window doesn't change this.
If FY2026's decline is "in every model," so is FY2027's lapping. Both are arithmetic on a comparison base anyone can see today.
The +30% only appears if margins don't fall further, which brings us straight back to Q3 opex.

5. Your new rules protect less than they look¶

The opex-spike trigger can't fire before your margin exit unless gross margin beats your forecast.
At your 40.2% gross margin, operating margin breaks your 6% exit once opex passes 34.2%.
A 35.7% trigger only fires on its own if gross margin is 41.7% or better, 1.5 points above your forecast.
The delinquency trigger is weakest when growth is fastest.
A 15–90-day ratio on a book whose revenue is growing 57% is diluted by loans too young to be late.
It's the flip side of your own CECL point: growth front-loads provisions and back-loads delinquencies.
The balance-sheet exit is now just a size cap. A full exit needs two failures at once, which is the structure you criticized in my downside rows.
"Reclassification" means debt now due within twelve months. That is exactly what the current ratio exists to measure.
Even excluding it, Q2's underlying drop (0.023) is larger than the room you have left (0.021).
The Q1 leverage unwind you cite (−0.26 in Q1'25) didn't happen this year. Q1'26 rose 0.13.
Your starter's filter is already met.
Friday closed at 1,696.56, above your 1,668.44 trigger.
So the starter buys on any Monday that falls less than 1.7%, about half a normal day's range, on the morning after a polarized election.
The technical report's bounce trigger is a close above 1,731.36–1,745.25 with RSI above 43.5. You've put your filter at the bottom of the box, not the top.
Your zone filter screens out the safest fills and keeps the worst.
USD/BRL is 5.19 and LatAm spreads are 2.41%, both inside your lines.
If MELI falls another 6–8% while the real and spreads hold, the selling isn't about Brazil. It's MELI's own news, the Nu credit read-across or US real yields.
The first two are exactly the fills that carry information about margins and credit.
Your pre-Q3 loss could be bigger than 6.5%. That figure assumes both tranches are bought at one price.
Suppose the zone fills first (~1,583) and Q3 then gaps −13% (~1,382).
The starter is down about 19% and the zone tranche about 13%.
That's about −16% on the capital deployed, or 8% of the plan.

6. My entry price doesn't fail my own test¶

My §7 point was aimed at a thesis that needs 35x. $1,400 is 29x frozen-margin FY2027. If the market refuses 35x for a confirmed floor, that confirms my thesis. And 29x is a price that doesn't need 35x to come back.
My condition is post-Q3. The pre-Q3 path you describe isn't my plan. On that path, your own monthly-close exit would already have fired.
"Buys at $1,870 or not at all": yes. Passing on a stock whose no-recovery branch earns less than cash is the point.

7. Your question¶

"If it prints 6.7%, with opex back near 33.5%, are you still trimming?"

At today's price, no.
That print means operating income flat YoY, EPS up about 9%, and the first quarter this year in which the opex ratio doesn't rise YoY.
It removes the near-term tail I've been trimming against, so I'd move holders to hold. I'm saying it now so you can hold me to it.
I still wouldn't start a position.
On your own forecast, that print comes with a 40.2% gross margin: a sixth straight YoY decline and a new low.
It confirms your floor row, which your table values at +8% a year out, about three points over cash.
If the stock gaps up 10% on that print, I trim into the gap. At ~$1,870, your floor row ($1,828 a year out) is a 2% loss. You've told me what the floor is worth, and I'd sell it above that.
For the record: after the last two prints in the 6.7–6.9% range, the stock gapped −12.7% (May) and −4.8% (August). Those are the gap days we've both treated as earnings reactions.

My position¶

MELI: don't start a position; holders should trim into strength. The tactical trade is still to short a failed bounce into 1,813–1,860, with a stop above about 1,875. I wouldn't short at 1,697.

What would change my mind: - Q3 gross margin above 40.9% (ideally 41% or more) and operating margin of 7.5% or more, on 40%+ growth. - Q3 opex at or below 33.5%, together with a provision line in the 10-Q that is flat or down as a share of revenue. That would show Q2's opex drop wasn't just Q1's spike reversing. - A current ratio at or above 1.12x, and liabilities/equity up less than 0.1. - A price around $1,400 (29x frozen-margin FY2027), with Q3 holding 6.7%. - MELI outperforming the NASDAQ through the runoff, or a daily close above about 1,860. - New: a 6.7% print with opex at 33.5% moves holders from trim to hold at today's price.

Closing¶

You said the bear case had narrowed. Here's what yours narrowed to: - Round one: half price for a faster grower, with margins back to 11–12.7%. - Round two: the 2021 playbook. - Round three: "a floor is enough." - Round four: half a position on 0.8 points of Q3 opex, with a gross-margin exit 0.2 points below your own forecast.

Q3 print	Your plan	Mine
Recovery: op margin ≥7.5%, gross margin >40.9%	Ahead by the gap (~10%) on half	Buy after the gap; miss the first leg
Floor: 6.0–7.5%, gross margin ≥40%	Add; your table says +8% a year out	Hold; buy nothing; trim a pop
Miss: op margin <6% or gross margin <40%	Exit after the gap: up to −16% on what's deployed	Cash

I'm not claiming Q3 prints 5.6%. I'm claiming three things about your own forecast: - Your floor tranche needs Q3 at or above your central case. - Your gross-margin exit is 0.2 points below it, and your recovery trigger 0.7 points above it. - In the row you expect, being early earns about three points over cash.

You're closer to selling than to adding.

So here's my last question. Your forecast needs Q3 opex to grow about 3.5% from Q2. That's half its pace in the quarter you called the floor, in a quarter whose loan-loss allowance is set on September 30. At Q2's own pace, Q3 prints 5.6%, and your exit fires only after the gap. What in the data, not the hope, says opex growth halves? Bear Analyst: # Bear Final: At $1,696.56 Neither of Us Buys, and the Floor You'd Buy Later Runs on Borrowed Growth

Bull, that was your most honest round. You priced no recovery, called Q3 a coin flip and let my multiple set your entry. I re-ran all nine cells of your grid. Here's what I concede:

The grid is right, every cell.
Your bear row is mostly dead after a 45% Q3. I put 30% on it two rounds ago. After a print that holds $683M on 45% growth, it's worth about 5%. But that 30% stood in for my whole "margins keep falling" branch, and a floor print only kills the growth-collapse part of it.
The starter fix and dropping pre-Q3 zone buying are real. A gap through your stop now costs about 3–4% of the plan.
Your "95 cents" split is right.
About $1.2B of the ~$1.55B gap to FY2024 margins is gross margin.
Outside the Q1 spike, opex sits within ~$50M of its FY2024 ratio.
My "a point a year" was quarter-picking. Full years were flat.
The flaw I'll show in your credit gate was in my version first (§5).

1. At today's price, we agree¶

Read your own plan. At $1,696.56 it buys nothing: - The starter needs a close above 1,731.36, which is 2% higher. - The other 75% waits for a print you now call a coin flip.

The label says BUY, but the plan says wait. On the decision in front of us, MELI at $1,696.56, we land in the same place. Two disagreements remain: 1. Buying a 2% breakout and holding it through four events. 2. Buying half a position on a floor print at 35x.

2. Your question: the weight, and why a floor print barely moves mine¶

The answer is about 5%, as conceded above. Here's what a floor print doesn't touch.

Your own decomposition answers your question. The recovery in your base and bull rows is a gross-margin recovery: - Over the trailing year, about 78% of the gap to FY2024 margins is gross margin. - In Q2 alone it's 88%: 5.2 of the 5.9 points between Q2's operating margin and FY2024's. - Every cell in your grid holds gross margin at 40.2%. That's a new low and a sixth straight year-on-year decline.

A floor built on opex says nothing about four-fifths of the problem. So it doesn't shift weight toward recovery. It shifts weight from "margins keep falling" to "margins stuck," and "margins stuck" is the floor branch. On your own year-out method:

Floor branch, a year out	Price	Return
Your floor row: 35%/30% growth, 35x	$1,828	+8%
Same growth, multiple repeats September (~30x)	$1,566	−8%
Growth at what a 6.7% margin funds (27–30%), 35x	$1,680–1,760	−1% to +4%
Same, ~30x	$1,440–1,509	−11% to −15%

Cash pays about 4.5%. Only one of the four rows beats it, and that row needs both your growth and your multiple to hold. §3 and §4 explain why I don't assume either.

3. A 6.7% floor can't fund the growth your cap pays for¶

Your cap is 35x FY2027 EPS on the 45%/35% revenue path. Run that path through the balance sheet.

Equity can grow about 27% a year. At a frozen 6.7% margin, forward-year net income is about $2.1B, or 27% of today's $7.8B of equity. That's how fast the balance sheet can grow without adding leverage.
It's about 30% if currencies keep adding to book as they did over the past year (+$258M).
September's moves in the peso and real argue against that.
Assets would grow about 44%. Your own figure for 1H26 is $0.46 of new assets per revenue dollar. At that rate, your revenue path grows assets about 44% over the next four quarters.

Liabilities/equity	Q2'26 (actual)	Q3'26	Q4'26	Q1'27
Earnings only	5.56x	5.78x	6.02x	6.22x
Plus currency gains at the 1H26 pace	5.56x	5.70x	5.87x	6.00x
Q4 at last year's seasonal asset build			6.2–6.3x

Assumptions: frozen 6.7% margin; 64% of operating income reaches net income; revenue +45% in 2H26 and +35% in 2027; new assets of $0.46 per revenue dollar ($0.68 for a Q4 like last year's); currency gains of about $100M a quarter.

So your floor row comes in two versions: - Growth slows to what the margin funds. Those are the third and fourth rows in §2: −1% to +4% at 35x. - Growth runs on your path. Liabilities/equity crosses your 6.0x line on the February or May balance sheet, and your rule stops adding. - If Q4 repeats last year's asset build, only a Q4 margin of roughly 10–12% keeps it under the line. - On a modest recovery (7.5–9.5%), your gate would block the recovery tranche in the very report where your recovery test could first pass.

That's my answer to "PEG near 1.2": the growth is borrowed. At a 6.7% margin, earnings fund about 27% growth, and the rest is leverage your own rule caps. A floor that has to borrow its growth isn't a trough. It's the investment phase, refinanced.

4. 35x isn't a floor for the multiple: Q2 already tested it¶

You asked why a floor print at 35x isn't a buy. The market ran that test two months ago. - Q2 is the print your add line is built on: $683M of operating income, up 11.8% from Q1. - It's the quarter you called the floor in round three.

Here is how it priced on your cap's own yardstick, FY2027 EPS frozen at 6.7% (about $48.5):

Date	Price	Multiple
Q2 print-day close (Aug 6)	~$1,830	37.7x
Sept 2	$2,006.58	41.4x
Today	$1,696.56	35.0x

The floor held, but the multiple didn't. It fell 15% in a month on unchanged earnings. Your line that the de-rating from 58x to 46x "happened while EPS fell 9%" skips this September leg.
Your cap would have kept you out at 37.7x. I grant that. But the cap equals today's price because the de-rating has already happened, not because it's finished.
Every force behind the de-rating has a date in the next four weeks:
CPI in mid-October
the runoff on Oct 25
the FOMC on Oct 27–28
At 35x the earnings yield is 2.86%, still below 10-year TIPS at 2.88%.

5. Your floor tranche needs a narrow outcome, and the cap picks the wrong prints¶

Your floor tranche needs	What Q3 has done on record
Gross margin ≥ 40% (a slip of no more than 0.9 points from Q2)	−0.7 in 2024, −2.3 in 2025: one pass, one fail
Operating income ≥ $683M	Fell from Q2 in both years (−23%, −12%)
Current ratio ≥ 1.10x (a drop of no more than 0.021)	Fell 0.024 in Q3'25; repeat that and it's 1.097x
Provisions flat or down vs credit revenue	Passes mechanically if lending slows (below)
Price at or below your cap	Fills only on prints the market prices at 35x or less

Opex. Every add cell needs Q3 opex to grow more slowly than in any Q3 on record. - The record: the two Q3s grew opex 14.8% and 9.5% from Q2. In your +9.5% column, the milder of the two, all three rows exit at 4.8%, 5.2% and 5.9%. - Three of your four add cells use a Q1 number. They sit in the +4.1% column, which comes from Q1'25. That quarter, revenue fell 2% from Q4 and the opex ratio rose 2.0 points. It's the same calendar mix-up we've spent three rounds catching in each other. - Your post-spike analog has already failed its first test. - After Q3'24's spike, a 14% revenue step came with opex up 2.5%. - After Q1'26's spike, a 15% revenue step came with opex up 6.9%, nearly three times the pace. - There's no spike left to give back. By your own decomposition, opex outside Q1 is already within ~$50M of its FY2024 ratio. Carrying Q2's narrowing forward to a 32% ratio counts the same reversal twice.

The credit gate. - It's built to pass in your base case. - Under CECL, a loan's lifetime losses are booked up front, while its interest arrives over its life. - Slow the book and provisions fall relative to credit revenue mechanically, even at unchanged loss rates. - Your thesis is that the book is slowing, so the gate passes whatever credit quality does. It's the mirror image of the delinquency dilution you accepted. - My version had the same flaw, only worse. Measuring provisions against total revenue gets flattered by mix as well. So let me fix both: measure delinquencies or charge-offs against the loan book from a quarter or two earlier, the loans those losses actually came from. - The allowance you'd read it from was set on September 30. On that date: - the 10-year hit its 2026 high (5.29%), and real yields hit their September peak (2.93%); - the Fed had hiked two weeks earlier; - the peso was about 4.7% weaker in three weeks; - the macro report flags that Brazil's central bank may pause.

August–September averages explain Q3's currency translation. They aren't a quarter-end loss forecast.

The cap. It's discipline, I grant you. But look at what it selects. - If the market prices a floor print above 35x, you don't buy. - You fill only on the floor prints the market prices at 35x or less. Those are the ones where it sees something under the headline, or where the multiple is still falling. - The nearest thing to a floor print on record, Q2, gapped −4.8%.

6. The starter is a coin flip against this year's tape¶

Every earnings-type gap this year was down, averaging −8.5%. Even the floor-like one, Q2, was −4.8%.
Your own grid gives four adds, one hold and four exits. That's at the mildest gross-margin slip on record. A 2025-sized step trips all nine.
The starter's job is to catch an up-gap MELI hasn't produced on any print this year.
You'd hold it through the estimated death cross (~Oct 21), the runoff, the FOMC and the print.
Its stop works on closes, so a gap can jump it.
A relief close after the first round just buys you a ticket to the runoff.
The technical report prices both ends of this bounce:
Its long entry near 1,745 risks about 1.4 ATR to make 1.2–2.1, which it calls "marginal."
Shorting a failure at 1,813–1,860 risks 0.7–1.1 ATR to make 2.6–3.1.
The bounce your starter buys runs straight into the band where I'd sell it.

7. A fair hit on my trigger, and the print that would make me a buyer¶

You said my recovery test catches your bull row, not your base row. That's partly fair. But your base row is a gross-margin recovery; that's the 78–88% from §2. If Q3 gross margin falls again, the base row hasn't started yet, and my test missing it is the test working.

Still, here's a test your base row can pass without a Q3 margin jump. It's the trough I've asked you to show me since round two.

Q3 print	Your plan	Mine
Recovery: gross margin > 40.9%, op margin ≥ 7.5%, growth ≥ 40%	Add floor + recovery tranches	Buy
Floor that funds itself: op income ≥ $683M, gross margin ≥ 40.9%, liabilities/equity up < 0.1	Add 50% at your cap	Buy at your cap (new)
Other floor prints: op income ≥ $683M, but gross margin < 40.9% or liabilities/equity up ≥ 0.1	Add 50% at your cap	Cash; holders hold on a 6.7% print with opex ≤ 33.5%
In between	Hold starter	Cash
Miss	Exit, ~3–4% of plan	Cash

That leaves one row of disagreement, plus the starter. On your own path, that row is the likeliest floor print: - Q3 gross margin fell from Q2 in both years on record. - Your path adds 0.14–0.22 to leverage in Q3. Leverage has risen at least 0.1 in each of the last three quarters. - Keeping the rise under 0.1 needs Q3 asset growth of about 7–9%, the slowest in the series. That would be your round-one CECL mechanism, made visible.

If that shows up alongside gross margin holding, I'm a buyer, and I'm saying so now.

My position¶

MELI: don't start a position at $1,696.56, and holders should trim into strength. The tactical trade is still a short on a failed bounce into 1,813–1,860, with a stop above about 1,875. I wouldn't short at 1,697.

What would make me a buyer: - A Q3 recovery print, as defined above. - A floor that funds itself: operating income ≥ $683M, gross margin ≥ 40.9% and liabilities/equity up less than 0.1. I'd buy at your cap. - A price around $1,400 (29x frozen FY2027) with Q3 holding 6.7%. - Price strength: a daily close above about 1,860, or MELI outperforming the NASDAQ through the runoff. - Standing commitment: a 6.7% print with opex ≤ 33.5% moves holders from trim to hold.

Closing¶

You closed with what hasn't changed. Every line has another half:

You said	The other half
Revenue +49.8%	Gross margin at a record-low 40.9%, down year on year five quarters running
Gross profit +$1.07B in a quarter	Operating income −$142M in the same quarter
Book value +37%	Liabilities +60%, and leverage up five quarters in a row to 5.56x
35x next year with no recovery	A 2.86% earnings yield, below TIPS, on growth that crosses your 6.0x line by February or May
Down 15% on macro, not on a print	41x to 35x on unchanged earnings, with CPI, the runoff and the FOMC still ahead

Look at how your case has moved: - Round one priced margins back at 11–12.7%. - Round two leaned on the 2021 playbook. - Round three said a floor is enough. - Round four put half a position on 0.8 points of opex. - Now it buys nothing at today's price: a quarter of the position on a breakout, and half on a floor print at 35x.

Each step was more honest. Each also moved toward where I started: don't pay for the trough before you see it.

What's left is one row of the table. The floor print you'd buy most likely arrives with gross margin at a new low and leverage up another 0.15–0.2. That would be a floor in operating expenses, which were never the main problem. And it would be financed with leverage, the very line you've told me can't cross 6x.

So here's my last question. If Q3 prints your $683M with gross margin at 40.2% and liabilities/equity up about another 0.2, what exactly has bottomed?

Research Manager¶

Recommendation: Underweight

Rationale: Quick take: the debate ended much closer than the labels suggest, and on the decision in front of us right now the bear carried it. The bull's foundation is solid and mostly undisputed. Revenue growth accelerated four straight quarters to 49.8% on a ~$35B trailing base, and the narrower revenue line accelerated too (+27.6% to +46.9%). Gross profit grew $1.07B YoY in Q2, there has been no dilution, book value is up 37%, and ROE is still in the mid-20s in the worst-margin quarters. His best valuation point survived every check: freeze operating margin at Q2's 6.7% and FY2027 EPS is ~$48.5, so $1,696.56 is ~35x next year with no recovery assumed. Once the 2026 compression is in the base, earnings grow with revenue (~30% in FY2027). The bear also conceded that the ~15% slide from the $2,006.58 Sept 2 close tracked the dollar and the peso rather than company news. That's why this isn't a Sell; even the bear won't short at $1,697. Over the next four to five weeks, though, the bear's case is stronger, and the bull conceded most of it. First, the line that matters hasn't stopped falling. Gross margin hit a dataset-low 40.9% in Q2, down YoY five straight quarters, with the latest decline (-4.7 pts) the steepest. Roughly 78-88% of the gap to FY2024 margins is gross margin. The 'floor' the bull found is mostly Q1's opex spike reversing, which says little about the bigger problem. Second, Q3 is seasonally weak. Operating margin fell 3.8 and 2.4 points from Q2 to Q3 in 2024 and 2025, and the bull's own grid puts the median Q3 print at 6.0%, exactly his exit; he called it a coin flip. All three earnings-type gaps this year were down (-8.05%, -12.70%, -4.82%), including the floor-like Q2. Third, even at 35x frozen-margin FY2027, the earnings yield (2.86%) sits below 10-year TIPS (2.88%). The no-recovery branch earns about cash or less, so the excess return depends on a gross-margin recovery that Q3 will start to reveal. That makes waiting cheap and carrying full size through the print expensive. Fourth, the balance sheet is drifting toward the bull's own limits. Liabilities/equity is 5.56x after five straight increases, and the 1.12x current ratio is at a series low. At a 6.7% margin, retained earnings fund only ~27% equity growth against ~44% asset growth on his revenue path. Credit, about 31% of revenue and growing 57%, is a blind spot: the packet has no delinquency, provision, segment-margin or GMV data, and Nu's slide is a live warning on the same Brazilian borrowers. Finally, the tape and the calendar argue against size. Daily and weekly trends are down, a death cross is estimated around Oct 21, and there has been no capitulation. Today's first-round vote, mid-October CPI, the Oct 25 runoff and the Oct 27-28 FOMC most likely all land before the print. The tell is that the bull's final plan buys nothing at $1,696.56; it waits for a breakout or the print. So the live question is whether to carry full exposure through a dense, negatively skewed event window into a coin-flip print, and the evidence says no. What decided it: gross margin still falling at an accelerating rate, Q3 seasonality putting the base case right on the bull's exit line, a valuation that only beats cash if margins recover, and leverage trending toward limits. Weighed against that is a franchise strong enough that I want to keep half the position and rebuild quickly if Q3 clears the thresholds both sides agreed on. That's Underweight, not Sell.

Strategic Actions: Target: ~50% of a standard MELI allocation through the Q3 print. Holders already at or below that level hold without adding, and accounts with no position stay flat until Q3 reports. 1) Sell strength, not support. At $1,696.56 MELI is oversold (RSI 33.5, daily TD 9 complete) and only ~6% above the 1,546-1,600 longer-term support zone, so don't dump at market. A full-weight holder sells half the cut (to ~75% of standard) on a rebound into 1,731-1,745, the top of the Oct 1 range and the technical bounce trigger. Sell the rest (to ~50%) into the 1,813-1,860 resistance band. 2) Deadline: be at target by the close on Fri Oct 23, the last session before the Oct 25 runoff, the Oct 27-28 FOMC and most likely the print. Sell at market if no bounce comes. Exception: if MELI is at or below 1,600 that day, stop at ~75%. At that price it is ~33x frozen-margin FY2027 EPS with an earnings yield above TIPS, and selling into support is poor value. 3) Accelerator: go straight to ~50% regardless of price, overriding the exception, if either of these happens: USD/BRL closes above 5.24 while LatAm corporate spreads are above 2.5% (the macro report's stress lines; now ~5.19 and 2.41%), or the runoff produces a fiscally negative result. That path hits currency translation, CECL reserves and Brazil's room to cut rates all at once. 4) Reversal: a daily close above ~1,860-1,875 flips the daily trend, heads off the death cross and clears the bear's own stop. If that happens, stop trimming and rebuild to 100% (Hold); flat accounts build to ~50% and wait for the print for the rest. If MELI outperforms the NASDAQ from Friday's close through the runoff, pause further trims. Do not buy a close above 1,731 by itself; that bounce runs straight into resistance. 5) Risk on the residual: a monthly close below 1,549.51 (the monthly SuperTrend; all three trends would then be down) -> cut to ~25%. A daily close below May's ~1,495 low -> exit. At 50% weight, a -13% print gap (this year's worst) costs ~6.5% of a standard position; at 75%, ~10%. If the mandate allows options, a put spread or collar through the Q3 date can stand in for the second trim tranche; the packet has no implied-vol data, so price it first. No outright short here; the technical read puts that trade near 1:1. 6) After Q3, re-size off the thresholds both sides accepted. (a) Recovery: gross margin above 40.9% (ideally 41%+), operating margin >= 7.5% and revenue growth >= 40% -> upgrade to Overweight. Rebuild to 100% even after a gap, and add toward ~125% on pullbacks to <= 35x FY2027 EPS frozen at the printed margin (~$1,900 at 7.5%). (b) Self-funding floor: operating income >= $683M (Q2's level), gross margin >= 40.9% and liabilities/equity up < 0.1x -> rebuild to 100% at or below the 35x cap (~$1,697 at 6.7%, ~$1,773 at 7.0%), and only above 1,549.51. © Plain floor: operating income >= $683M and gross margin >= 40%, but either gross margin below 40.9% or liabilities/equity up >= 0.1x -> hold ~50%. Move to ~75% only if opex is <= 33.5% of revenue and credit holds, meaning provisions and any disclosed delinquencies or charge-offs, measured against the loan book from one to two quarters earlier, are flat or better. Reassess at Q4. (d) In between: operating margin >= 6.0% but operating income below $683M -> hold ~50%, no adds. (e) Miss: operating margin below 6.0%, gross margin below 40%, or opex >= 35.7% of revenue -> exit the remainder, and revisit only after Q4 shows gross margin stabilizing. 7) Gates on any rebuild: no adds if the Q3 balance sheet shows a current ratio below 1.10x or liabilities/equity at 6.0x or higher. If either coincides with deteriorating credit metrics, exit. 8) Not in our packet, so pull it on the print: the Q3 report date, the provision-for-doubtful-accounts line, delinquency and charge-off ratios, loan-book size, segment margins and GMV. We also don't yet know today's first-round result. 9) Watch list: Monday's election reaction, mid-October CPI, the ~Oct 21 estimated death cross, the Oct 25 runoff, the Oct 27-28 FOMC, the 10-year vs 5% (a move back under 5% helps MELI most), and USD/BRL vs 5.24.

III. Trading Team Plan¶

Trader¶

Action: Sell

Reasoning: The plan's Underweight maps to a Sell, executed as a trim rather than a short. Over the next four to five weeks gross margin is still falling (a dataset-low 40.9%, with the steepest YoY drop yet at -4.7 pts), Q3 seasonality puts the median operating margin right at the 6.0% exit line, the ~35x frozen-margin FY2027 multiple (~$48.5 EPS) yields 2.86%, below 10-year TIPS, and leverage keeps rising (5.56x liabilities/equity, 1.12x current ratio) into a dense runoff/FOMC/print window in which all three 2026 earnings-type gaps were down (-8.05%, -12.70%, -4.82%). The tape confirms the direction (weekly and daily SuperTrend down, price 7.7-8.8% below falling 200/50 SMAs with a death cross estimated around Oct 21, MACD -50.37 below its signal, OBV at a 90-session low on 09-28, no capitulation), but at 1,696.56 MELI is short-term stretched (RSI 33.49, daily TD 9, ~0.9 ATR above the 1,646.73 lower band, light-volume inside day) and only ~6% above the 1,546-1,600 monthly-SuperTrend support, so a short is ~1:1 and selling at market is poor value; the cut is therefore sold into strength at 1,731-1,745 and 1,813-1,860, with a market fallback by the Oct 23 close. Half the position is kept because the franchise is intact (49.8% revenue growth on ~$35B, mid-20s ROE, no dilution, ~30% FY2027 EPS growth even with frozen margins), and a daily close above ~1,875 (above the 1,860 daily SuperTrend stop and 50 SMA) invalidates the trim and triggers a rebuild to full weight.

Entry Price: 1738.0

Stop Loss: 1875.0

Position Sizing: Target ~50% of a standard MELI allocation through the Q3 print; no outright short. Full-weight holders sell ~25% of standard at ~1,738 (rebound into 1,731-1,745) and the other ~25% at ~1,835 (1,813-1,860 band). If no bounce comes, finish at market by the Fri Oct 23 close, but stop at ~75% if MELI is at or below 1,600 that day. Holders already at or below 50% hold without adding; flat accounts stay flat until Q3 reports. Accelerator: go straight to ~50% at any price if USD/BRL closes above 5.24 while LatAm spreads exceed 2.5%, or if the Oct 25 runoff is fiscally negative. Pause trims if MELI outperforms the NASDAQ from the 10-02 close through the runoff. Invalidation: a daily close above ~1,875 -> stop trimming and rebuild to 100% (flat accounts to ~50%). Residual risk: a monthly close below 1,549.51 -> cut to ~25%; a daily close below 1,495 -> exit. At 50% weight a -13% print gap costs ~6.5% of a standard position, vs ~10% at 75%. A put spread or collar can replace the second tranche, but the packet has no implied-vol data to price it. After Q3: gross margin above 40.9%, operating margin >= 7.5% and revenue growth >= 40% -> rebuild to 100%, adding toward ~125% at <= 35x FY2027 EPS. Operating margin below 6.0%, gross margin below 40% or opex >= 35.7% of revenue -> exit. In-between outcomes follow the plan's floor rules (mostly hold ~50%). No adds if the current ratio is below 1.10x or liabilities/equity reaches 6.0x. Not in the packet: the Q3 report date, provisions/delinquencies/charge-offs, loan-book size, segment margins, GMV and today's first-round election result.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: Nobody else has spoken yet, so I'll set the frame before the other two chairs pull this somewhere it shouldn't go. I'm usually the one arguing to press a position. I'm arguing to press here too, just with the timing on our side. This Sell isn't a retreat from MELI. It's the most aggressive version of the trade the data supports. We sell into the bounce the chart is setting up, keep half the position in a franchise that grew revenue 49.8% on a $35 billion base, and hold a pre-set path back to full weight, and even 125%, once Q3 answers the margin question. I expect the conservative case to be "get out now" and the neutral case to be "it's oversold, sit tight and let the print decide." The first sells the bottom. The second bets the whole position on a coin flip.

Start with why we cut at all. Every input that matters over the next five weeks points the same way. Weekly and daily SuperTrend are both down. MELI has closed below its 200-day for 14 straight sessions. MACD is at its lowest reading in the 60-session lookback. OBV hit a 90-session low on 09-28, which means the July and August buying volume has been handed back, on mid-September volume running about 2.6 times July's pace. The selling is specific to this stock, not general market risk. Zacks headlined MELI falling while the market rose, and even Friday's 0.7% bounce lagged a 1.19% NASDAQ gain.

The fundamentals give no cushion either. Gross margin is 40.9%, the lowest in the dataset and down 4.7 points year over year. That's the fifth straight decline and the steepest yet. The easy year-over-year comparison doesn't protect you quarter to quarter: Q3 operating margin came in below Q2 in both of the last two years, 14.3% to 10.5% in 2024 and 12.2% to 9.8% in 2025. Starting from 6.7%, it doesn't take much of a dip to reach the 6% exit line.

On valuation, about 35 times frozen-margin FY2027 EPS of $48.5 is a 2.86% earnings yield, against 2.88% on 10-year TIPS. I'll concede to the neutral side up front that this is basically a tie. That's the problem. A tie means zero margin of safety if margins slip again, with the 10-year at 5.24%, just off its 5.29% high.

Then add the calendar: 1. Brazil votes today, so Monday is the first market reaction. 2. CPI comes mid-month. 3. The technical work puts a death cross around October 21. 4. The runoff is on the 25^th. 5. FOMC is on the 27^th and 28^th. 6. The Q3 print probably follows, though the date isn't confirmed.

All three earnings-type gaps this year were down: 8.05%, 12.70% and 4.82%. May's opened about 3.3 ATRs below the prior close, and no stop survives that. You either size for it or it sizes you.

Now the conservative argument I'm expecting: if it's that ugly, why keep half and wait for a bounce instead of just exiting? Because exiting here is the worst-priced trade in the packet. RSI is 33.5, the daily TD 9 is complete, price is less than one ATR above the lower band, and Friday was an inside day on the lightest volume since 09-11. The technical report puts selling at this level at roughly 1 to 1.

Look at what happened after this year's gaps. After May, the low was in within a week at a 1,546.81 close, and the stock then ran almost 30% to 2,006.58. After August, it closed back above the pre-gap level within three sessions. The message board right now shows fatigue, not euphoria. Bullish-tagged posts are 31% of messages, and one account supplies five of the nine bullish tags. Liquidating into that kind of sentiment low is how you hand the next buyer the 30%.

The fundamental bear case also isn't a solvency story: - Liabilities to equity of 5.56x is moderate for what is financially a lender. - ROE is still 27.5%. - Cash is up 21%. - Operating plus investing cash flow rose nearly 80% to $1.58 billion in the first half. - There's no dilution.

Q3 also has tailwinds. It faces an easy comparison against a 9.8% margin and $724 million of operating income. Currency translation helps: over August and September the real averaged about 5% stronger than a year ago and the peso nearly 9% stronger. Brazil has cut rates roughly 95 basis points.

And every tail the conservative fears already has a tripwire in the plan: - A monthly close under 1,549.51 cuts the position to 25%. - A daily close under 1,495 means a full exit. - Operating margin under 6% or gross margin under 40% means a full exit. - No adds if the current ratio breaks 1.10x or leverage hits 6x. - If MELI is at or below 1,600 on the 23^rd, the trim stops at 75% instead of finishing.

You don't need to sell at capitulation prices to be protected.

To the neutral seat, which I suspect will say it's oversold and the franchise is fine, so hold full weight: the oversold condition is already built into how we execute. We're not selling at 1,696. We're selling into 1,731 to 1,745, then into 1,813 to 1,860, where the 20-day, 200-day and 50-day averages and the daily SuperTrend are stacked. The technical work finds roughly 3 to 1 odds for trend-following sellers in that upper band. So we collect the best odds in the dataset without the squeeze risk of an outright short.

Don't lean on the TD 9 either. The first one printed on 09-18, and price fell another 5.1%. The weekly count is only 3 of 9, and the earliest possible weekly exhaustion is the week of November 13, after the print.

"Wait for Q3 at full size" isn't neutral. It's a full-size bet on a binary event, under these conditions: - LatAm credit spreads are at 2.41% after widening 51 basis points in six sessions. - USD/BRL is at 5.19 on the last data point, against our 5.24 trigger. - What looks like credit income is now about 30% of revenue and growing 57%. - Nu, the closest Brazilian fintech peer, is getting crushed. - We have no delinquency data at all.

Carrying that many unknowns at full weight is reckless, not bold. If you'd rather collar the second tranche, the plan allows it. But there's no implied volatility in the packet, and buying protection without seeing its price, ahead of an election and an earnings print, is how you overpay.

Here's why this is the high-reward line and not the timid one: - If both tranches fill, the average exit is about 1,786, roughly 5% above Friday's close. That's about 2.6% of a standard position earned just by being patient instead of selling at market. - If we're wrong and MELI closes above 1,875, clearing the daily SuperTrend and the 50-day, we rebuy into a confirmed trend repair. The whipsaw costs about 2.5% of a standard position. - If we're right and it revisits the 1,549 monthly stop, the sold half saves about 6.6%. - A repeat of May's gap costs 6.5% at half weight instead of 13% at full.

That's a small, defined cost against a larger avoided loss, with upside kept on half the position. That's positive skew.

The part both sides will underrate is the rebuild. If Q3 shows gross margin above 40.9%, operating margin at 7.5% or better and revenue growth of at least 40%, the plan goes back to 100%. It then adds toward 125% at 35 times FY2027 EPS or less. Thirty-five times $48.5 is about $1,697, which is Friday's close. So this plan is willing to be overweight MELI at today's price once the margin question is answered. It just refuses to pay for that answer in advance, at full size, through five events. We sell the uncertainty into strength and use the proceeds to buy the answer.

So for tomorrow: - If the vote delivers the Monday pop that one StockTwits poster is calling for, that's our chance to sell into 1,731 to 1,745. Sell it and don't fall in love with it. - If the result is fiscally ugly and USD/BRL closes above 5.24 with LatAm spreads through 2.5%, the accelerator says go straight to 50% at any price. Speed beats a few dollars when the regime breaks. - If MELI starts outperforming the NASDAQ from Friday's close through the runoff, we pause the trims. That protects us against a relief squeeze.

Every branch is decided in advance. That's aggressive risk-taking done right: decide ahead of time, act fast, and keep enough on the table to win big when the data turns. Trim into strength, hold half, and keep the cash ready for the rebuild. Aggressive Analyst: Fair hits, both of you. I wrote your speeches for you, and you each gave a better one than I did. So I'll start by accepting the fixes that make this plan sharper, because sharper doesn't mean more timid.

The 1,600 clause goes. The neutral is right that it can never fire once a close under 1,646.73 sells the second tranche. The conservative is right that it would have left three-quarters of the position sitting next to the monthly line going into a gap. The outperformance pause goes too. A Monday pop that beats the NASDAQ is exactly the fill I asked for, and a clause that cancels the fill it was written to capture is a bug. I'll take the neutral's dial instead, where relative strength moves the deadline rather than freezing the trims.

On the accelerator, a USD/BRL close above 5.24 now fires on its own. We check Monday's Fed release first, because our 5.19 is a September 25^th number. LatAm spreads need a second close above 2.5. On the upside, a daily close above 1,875 stops the trims, and only a weekly close buys back a tranche, to 75. Forty points between selling at 1,835 and rebuying at 1,875 is less than one ATR, and I won't defend paying that whipsaw. Flat accounts wait for the print. And you're both right that the 2.6 percent is what patience earns on the paths that bounce. It was never an expected value.

Two corrections to my own opening before anyone else makes them. First, this selloff is regional, not purely MELI's. Nu is getting hammered, LatAm spreads are out 51 basis points, and nothing in the news explains MELI's slide on company grounds. I'll take that correction gladly, because it argues for the core. A regional de-rating driven by a real-yield shock reverses when the shock does. The macro report puts MELI among the names with the most to gain if the 10-year gets back under 5 percent. Company-specific rot doesn't reverse on a CPI print. Regional fear can.

Second, the May run started from a retest to a 1,583 close six weeks later, not straight off the low. But that retest held about 2 percent above the May closing low, inside the 1,546-to-1,600 zone, with the monthly SuperTrend still up. That's what a base looks like, and it's the zone the half we keep is meant to sit through. Conservative, you called those bounces rentals, not recoveries. For anyone who held full size through them, that's fair. But a tranche structure is a rental agreement. Those rentals paid about 30 percent off the May low and erased the August gap in three sessions. I don't need them to be recoveries. I need them to be where we sell.

So look at what survives all those fixes, because it's the backbone of the trader's plan: half the position, sold into stacked resistance rather than at market, no short, and a live way back in. Neutral, you said my plan optimizes the average exit price. That was the least important thing I said, and I'll drop it. What this plan is built for is being at size when the margin answer comes back good, without being at size if it comes back bad.

We still disagree on three things: when the second tranche goes, how big the core stays, and how easy the way back in should be. On all three, the extra caution costs real money and buys protection that the triggers and the hedge already buy more cheaply.

Start with the conservative's best point, that the old plan only reached half on the paths that didn't hurt. Run that path again with the triggers in: - The grind closes under 1,668 and the first tranche goes. - It then closes under 1,646.73 and the second goes. - Both leave around 1,650.

A revisit of the monthly line at 1,549 then saves about 3 percent of a standard position, against the 0.7 to 2.8 you rightly said the old plan delivered. The bounce path still saves 6.6. The hole you found is closed, and a trigger closed it, not a market order.

I'll also grant that oversold isn't washed out. RSI hasn't closed under 30, ATR is shrinking, and the first TD 9 failed. But the first tranche doesn't need a bottom. The low end of its band is about 35 points away, roughly 0.6 of an ATR. MELI traded there intraday on two of the last three sessions: 1,739.88 on the 30^th and 1,731.36 on the 1^st. With a trigger 1.7 percent below, that isn't a counter-trend long. It's a one-week bracket on stock we already own, and it needs an ordinary day, not a rally.

Where I won't move is the second tranche. Conservative, you want it sold at market before CPI. The neutral did the math right: on a tape with no edge, a limit above and a trigger below costs nothing in expectation versus selling now. That cuts against you too. On a coin-flip tape, your market fallback earns nothing either. All it buys is certainty about the exit price, and the trigger and the hedge already buy that. If you think the drift is down, the 1,646.73 trigger catches it, at most 3 percent below today.

I don't think the next three weeks are a pure coin flip, though. Look at what's in them: - Tomorrow's reaction to Brazil's first round. - A CPI print after a 29,000 payroll number, which has already pulled hike pricing back. - The relief signals the macro report spells out: the real back toward 5.08 and LatAm spreads back under 2.2.

The technical report calls the relief-bounce setup ripe. The band it runs into, 1,813 to 1,860, is the best-odds level in the packet, about 3 to 1 for a seller trading with the trend. Your deadline sells that tranche the session before the likeliest catalyst.

Here's the trade in numbers, as a share of a standard position: - About 2 points gained if the band fills. - About three-quarters of a point lost if the trigger fires. - Maybe a point and a half lost if a hot CPI gaps it down.

That's a small bet with positive skew, which is exactly what this book should be making.

As for the death cross, the report's October 21 estimate assumes the price sits still. If it does, our trigger hasn't fired and two more days of holding is noise. If it falls, the trigger fires first. If it rallies, the cross moves out. And if MELI lags a strong Brazil Monday, the neutral's dial pulls the deadline in to the session before CPI anyway. I said speed beats a few dollars when the regime breaks, and I meant it. A scheduled data release isn't a regime break. The real breaking through 5.24 is, and that trigger now fires on its own.

Next, the size of the core. Conservative, if the put spread is expensive, your fallback is to cut to a third, on the logic that expensive protection means the market is pricing a big move. But a big move priced into an earnings print is a big move in both directions. MELI is 28 percent off its high. It's down 15 percent since September 2^nd with no company-specific reason in the news. Only 31 percent of posts are tagged bullish, and more than half of those come from one account. On that setup, the upside half of the distribution isn't a rounding error.

When puts are expensive, calls are expensive too, and the answer is the neutral's: sell the 2,060 call to pay for the 1,600-to-1,450 put spread. That strike is the weekly SuperTrend stop and the September rejection high, a level MELI hasn't closed above since the February gap. I'll happily give up anything past plus 21 percent over the next six weeks or so to keep the whole move from 1,600 to 2,060 on a full half-position. And the pricier the puts get, the more that call pays, so the financed version fits the budget far more often than the plain one.

One execution point on the hedge. Buy it on the same bounce we sell the second tranche into, or by the 23^rd, whichever comes first. The same strikes cost less with MELI at 1,800 than at 1,700, and the first-round premium will be out of the price by then. We're selling stock into strength. We should buy protection into strength too.

Be precise about what each fallback buys. Take a half-position with that spread on, expiring just after the print and costing the neutral's 1 percent budget, against your unhedged third:

Outcome	Hedged half	Unhedged third
Repeat of May's 12.7% day-one drop	about −3.9%	−4.2%
Full May path, to about 1,403	about −5.2%	about −5.8%
Good print, MELI up 15%	about +6.5% after the premium	+5%

The third does better on a milder gap, by one to two points on an August- or February-sized move, and on a flat outcome by the cost of the premium. So the third is built for the mild outcomes. The hedged half is built for the two that decide the year, a May-sized hole or a margin turn, and it wins both.

The hedge also fixes your May analog. Unhedged, a 1,481 close sells our half into the hole under the 1,495 rule. Hedged, we can work that exit over a session or two with the gap-day low as the line. That matters when August was back above its pre-gap close within three sessions. You said that when you can't see a risk, you size it small. I'd say you insure the part that can hurt you and keep the part that can pay you. Cutting size is insurance paid for with upside. So I'd work hard to make the hedge fit before I'd cut a share. If even the financed spread won't fit, I'll meet the neutral at 40 percent. Not a third.

Now the way back in, which is where the real money is. You both call the rebuild the least likely branch. That's probably true. But conservative, "even odds our rules force an exit on a gap" treats our exit line as if it were the market's line. If the trader's median estimate is 6 percent, a 6 percent print is close to what anyone reading the same filings would expect, and expected outcomes don't gap. Surprises do, in both directions, which is what a hedged half is shaped for. Also, the three 2026 gaps came off pre-print closes of 1,870 to 1,922. This one comes off a stock that has already been marked down 15 percent in a month.

There's also more pointing toward repair than either of you credited. The fundamentals report lists four likely drags on margin: - Shipping subsidies. - A shift toward lower-margin goods MELI sells itself. - The cost of funding loans. - Upfront loan-loss provisions under CECL, which fast loan growth pulls forward.

Two of those four were already easing going into the quarter that just closed. Brazil's interbank rate is down about 95 basis points from 15 percent, which goes straight at funding costs. And quarterly asset growth roughly halved, from 16 to 19 percent last year to 9 to 10 percent this year. That is the condition under which the report says the upfront-provision drag eases. It fits with operating expenses falling 2.6 points of revenue in Q2, and with operating margin slipping only 0.2 points from Q1 to Q2 this year, against 0.7 last year. Neutral, you're right that Q3 is in the books. My point is that what's in the books came from a better backdrop than the late-September tape MELI is pricing.

You're also right that the easy comparison against $724 million doesn't touch our rebuild tests. But it touches the stock. On roughly $10.7 billion of revenue, any operating margin above about 6.75 percent puts operating income above last year's, its first year-over-year rise this year. That print fails my 7.5 percent test and still hands the market a "profits are growing again" headline, with our half on board. Our tests decide whether we add. The headline decides how the half we hold trades.

On valuation, conservative, 46 times trailing earnings is a multiple on a margin trough. Operating margin was 14.6 percent in 2023 and 11.1 percent last year, and it's 6.7 now. Put last year's margin on the $35.2 billion of revenue MELI has already booked over the trailing year, and EPS is about $49. That's 34 times, a 2.9 percent earnings yield, a tie with TIPS with no growth assumed at all. You don't need to assume the future to get the tie. You only need last year's margin back.

Go one step further. The company took its margin from minus 6.7 percent in 2019 to 14.6 percent in 2023. If it does something similar, the trader's frozen-margin 2027 estimate, recalculated at last year's margin, lands in the mid-60s or better. At $65, MELI trades at 26 times earnings, a 3.8 percent yield. That's nearly a full point over TIPS, on an earnings stream that grows, which a TIPS coupon never does. That's the payoff the core exists for. Cut it to a third and you keep a third of it.

On the current ratio, I'm with the neutral, and I'd add a reason. Current liabilities jumped $4.4 billion last quarter while long-term liabilities fell $534 million, which looks like debt moving inside a year to maturity. For a payments platform, much of the rest is usually customer balances and money owed to merchants, and those grow when the franchise grows. A ratio that falls because the deposit base is expanding is a different signal from one that falls because funding is tight. So a reading under 1.10 should cap the rebuild at 75 until the filing tells us which it is. It shouldn't veto it.

Now the 125. You both want a second confirming quarter, and I see two problems with that.

First, the add is already self-limiting. It only happens at 35 times FY2027 earnings or less. If Q3 is good and MELI re-rates, that gate holds us at 100 on its own. The add only fires when the market hasn't paid for a good quarter, which is exactly when an overweight is worth the most.

Second, look at which quarter you're waiting for. Q3 is the seasonally hard one: operating margin fell from Q2 to Q3 in both of the last two years. Q4 is the easy one: margin rose from Q3 to Q4 both years, 10.5 to 13.5 and 9.8 to 10.1. A 7.5 percent margin in Q3 is the stronger confirmation. You're asking for the weaker one after the stronger one, and you'd be buying early next year, after the market has already priced Q4's seasonal lift.

The neutral's credit point is real, though. A margin pass with rising delinquencies is a false signal, and this release is our first look at the loan book. So stage it. A clean Q3 takes us to 100 plus half the overweight, about 112. Clean means: - All three tests pass. - Delinquencies and provisions are stable. - Leverage stays under 6x. - The price is inside the 35x gate.

The last 12 and a half points wait for Q4. On another 13 percent gap, that increment costs about 1.6 percent of a standard position. That's a bet I'll make on the hardest quarter of the year coming in clean.

The neutral's point about other holdings cuts both ways. If the caller owns Nu or a Latin America fund, count it toward the core. If MELI is their only Latin American exposure, that half is their entire stake in the trade that pays off if the 10-year falls back under 5 percent. That's one more reason not to shrink it to a third.

So here's where I land. The Sell stays, the half stays, and there's no short: - First tranche: sell on whichever end of the 1,668-to-1,731 box breaks first, at market by Friday. - Second tranche: the limit at 1,813 to 1,860 keeps working through the 23^rd. It sells at market on a close under 1,646.73, and the neutral's dial pulls the deadline in if MELI lags a strong Brazil Monday. - Accelerators: the real above 5.24 accelerates the trims on its own, and spreads need a second close above 2.5. - Upside: a daily close above 1,875 stops the trims, and a weekly close buys back to 75. - Hedge: the core gets a 1,600-to-1,450 put spread through the confirmed print date, financed with the 2,060 call and bought on the bounce or by the 23^rd. If it won't fit the budget, the core goes to 40 percent, not a third. - Exits: the residual-risk lines and the post-print exits stand, worked over a session or two if we're hedged. - Rebuild: back to 100 needs the three tests, stable credit and the leverage gate. A current ratio under 1.10 caps it at 75 until the filing explains it. Half the overweight comes on a clean Q3 inside the 35x gate, and the rest on Q4.

The conservative built a version where we never need the rally. Mine doesn't need it either, but it's still there, at size and hedged, when the rally comes. Every protection in it is bought with a trigger or an option, not by handing back exposure we'd have to rebuy after the answer is already priced. That's the high-reward version of this trade, and it's still a Sell. Aggressive Analyst: I'll start by dropping a rule I signed last round, because the neutral found the argument that actually kills it. MELI can't close above 1,875 without trading through the 1,813 to 1,860 order on the way up. So "stop the trims" never did anything, and the weekly rebuy to 75 was the whole rule. It was the last place this plan added size before the print, and it only fired once the 15 percent cushion I'd been leaning on was gone. I said this plan refuses to pay for the answer in advance at full size, and that rule did exactly that. It goes. Conservative, you called it first.

I'll take the rest of last round's fixes just as fast, because none of them costs the upside I'm here to defend: The state test on the session before CPI. Hedge strikes set off the price on the day we buy. The hedge closing with any exit and shrinking with any cut, since puts on stock we've sold are a short. Two sessions to work a hedged exit, with the gap-day low as the line and no extensions. A live rate for the real. Use the Brazilian central bank's daily fixing so nobody argues about which close counts. Both halves of the spread rule. A stated test before the current-ratio cap lifts. The 10-Q and the reserve test before 112, the price gate pinned to the pre-print $48.5, and 125 waiting for Q4. Opex as something we watch, not an exit.

Conservative, you called the hedged half a more bullish position wearing a protective label, and the neutral agreed. So do I, and I'll argue it on exactly those terms. In the two disasters, it does slightly better than your third. On a February- or August-sized gap, or a flat print, it costs a point or two. Two of this year's three gaps were that mild kind, so I accept the one-point budget as a hard limit. On the outcome that decides the year, a margin turn, it earns more, and it's already in position when the rebuild starts.

That's the trade I want. I'll give up a point or two in the middle of the range of outcomes to be at size, with a floor, when the answer is good. Everything else I'm asking for follows from that: protect the half with insurance, and don't let the rules give back the payoff it's there for.

First, CPI. Conservative, your best remaining point is that we could walk into CPI with nothing under us but a closing trigger, and closes don't protect against opens. The neutral's state test handles the second tranche. We only carry 75 percent through CPI if MELI closes above 1,731 the day before. But the core can still go into CPI unhedged in every branch, because the hedge doesn't have to be on until the 23^rd.

So move the deadline. The hedge goes on after Monday's reaction, on an up day if we get one, and no later than the close of the session before CPI. That one close then does two jobs: it decides the second tranche, and it's the hedge deadline. One hedge covers CPI, the runoff, the FOMC and the print.

On rough math, buying about a week and a half earlier costs a few tenths of a percent of the stock it covers. That's one or two tenths of a point of a standard position, against the event you called a regime break that arrives on a schedule. You asked me to defend the line that MELI has the most to lose if the ten-year breaks 5.29. I don't need to defend against that outcome. I'll insure against it.

That also answers your variance argument better than your own fix does. You said that when the expected value is the same, variance breaks the tie. Fine. Selling the second tranche before CPI cuts variance on both sides, because it gives up the bounce along with the downside. The put spread cuts only the side we don't want. If variance is the mandate, the hedge is the efficient way to meet it.

And the second tranche stops being a lottery ticket. From 1,697 you're right. The band is 6.9 percent up, the trigger is 2.9 percent down, and on a tape with no drift the limit fills maybe three times in ten. But the state test only keeps the band working if MELI closes above 1,731. From there, the band is about 4.7 percent up and the trigger about 4.9 percent down. That's even odds or better of filling at the best-odds level in the packet. A lottery ticket costs money and loses on average. This costs nothing on average, has a closing trigger about five percent below, and only stays in play once the bounce has actually shown up.

On the events themselves, neither of us knows. The prediction markets on Brazil were withheld, so the plan doesn't bet on the vote. Monday's trading decides the first tranche, and the fixing runs the accelerator.

On CPI, the headline will probably run warm, because oil spent September well above August levels. But "the evidence leans hot" overstates it: Ten-year breakevens moved five basis points through the whole September selloff. About 90 percent of the rise in yields was real yields, in the month the Fed hiked. Hike pricing started fading on Friday's 29,000 payroll print. Core PCE did pick up in August, but its three-month pace is still about 2 percent.

With the hedge on before the release, neither of us has to win that forecast.

Two details, so the hedge doesn't undo itself.

Neutral, your best rule was that we don't slide the puts lower to make the spread fit the budget. The mirror rule matters just as much: we don't pull the call closer either. If we sell one, it goes at 2,060 or 20 percent above that day's price, whichever is higher. Otherwise the half we're keeping for the turn gets capped right where the turn would show up.

Conservative, your strike critique applies to my own proposal too. Say we buy at 1,720 and MELI rallies to 1,880 before the print. Then we're back at the prices the last three gaps started from, holding puts struck for a stock 160 points lower. So a close above 1,860 before the print resets the whole hedge off that close. By then the core is up four or five points of a standard position, so the rally pays for it.

Second, the gross-margin exit. Conservative, you counted three ways out after the print and said the odds of a forced exit start at even and go up. The neutral showed the opex exit only fires on good news. Operating margin is gross margin minus opex, so the opex test can only fire on its own after gross margin climbs most of a point. Run the same arithmetic on the gross-margin exit and you find half the same mistake.

A gross margin under 40 only forces an exit the operating-margin test wouldn't already force when operating margin stays above 6. That means opex is doing the work. So look at what a gross margin in the high 30s actually says in Q3: Last year's Q3 gross margin was 43.3. Part of the trader's case for selling was Q2's 4.7-point drop from a year earlier, the steepest in the series. The two seasonal outcomes you've both cited, 40.2 and 38.6, mean year-over-year declines of 3.1 and 4.7 points. That's flat to narrower. A 39.8 would show the decline narrowing by more than a point on the trader's own yardstick, and the rule as written exits.

You'll say the quarter-to-quarter drop got steeper, 2.8 points this year against 1.1 last year. True. And if it keeps steepening and opex can't fall again, operating margin goes under 6 and we exit on that test anyway.

Here's the case the gross-margin exit decides on its own. Gross margin comes in at 39.8 and opex falls to about 33 percent of revenue. On about $10.7 billion of revenue, that's an operating margin of about 6.75, enough to clear last year's $724 million of operating income. That would be the first year-over-year rise in operating income this year, and the current rule sells the half into it.

So add a condition. Gross margin under 40 is an exit unless operating income is up year over year and credit is stable. In that case we hold the half and add nothing, and the rebuild still needs gross margin above 40.9. Conservative, you said a squeeze on opex like Q2's only happens once. If you're right, this exception never fires and costs you nothing. If you're wrong, it fires on the quarter that proves it, which is the one quarter we most need to still own.

Third, the way back in. Conservative, your case against 112 was that one quarter of credit data can't tell a real margin turn from a provisioning effect. The neutral's reserve test settles that in one quarter. Under CECL, the loan-loss reserve is the expected loss over the life of the loan book. If margin rose while the reserve held or grew as a share of loans, the margin wasn't borrowed from the reserve. If the share fell, we don't go. Delinquencies flat or lower are required on top of that.

Your other objection, that the price gate rises with a good quarter, was right. Pinned to the pre-print $48.5, the gate sits about where the stock is today. So 112 happens only after the gap risk has passed, only after the 10-Q clears the credit test, and only if the market hasn't paid for a clean quarter. That isn't size going into a fourth gap. It's size after the answer, at a price that says nobody believed it.

You said a recovery takes years and there'll be plenty left after a second clean quarter. This stock ran almost 30 percent from the May low to the September high without a single quarter that would pass our tests. It gave most of that back because margins never turned. The first quarter that does show a turn is when the turn gets priced, and waiting for the second means paying the market for the first. Outsized returns in a name like this come from being at size while a turn is still doubted, not from buying after two confirmations.

Nobody has answered the seasonal point either. Q3 is the quarter in which margins fell from Q2 two years running, and Q4 rose both years, so a clean Q3 is the harder test. And the overweight has an end date built in, because at this year's pace leverage reaches the 6x limit in about a year.

One more gap in the plan. Exits get two sessions after the print, with the gap-day low as the line. The rebuild should get the same discipline. Once the release clears the tests, we're back to 100 within two sessions, with no waiting for a pullback that a clean print won't give us. A plan that hurries out and dawdles back in has a bearish tilt nobody voted for.

A few quick ones.

Conservative, on the regional argument, you're right that the slide didn't lower the bar on margins. What it raised is the payoff for answering the credit question. The market is asking Nu whether credit quality holds while lending grows, and this release is the first answer we'll see from MELI. A good answer separates MELI from the group. A bad one is what the hedge and the exits are for.

Neutral, fair point: "expected outcomes don't gap" was too strong. But your read of how the stock reacted to each print makes my point better. The worst quarter got the biggest gap and kept falling. The quarter that steadied got the smallest gap and recovered in three sessions.

On funding, I'll concede the rate cut is worth tenths of a point of margin, not points. The real lever is slower asset growth, and the reserve test tells us whether that's showing up honestly. Whether the debt coming due is in dollars or reais is a 10-Q question, which is why the current-ratio test sits in the rebuild path.

On valuation, neutral, fair again: mid-60s earnings is a bull case. That's why we hold it as an option with a floor, not as a base case.

Conservative, the 2019 comparison cuts the other way. That raise was more than five times the equity it went into, and today MELI earns about that much in a year. The recovery doesn't need outside capital. It needs margins.

On other holdings, I take the correction. The core is a bet on the franchise and the margin turn, not on the ten-year. Treasuries are the cleaner rates trade, and any Nu or Latin America fund counts toward the core.

So here's the version I'll sign. Sell, hold half through the print, no short. Confirm the print date and the CPI date on Monday. Scale every step to what you hold. If you're already at half or below, skip the trims, but follow the hedge and the post-print rules. Flat accounts stay flat until the release.

Before the print: The first tranche sells at about 1,738 on a pop or at market on a close under 1,668.44, whichever comes first. If neither happens, it sells at market by Friday the 9^th. The second tranche has a resting order at 1,813 to 1,860 and sells at market on a close under 1,646.73. It stays open past CPI only if MELI closes above 1,731.36 the session before. Otherwise it sells at that close. Either way, it's done by the 23^rd. A fixing above 5.24 on the real speeds up the trims on its own. Credit spreads speed them up on two closes above 2.5, or one plus a MELI close under 1,668.44. Nothing gets bought back before the print, whatever happens around 1,875.

The hedge: A put spread with strikes about 6 and 15 percent below the price on the day we buy. Bought after Monday's reaction, on an up day if we get one, and no later than the close before CPI. Expiring just after the print, and costing no more than about one point of a standard position. If selling a call helps it fit, the call is struck at 2,060 or 20 percent above that day's price, whichever is higher. No lower puts and no closer calls. If it won't fit, the core goes to 40. A close above 1,860 before the print resets the strikes off that close. It closes with any exit and shrinks with any cut.

After the print: Operating margin under 6 is an exit. Gross margin under 40 is an exit, unless operating income is up year over year with stable credit. In that case we hold the half and add nothing. Opex is something we watch. A monthly close under 1,549.51 cuts to 25 percent, and a close under 1,495 is a full exit. A hedged exit gets two sessions, with the gap-day low as the line. The three tests plus stable credit and the leverage limit take us back to 100 within two sessions. A current ratio under 1.10 caps that at 75 until the 10-Q shows two things: the new current liabilities are mostly customer funds matched by liquid or restricted assets, and debt due within a year is covered by unrestricted cash and investments. 112 comes after the 10-Q shows reserve coverage held and delinquencies flat or lower, at or below 35 times the pre-print $48.5. 125 waits for Q4.

Conservative, you said you'd rather pay a little for the answer than pay in full for a fourth gap. In this version you don't have to choose. The insurance is on before every event we can see, and moving it up costs tenths of a point. The size we keep is the size that gets paid if margins turn. And the only time this plan goes overweight is after the answer is in, at a price the market refused to raise. It's still a Sell. It just doesn't forget why we kept half. Aggressive Analyst: Last round, so I'll start where both of you did, with what I owe.

Conservative, the exception I wrote last time was too loose, and you showed exactly how. If revenue grows near 50 percent, beating last year's $724 million of operating income takes only about a 6.5 percent margin. That's below where Q2 already ran, so it was a growth test wearing a margin costume. My yardstick for calling a 39.8 gross margin an improvement also leaned on last year's 2.3-point drop from Q2 to Q3. Anything above about 38.6 would have scored as a narrower decline. Both hits land.

Neutral, you're right that opex didn't fall from Q2 to Q3 in either year. I'd only note that one year was a 3.1-point jump and the other was flat. Two years is a trend, not a season, which is what you told the conservative in round one. You're also right that if opex does fall that far, the likeliest route is lower provisions. Where I part with you is what lower provisions prove, and I'll come back to it.

The rest I'll take without a fight.

The reserve test goes in front of the rebuild, not just the overweight. The neutral's reason is the right one: under CECL, the test can only downgrade a good-looking quarter. It can never rescue a bad one. Conservative, that's the reason, not the trader's vote. The trader wrote rebuild to 100 and add toward 125 on the same quarter. The trader voted for speed.

So I'll sign the neutral's staging. If the release carries the loan book and the allowance, we test it there and go to 100 within two sessions. If it doesn't, we go to 75 and the 10-Q decides the rest. If the 10-Q lands inside the window anyway, the staging costs nothing.

"Even odds or better" on the band oversold it. From just above 1,731, it's about a coin flip to touch 1,813 before 1,646.73. It's worse for 1,835, and the trend is down. The state test was never meant to create an edge. It keeps us from carrying 75 percent into CPI on hope, and it does that.

"The rally pays for it" was the budget stretching. So we allow one reset above 1,860, with its own half point. The core gets sized to whatever we can re-strike, the call stays where it is, and any share of the call matching a cut gets bought back inside that half point. If that path comes, we'll have sold the second tranche in the band and another sliver above 1,860. That's the best version of a Sell this plan can produce.

I'll take the conservative's mechanics too. Expiry comes at least three sessions after the print. Every "by the 23^rd" means the earlier of the 23^rd and the session before the print. If an accelerator fires, the hedge gets decided that same session.

Neutral, I agree the first-tranche deadline moves up if CPI lands by the 9^th. One wording change, though. Your line that 40 percent will usually be the honest answer after a break should just be the budget rule we already have. If the spread fits at percentage strikes inside the point, we buy it. If it doesn't, we go to 40. Let the price decide, not a presumption.

I'll also withdraw "a clean print won't give us a pullback," as I said it. But conservative, your evidence doesn't reach it either. May's retest came after the worst quarter of the year. There isn't one print this year where margin rose year on year, so neither of us knows how a turning quarter trades. That's why the window is two sessions in both directions. We don't chase, and we don't sit waiting for a pullback neither of us can prove.

Now your headline problem, conservative: both of my post-print rules put on size after the hedge is gone. The neutral answered that better than I could. The hedge was bought for the gap, not for every week after it. The trader's plan has always held half unhedged after an in-between print, and no one here has objected. Size after the print should be set by evidence, and on the evidence I've moved. I'll take 25 through a broken gross margin until it's verified, and 100 only on a release that carries the reserve data.

That leaves one real problem, and it's the kind the neutral warned about: two rules that disagree where they meet. Both mistakes cost us upside.

Neutral, your decomposition test says that if provisions fell as a share of revenue and did most of the work, the gain was borrowed and the exit stands in full. Last round you said something different, and I'll quote it back. If margin improved because provisions fell, look at the reserve as a share of the loan book. If that share held, slower loan growth lifted the margin honestly. If it shrank, the margin was borrowed.

Those two rules split on exactly one quarter: provisions are down because MELI booked fewer new loans, and the reserve share holds. Under CECL, expected lifetime losses are reserved the day a loan is made, so slower originations mean lower provisions mechanically. That isn't borrowing. It's the up-front drag easing, the one mechanical repair route the fundamentals report identifies. Your decomposition exits that quarter, and your reserve test passes it. The reserve test is right, because it's the only one of the two that measures whether the reserve kept pace with the risk.

Then look at 112, where you've both added a requirement that the loan book slow. So this plan demands slower loan growth before it adds. Then, when it decides the exit, it treats the provision drop that slower loan growth produces as borrowed margin. It can't be both.

So make one number the judge everywhere: the reserve as a share of the loan book. Falling provisions are a question, not a verdict. Conservative, your borrowed-margin quarter still exits under this. If the provision cut came out of the reserve, the share falls and we're out. All I'm removing is the false positive.

On size in that branch, I'll meet you both on release day. Gross margin under 40 with operating income up means we hold 25. We don't yet know which kind of quarter it is, and 25 fits evidence that ambiguous. But the reserve test shouldn't decide between 25 and zero. It should decide between zero and half.

Here's why. Take the neutral's in-between quarter: an operating margin of 6.5 on a gross margin of 40.3, on about $10.7 billion of revenue. That puts operating income near $696 million, down about 4 percent on last year, and we hold half through it with nobody objecting. Once it's verified, the quarter we're arguing about has operating income growing and an intact reserve. Holding it at 25 while we hold the weaker quarter at half is a cliff built on a few tenths of a point of gross margin.

Neutral, you matched 25 to the size we use after a monthly close below the 2026 base. That's the market telling us the structure broke. Operating income growing again on an intact reserve is the company telling us the opposite. They shouldn't share a size.

Before anyone calls the gross line sacred, look at the first two years of the margin run all three of us keep citing. In 2020, gross margin fell five points, from 48.0 to 43.0, and it slipped again in 2021 to 42.5. Both were new lows for the series. Over those same two years, operating margin went from minus 6.7 to 3.2 to 6.2, because opex fell from about 55 percent of revenue to about 36. Gross margin didn't turn until 2022.

A rule that read a new low in gross margin as a broken thesis would have sold the opening of the best margin cycle in this company's history. Conservative, you'll say MELI is more of a lender now and the gross line carries funding costs. It does, along with shipping and the goods MELI sells itself. That's exactly why I'm not asking to hold on gross margin alone. The reserve test sits on top.

So apply the neutral's own closing line here. Where the release carries the evidence, act within two sessions, and where it doesn't, wait for the filing. If the release shows the reserve share and the delinquencies holding, we're back to half within two sessions. If it doesn't carry that data, we stay at 25 until the 10-Q. Going above half still needs gross margin over 40.9, like every other path.

Second, the loan-growth gate on 112. Conservative, you wanted the book to slow so that a flat delinquency ratio actually means something. That's the right concern with the wrong instrument. Young loans flatter the ratio because the denominator is full of loans that haven't had time to go bad.

The standard fix is to divide today's delinquent balances by the loan book from a couple of quarters back, the loans that actually produced them. That strips the flattering out directly, at any growth rate. It's also the stricter read, because on a growing book the lagged ratio always sits above the headline one. The neutral's right that your 56.7 against roughly 52 is dollar growth with currency mixed in, so nobody here knows whether the book is speeding up. With a lagged ratio, we don't need to.

Requiring the book to slow does something else entirely: it rules out the strongest quarter MELI could print. Picture credit still growing fast, the reserve share holding, lagged delinquencies flat, and operating margin through 7.5 in the quarter that fell from Q2 two years running. Under CECL, fast growth pulls provisions forward. So clearing 7.5 with the book still growing fast and the reserve intact means clearing it against the headwind. That's the best version of the turn, not a weaker one, and your condition shuts the door on it. What looks like credit income is about 30 percent of revenue. Demanding that it slow before we add is demanding that the growth engine throttle back first.

Everything else on 112 I'll sign: the reserve share held; lagged delinquencies flat or lower; MELI at least matching Nu or a Latin America fund from the pre-print close through the 10-Q; the price at or below 35 times the pre-print $48.5.

Neutral, your group test is the best answer anyone has given to "the market saw something." On this tape it's the right question. Nothing in the news explains MELI's slide on company grounds, while Nu keeps getting hammered and LatAm spreads widened 51 basis points in six sessions. Conservative, one look being weak evidence is exactly why this is 112 and not 125. The staging already prices that in.

Think about what the add buys. The $48.5 is a frozen-margin number, and a quarter that clears 7.5 is evidence the margin isn't frozen. So at the gate price, the real multiple is under 35. The earnings yield is then above the TIPS tie we started with, on margins we've seen rather than hoped for.

That's why the summer is the wrong analogy, conservative. That rally ran 30 percent without a single quarter that would pass our tests, and it gave most of that back because margins never turned. 112 only happens after a quarter that passes, with the reserve verified, at a price the market refused to raise, and with MELI holding up against its group. That's the opposite of the summer. It's being at size while a real turn is still doubted, and that's where the outsized return in a stock like this comes from.

Add one line to Monday's list. Conservative, you said we have no estimates to tell us whether the bar has moved. That's a hole in our packet, not in the market. Pull consensus Q3 gross and operating margins along with the print date. That sharpens the group test too. A 7.5 that misses a consensus of 8 is a miss, not the tape, whatever the group does, and the add shouldn't fire.

Last, your point that the regional slide raised the payoff for a good credit answer and the penalty for a bad one by the same amount. For a symmetric position, that's a wash. We've spent this whole debate building an asymmetric one. The penalty side has a put spread, a closing trigger and hard exits. The payoff side has a half and a rebuild path. Raise both stakes equally on that shape and we come out ahead.

Your steadying quarter shows it. August's 4.8 percent gap wouldn't even reach a long put 6 percent down. It cost a half-position about two and a half points of a standard allocation, and the stock was back above the pre-gap close in three sessions. May's kind of gap is the one we insured.

So here's what I'll sign. It's a Sell, with half held through the print and no short. Scale every step to what you hold. If you're already at or below half, skip the trims, but run the hedge and the post-print rules. Flat accounts stay flat until the release.

On Monday, confirm: the print date; the CPI date; when the 10-Q lands; whether the release carries the loan book and allowance; where the provision line sits; consensus Q3 margins.

Before the print, the first tranche sells on a trade into 1,731 to 1,745, or at market on a close under 1,668.44. Otherwise it goes at market by Friday the 9^th, or the session before CPI if that's earlier.

The second tranche rests at 1,813 to 1,860 and sells at market on a close under 1,646.73. It keeps working past CPI only if MELI closes above 1,731.36 the session before. Either way, it's done by the earlier of the 23^rd and the session before the print.

The central bank's daily fixing above 5.24 accelerates the trims on its own. Spreads need two closes above 2.5, or one plus a MELI close under 1,668.44. Nothing gets bought back before the numbers.

The hedge is a put spread about 6 and 15 percent below the price on the day we buy. We buy it after Monday's reaction, on an up day if we get one, and no later than the close before CPI. It costs at most about a point of a standard position and expires at least three sessions after the print.

If we sell a call, it goes at 2,060 or 20 percent up, whichever is higher. No lower puts and no closer calls. One reset above 1,860 gets its own half point, under the terms I laid out. The hedge closes or shrinks with the stock. If it won't fit, the core goes to 40. If an accelerator fires, the budget decides that same session.

After the print, operating margin under 6 exits. Gross margin under 40 exits too, unless operating income is up year on year. In that case we hold 25, and the reserve share and lagged delinquencies decide. If they hold, we go back to half. If not, we're out. Opex is a watch item.

The price rules stand. A monthly close under 1,549.51 cuts to 25, and a close under 1,495 exits. A hedged exit gets two sessions, with the gap-day low as the line.

A clean release, meaning the three tests pass and credit holds, goes to 100 within two sessions if it carries the reserve data, with the current ratio at or above 1.10 and leverage under 6x. Without that data, it goes to 75 and the 10-Q decides the rest. A current ratio under 1.10 caps us at 75 until the filing passes the conservative's two-part test.

112 needs the reserve share held, lagged delinquencies flat or lower, MELI at least matching its group, no miss against consensus, and the price inside 35 times the pre-print $48.5. 125 waits for one clean quarter beyond 112.

Conservative, you said my version had forgotten why it was a Sell. It hasn't. The Sell is the part that's settled: we're selling into resistance with insurance on before every event we can see.

What this last round decides is whether the plan can recognize a real turn when one arrives. As written, one rule would sell us out of the cleanest repair mechanism in the fundamentals report, and another would keep us out of the strongest quarter MELI could print. Make the reserve share the judge in both places, and this plan does what the trader built it to do. It loses small if the bear case is right, and it's at size, early, if it isn't. Aggressive Analyst: Both of you have had your last word, so this is mine. I'll spend it only on what's still open. The Sell, the half, no short, everything before the print and the hedge are finished, and I'm not reopening any of it. What's left is how this plan treats good news. That's the part this chair is here to defend, because good news is the only reason we kept half instead of a third.

Debts first, because you both earned them.

Conservative, you caught me with my own logic on consensus. If a 7.5 that misses a consensus of 8 is a miss at 112, it's a miss at 100. Staging to 75 and letting the filing decide the rest is right.

The region gate on 112 is right too, and you built it from my own words. I called the real breaking 5.24 a regime break. A lender with 84 percent of its liabilities short-term shouldn't run an unhedged overweight while its funding market is breaking.

Charge-offs belong next to the lagged ratio. A lender that writes off faster or sells its bad paper can keep delinquencies flat while losses rise. And one look at a revolving book only catches the front of the loss curve, which is why 125 waits.

I'll take the rest of your mechanics as written. That covers expiry at least three sessions after the later of the print and the FOMC, price rules outranking every fundamental branch, and a monthly breach cancelling any pending add. It also covers the group test over at least two sessions, a balance sheet on the release before any two-session move to 100, and flat accounts going to half on a clean release.

You're also right that what we've built isn't late. Back to 75 within two sessions of any clean print, and to 100 when the release carries the evidence, is not late. The four things I'm still pushing are the places where it could turn late by accident.

Neutral, your correction of the conservative is right. What rescues the exception quarter is operating income growing, not the reserve test. I'll take your conclusion with it: credit can't be what lifts 25 to half.

I'll sign your pro-forma read on the 6 percent exit exactly as written. If the reserve share fell while lagged delinquencies didn't, the margin was borrowed, and we read it with the reserve at last quarter's share. That's my one-number principle judging against me. A principle that only rules in my favor isn't a principle. I'll also take the add waiting rather than dying, the hedge deadline on the earlier-of rule, and your line that missing the last twelve and a half points is the cheapest mistake this plan can make.

Conservative, sign the neutral's charge-off point, because the arithmetic is airtight. Under CECL, the allowance at the end of a quarter is the opening allowance plus the provision, minus net charge-offs. If the reserve kept its share of the book, every extra dollar charged off was replaced through the provision. The provision sits inside the operating income we're reading. So if the share held and operating margin still cleared 7.5, any rise in charge-offs is already paid for inside that 7.5.

Missing charge-offs on the release shouldn't hold back normal weight. They belong in front of 112, and they should be able to take us from 100 back to 75 when the 10-Q shows them building. That's the job they can actually do.

Now the open part. Every rule added in the last two rounds says less. For adds, that's correct, and the conservative's principle is a good one: evidence that can only downgrade belongs in front of purchases and can't soften an exit. But add it all up. A plan where every new number can only subtract can never be surprised upward, and an upward surprise is the whole reason the half exists.

Neutral, your test was that no number gets a job it can't do. The other half of that test is that no number gets refused a job it can do. The plan still refuses four.

The first, and the most expensive, is the gross-margin branch. Here I'm signing the neutral's version over the conservative's, with one amendment.

Conservative, put the two quarters side by side. Start with the neutral's in-between quarter: operating margin 6.5 on a gross margin of 40.3. That needs opex at 33.8 percent of revenue. Operating income lands near 696 million, down about 4 percent, and we hold half through it without a word.

Now the exception quarter: gross margin 39.8, with operating income back above last year's 724 million. That needs opex near 33. Under your rule it sits at 25 until the Q4 numbers in February, even with credit passing on all three legs.

That's the same quarter, give or take half a point of gross margin and eight-tenths of opex. Yet the one with profits rising carries half the size of the one with profits falling, for four months. If the turn is real, those are the four most expensive months of the year to be underweight.

You defended the cliff by saying the half in the in-between quarter isn't an endorsement. It's just what we own because no line broke. And you named what 25 is for: broken, not yet explained. Take your own definition at its word, because the neutral's test explains it.

You listed what the gross line carries yourself: funding costs, shipping subsidies and first-party mix. The 10-Q's revenue and cost detail can tell us which one did the damage. If funding costs outran credit revenue, that's your "start of something," the region getting into MELI through its funding. Then the quarter stays at 25 until Q4. If the drop came from the commerce side and credit holds, it isn't unexplained anymore, and by your own definition it no longer belongs at 25. Neither of us gets to name the cause in advance. That's the point of the test.

Here's why the gross line has to explain itself in that one sliver rather than simply be obeyed. The trader's reasoning leads with the falling gross line and lands on a forecast: a median operating margin right on the 6 percent exit. The gross line was the lead evidence, and operating earnings were what it was forecasting. If the gross line breaks and operating income rises anyway, that forecast has failed in our favor.

We've already agreed on the principle. We killed the opex door because it could only fire on good news. The gross door has exactly one sliver where it fires alongside good operating news. I'm not asking to remove the door. I'm asking it to show its work there.

Two of your arguments against the exception don't survive the record.

First, the wind at Q3's back. In your second round, you told me Brazil's move from 15 to about 14.06 was "a 6 percent cut in a funding benchmark that still sits around 14." You were right, and the neutral added that only part of it landed inside the quarter. The cut can't be too small to help margins in round two and big enough to make a gross break ominous in round four. Calm regional credit until the last week of September describes Q3's market backdrop, not its income statement.

Second, the room. You said 2020 had nearly twenty points of opex to cut, and that today's band of roughly 32 to 37 leaves nothing. The neutral already said the exception doesn't need 2020's room, and the numbers back him. It needs 2025's.

Q1 2026 ran opex at 36.8 percent of revenue, the highest of the nine quarters we have. Q2 didn't squeeze opex. It reversed that spike, to 34.2. All four quarters of 2025 sat between about 33.1 and 33.8. The exception asks for roughly 33, the bottom of last year's normal range, not a new low.

A band five points wide isn't narrow when the entire operating margin is 6.7. In nine quarters, opex has swung through three-quarters of today's operating margin. That's exactly the room operating leverage needs. As for opex rising from Q2 to Q3 in both years, in 2025 it moved a tenth of a point.

The record also answers whether a commerce-side gross decline comes back. When MELI last gave up gross margin to build the business, it recovered: 42.5 percent in 2021, then 48.2 and 50.2, on the report's numbers. And the repair you say doesn't need the exception arrived in 2020 and 2021 alongside new gross lows. Operating margin went from minus 6.7 to 3.2 to 6.2 over that stretch. A cap that binds only when the repair comes with a new gross low binds on exactly the shape MELI's last repair took.

Now the amendment. It's the neutral's own line from two rounds ago: where the release carries the evidence, act within two sessions, and where it doesn't, wait for the filing.

So suppose Monday's check shows the release carries the commerce and fintech revenue split and enough cost detail to answer the funding question. Then the lift from 25 to half can happen within two sessions of the release, with credit holding on all three legs. If the release doesn't carry it, the 10-Q decides.

And make it one rule at the 10-Q, whether we waited in stock or in cash. Credit passing with a commerce-side explanation is half. Credit passing alone is 25. Credit failing is zero. As written, the cash path just "comes back." That could leave an account that followed every rule at 25 on the same evidence that takes the stock path to half. Anything above half still needs gross margin over 40.9, like every other path.

The second place is the neutral's pro-forma margin. I want to use it in both directions, the way he said one number should judge.

As written, suppose the reserve share fell but lagged delinquencies fell with it. Then the credit "earned that release." It isn't an exit, but it can't fund an add. I agree a reserve release can't fund an add. So strip it out and see whether what's left can.

Say the reserve share fell, lagged delinquencies and charge-offs both fell, and operating margin still clears 7.5 when we read it with the reserve at last quarter's share. Then the release didn't pass on the reserve. It passed at the old, more cautious reserve rate, with losses falling. That's a cleaner quarter than one that clears 7.5 with the share merely holding, and as written it's a quarter the rebuild can never reach.

In this branch the pro-forma read can only lower the margin, so it's strictly tougher than the headline. Let it be the measuring stick here instead of a veto. "Credit holds" would then mean one of two things. Either the share held, with lagged delinquencies and charge-offs flat or lower. Or the share fell, with both of those lower and the 7.5 test read on the pro-forma margin.

Conservative, this doesn't let credit rescue anything. The margin does the work, and the reserve only gets subtracted out. That's exactly how we agreed to use it on the exit.

The third place is three definitions. The neutral is right that plans like this break where rules meet, and these are the meeting points every good outcome has to pass through.

First, what "clean" means on release day. The neutral's handover defines a clean release as the three margin and growth tests plus credit holding. It then goes to 100 if the release shows the credit data, and to 75 otherwise. Read literally, a release that passes every margin test but carries no credit data isn't "clean." So it never reaches the staging rule, and we sit at 50 until the 10-Q. That's not what anyone intends. Write it so that on release day, clean means the three tests pass and no credit data the release does show fails. Missing data stages us to 75. It doesn't disqualify us.

Second, what "settled" means. Conservative, you exempted normal weight from the region gate and said it only gates the bet on top. The neutral extended it to everything above 75. I'll take the neutral's version. Before the print, a regime break changed how fast we reached our target, not the target itself. After a clean print, this gate does the same thing on the way back. A quarter of a position held back for however long the real sits above 5.24 is cheap.

But only if "settled" is defined now, mechanically. That means the fixing at or below 5.24 and spreads closing at or below 2.5, checked every session. The last quarter goes on the first session the gate is open with everything else still holding. It doesn't wait for the macro report's relief levels of 5.08 and 2.2. That would turn a wait into a veto.

This matters right now. Latin American spreads were at 2.41 on October 1, nine basis points from the line, after an 18 basis point move in a single day. Neutral, in your first round you called one close on that series a hair trigger, when it was a sell signal. I'll accept it as a buying gate, because a noisy close only costs us a day. But a gate that shuts on one noisy close has to open just as easily, or that one close costs us until February.

Third, consensus is one line: operating margin, pulled the session before the print and frozen. Not gross margin, revenue and EPS stacked on top of it. Otherwise a quarter that clears every absolute test we wrote can fail on whichever line the Street happened to be most optimistic about. Then a gate meant to catch what the market saw ends up catching noise.

The neutral also flagged that if consensus sits at or below our 6 percent line, an exit can land on a beat. That's exactly when we use the full two-session window instead of selling into the open.

The fourth place is the overweight, and the conservative's asymmetry argument. You said the shape is asymmetric in one band for about a week. Above minus six and below minus fifteen the half takes the loss, and after expiry it's a plain long.

Check that band against this year's gaps. February's was minus 8.05 and May's was minus 12.70, both inside it. August's minus 4.82 sat above it and was back over its pre-gap close within three sessions. Nothing this year went past minus 15. The band sits exactly where this year's damage was, and the part outside it is the part that healed. After expiry, the half is sized by evidence, which is what the entire post-print rulebook now does.

You also dropped the hedge-expiry argument as your reason for 25. Then it came back for the overweight, which you said is never hedged at all. Fine. Let's answer it with an actual hedge instead of a delay.

The step to 112 goes on only with its own put spread through the Q4 print, at the same percentage strikes and under the same call-financing rule as the core. It gets priced on the day the add would fire, after the print has taken the event premium out. Cap it at the core's rate, about 2 percent of the stock it protects. On twelve and a half points, that's a quarter point of a standard position. If it fits, the add is insured in the band where this year's damage happened. If it doesn't, the add waits, which is your answer anyway.

You conceded that a 7.5 quarter means the true multiple at the 35-times gate is under 35. Picture an insured add below 35 times earnings, on a margin we've actually seen, in a region that has stopped breaking. That's the best-priced purchase this plan will ever make.

You said separation is relative and the firm's capital isn't. Agreed, so insure the capital rather than refuse the separation. Nu's version of the credit question has been open since September, with Goldman still calling for a double, and the market hasn't gotten an answer it believes. MELI's first credit disclosure is the chance to give one. It comes on a stock 28 percent below last October's close, where bullish tags are 31 percent of messages and most of those come from a single account. That separation is where the payoff is.

One line goes on Monday's list: whether the release carries the commerce and fintech revenue split and enough cost detail to answer the funding question. That decides whether the gross-margin explanation takes two sessions or two weeks.

The rest of Monday is settled. Brazil votes today, so tomorrow the box decides the first tranche and the fixing runs the accelerator. The hedge goes on after the reaction, on an up day if we get one.

So here's what I'll sign: the neutral's handover version, scaled to whatever you hold. Flat accounts stay flat until the release and go to half on a clean one. On top of that go four amendments.

First, the gross-margin exception lifts from 25 to half on a commerce-side explanation with credit holding on all three legs. That happens at the release if the release carries the evidence, and at the 10-Q if it doesn't. The same rule applies whether we waited in stock or in cash.

Second, when the reserve share fell with lagged delinquencies and charge-offs both lower, the 7.5 test is read on the pro-forma margin, and a pass on that number counts.

Third, a clean release means the three tests pass and nothing shown fails, with missing data staging us to 75. The region gate reopens on the first session the fixing is at or below 5.24 and spreads close at or below 2.5. Consensus is one line, frozen.

Fourth, the step to 112 carries its own put spread through the Q4 print within a quarter point, or it waits.

Conservative, you said the one thing this plan must never do is hold size through the line it was built on, in the very quarter that line breaks. I'd add the other half. It must also never stay small through the quarter that proves the line wrong. Your rules guard against the first. These four amendments guard against the second.

None of them does anything in a quarter where the bear case is right, because every one of them needs operating earnings to turn up first. We sell into resistance, we insure the gap, we keep half, and when the evidence turns, this plan lets it count. It's still a Sell, but it's one that can still win.

Conservative Analyst¶

Conservative Analyst: Conservative Analyst: Let me take the strawman off the table first, because the aggressive seat wrote my speech for me and it isn't the one I'm giving. I'm not arguing to dump MELI at market at 1,696. I agree with the Sell. The trend, the margins, the valuation and the calendar all point the same way. My objection is narrower and, I think, more dangerous. The plan as defended doesn't get us to 50% in the scenarios that hurt. It mostly gets us there in the scenarios that don't.

Walk the branches with me. Both trims are limit orders above the market. So until the 23^rd, short of a crash through 1,495 or a macro regime break, the only way we get smaller is if the stock goes up.

If it rallies hard enough to close above 1,875, we're back at 100% before the print. If it rallies modestly and beats the NASDAQ, the pause clause can freeze the trims. If it keeps doing what it has done every week for a month, grinding lower in a staircase, neither order fills. And if it's at or below 1,600 on the 23^rd, we stop at 75%.

The accelerator needs the real and LatAm credit to break together. Its runoff branch fires the Monday after the runoff, which is after the gap. None of that helps in the scenario you described yourself, which is selling specific to this stock. You called carrying these unknowns at full weight reckless. The plan's own exceptions can leave us at full or three-quarter weight going into exactly those unknowns.

The 1,600 clause is the first thing I'd strike. If it triggers, the stock is about 3% above the monthly SuperTrend stop. It's only a 6.6% drop from the 1,495 full exit, and we walk into the runoff, the FOMC and the print at three-quarters size.

From 1,600, a repeat of this year's moves lands near 1,471 for February's, 1,397 for May's and 1,523 for August's. All three would cut through the monthly line, and two of the three through the full-exit line. So the clause doesn't avoid selling at bad prices. It moves the sale to a worse price, on a gap, at a bigger size.

The justification is the 1,546 to 1,600 buying zone. But the technical report says that zone fails on a monthly close below 1,549.51, and October's monthly close is the 30^th, after the FOMC. A month-end check can't catch a mid-month gap. The report says to act either on a bounce into 1,745 to 1,860 or on a confirmed break below 1,668.44 and then 1,646.73. It calls the breakdown the path the trend favors. The plan only implements the first half of that.

That changes your skew math too. The 6.6% you say the sold half saves on a revisit of 1,549 assumes both tranches filled at an average of 1,786. But the paths that revisit 1,549 are mostly the ones that never bounce to 1,835.

On those paths, the first tranche goes either on a brief pop at 1,738 or at market near 1,600 on the 23^rd. The clause then stops us at 75%. We've saved somewhere between about 0.7% and 2.8% of a standard position before the monthly line is even tested, while carrying three-quarters of it into every event. The 6.6% is what we get if we're right after first being handed a rally. It isn't what we get if we're simply right.

Now, "selling here sells the bottom." The technical report says this isn't capitulation: RSI has never closed below 30 in this decline. ATR has shrunk from 64 in mid-September to 55 while price fell. The report reads that as steady grinding and notes that washout lows usually come with widening ranges, which we haven't had. The first daily TD 9, on September 18^th, was perfected, and the stock still fell another 5.1%. The weekly count is 3 of 9. Friday's inside day is described as a pause, not a reversal candle.

The one-to-one odds you quoted are for opening a short. For a holder, every share we keep while waiting for 1,738 is a long we've chosen to own for a trade. The report rates a counter-trend long as marginal even when it waits for its trigger.

The prize for patience on the first tranche is about 2.4% on a quarter of the position. That's roughly 0.6% of a standard allocation. You said speed beats a few dollars when the regime breaks. I'd say speed beats 0.6%, full stop, with a CPI print in the way.

On the post-gap recoveries: yes, the stock bounced after every 2026 gap. But look where that left anyone who held through them. Today's price is about 12% below the close before the February gap, 9% below the one before May's and 12% below the one before August's. About three-quarters of the summer rally was handed back within a month, and OBV says the July and August buying went with it. Those bounces were rentals, not recoveries.

Take your May analog seriously for a second. From the pre-gap close to the low close a week later was about 17%. Do that from here and you're near 1,403. The day-one move alone, minus 12.7%, closes around 1,481, which is below the 1,495 exit. So the plan's own rule sells the half we kept at the gap price, before the rebound we kept it for can start.

That's the general problem with the tripwires. Every one of them is a close, and closes don't protect you from opens. The sentiment low doesn't rescue it either. It rests on 29 messages from 17 accounts with Reddit switched off, and the report itself says washed-out tone doesn't imply a reversal.

On the fundamentals, I agree it isn't a solvency story. It's a confidence story, and for a lender that's what counts: What looks like credit revenue is about 30% of the total and growing 57%. Liabilities to equity of 5.56x may be moderate for a lender, but it has risen five quarters running. The current ratio is at a series low of 1.12x. Another 0.04 drop like last quarter's would put it under the 1.10x no-add line on the day Q3 reports. So the rebuild we're keeping half the position for could be blocked even on a good margin quarter. Cash covers about 10% of current liabilities, against 13.8% a year ago, and 84% of liabilities are short-term. ROE is 27.5%, down from 36% and 51.5%.

The $1.58 billion of operating plus investing cash flow is real, but it's small next to a $51 billion balance sheet. About $7.8 billion of last year's reported cash flow never showed up as ordinary cash. We have no delinquency, provision or charge-off data. The closest Brazilian lender is being punished, and LatAm spreads just widened 51 basis points in six sessions. When you can't see a risk, you size it small.

On the Q3 tailwinds, you made the seasonal point yourself. If Q3 merely repeats the Q2-to-Q3 move of either of the last two years, operating margin lands between about 2.9% and 4.3%. Gross margin lands between 38.6% and 40.2%. The trader's own estimate is kinder and still puts the median operating margin right on the 6.0% exit line.

The rebuild needs gross margin above 40.9% and operating margin of at least 7.5%. That means breaking a two-year seasonal pattern on both lines at once. Currency translation mostly scales revenue and costs together. It helps the 40% growth test, which is the easy one, and does little for the margin tests that actually decide the outcome.

Brazil's cuts have only taken the interbank rate from 15% to about 14%. The macro report also flags that the central bank may slow down after the Fed's hike. The branch you say we're underrating, back to 100% and on to 125%, is on this evidence the least likely of the three.

On valuation, the tie with TIPS uses frozen-margin FY2027 EPS of $48.5. That assumes the margin decline stops, which is the very question we're waiting on. On actual trailing EPS of $36.77, MELI trades at about 46 times earnings. That's a 2.2% earnings yield, roughly 70 basis points below the 10-year TIPS, with real yields up 44 basis points in a month. I wouldn't sign a pre-commitment to 125% on one good quarter, in a lender whose loan book none of us can see.

Then there are three contradictions in the plan itself.

First, you want to sell a Monday pop into 1,731 to 1,745. But a 2 to 3% pop from Friday's close will very likely outperform the NASDAQ, which is exactly what the pause clause says should stop the trims. A relief squeeze is a risk to shorts. We're a long reducing exposure, so a squeeze is the gift we're waiting for.

Second, the thesis is not to pay for the answer in advance at full size. Yet one daily close above 1,875 puts us back at 100% before the runoff, the FOMC and the print. The weekly SuperTrend, which the report says carries the most weight, stays down until 2,061.81. The September 8^th golden cross was followed by an 11.9% decline. And selling the second tranche near 1,835 and buying it back above 1,875 is less than one ATR apart.

Third, the accelerator. The 5.19 USD/BRL in the packet is the September 25^th reading, so we can't see the pre-election week at all. LatAm spreads are 9 basis points from 2.5% after moving 18 in a single day. Requiring both to break before we act means acting late.

On hedging, you said that without implied vol we'd overpay. The only volatility evidence we have is the macro report's read that equity vol looks cheap relative to credit. US high-yield spreads rose 56 basis points in seven sessions while the VIX barely moved, and the report says defined-risk structures or smaller size fit the data. If a put spread does turn out to be expensive, that price is information. It means the market is pricing a big move, which argues for less stock, not unhedged stock.

So here's my adjustment. Keep the Sell, and change the execution as follows: Sell the first tranche into any Monday pop toward 1,731 to 1,745, and at market if it hasn't filled by Friday the 9^th. Keep the 1,813 to 1,860 order working for the second tranche, but move its market fallback from the 23^rd to before the mid-month CPI print. That gets us to 50% before the death-cross window, the runoff, the FOMC and the print. Replace the 1,600 clause with a downside accelerator: a daily close below 1,646.73 finishes the trims at market. Make the macro accelerator fire on either signal instead of requiring both. Delete the outperformance pause. Before the print, a close above 1,875 stops further trimming but doesn't rebuild. Flat accounts stay flat until the numbers are out. By the 23^rd, price a put spread through the print on the half we keep, covering roughly 1,600 down to 1,450. This is protection for the core, not a substitute for the second tranche. If it's sensibly priced, buy it. If it isn't, take the core to about a third of a standard allocation, where a May-style move costs about 4.2% of a standard position instead of 6.4%. After the print, rebuild to 100% only if all three margin and growth tests pass, the current-ratio and leverage gates hold, and the credit disclosures don't show deterioration. The 125% add waits for a second confirming quarter.

And to the neutral seat, before you make the case that it's oversold and the print should decide: oversold isn't washed out. By the trader's own estimate, the median print lands on our exit line. Letting the print decide at full size means accepting roughly even odds that our own rules force a full exit on a gap. Today's price already sits 9 to 12% below the close before each of this year's three prints.

The aggressive version protects us well if we get a rally first. Mine protects us whether we get one or not. This year has produced three down gaps out of three, margins haven't stopped falling, and nobody in this room can see the credit book. I'd rather not need the rally. Conservative Analyst: Most of what I asked for last round is now in the plan, and the neutral deserves credit for the cleanest piece of it. The box decides the first tranche, a close under 1,646.73 caps the wait on the second, and the 1,600 clause and the pause are gone. That closes most of the hole I found. So before I argue what's left, let me give back what I got wrong.

The neutral is right about my seasonal math. Scaled proportionally, last year's Q2-to-Q3 drops put Q3 operating margin around 4.9 to 5.4 percent, not 2.9 to 4.3. I'll take the correction. It's still under the 6 percent exit line, which was my point. Aggressive, you're right that the death cross adds nothing the triggers don't already cover. You're also right that 1,731 is an ordinary day away, since it traded there intraday on two of the last three sessions. On the current ratio, I'll take the neutral's version: a reading under 1.10 caps the rebuild at 75 instead of vetoing it. I'll come back to what it should take to lift that cap.

The neutral said the job is to control the tails directly and let the average take care of itself. I agree, and by that standard there are still tails in this plan that nobody is controlling. There are four places where it puts size in front of an event on hope rather than evidence. I'll take them in order of what they can cost.

The worst is the weekly close above 1,875 that buys us back to 75 percent before the print. You've both endorsed it now, and I think it's the most dangerous line left in the plan.

Aggressive, you said this year's bounces were rentals. You said you don't need them to be recoveries, you need them to be where we sell. I agree with every word. But then a weekly close above 1,875 is the top of a rental, and that's exactly where this plan buys.

We don't have to guess how that rule behaves on this tape. The week ending September 11^th closed at 1,897.37, a weekly close above 1,875. Two sessions later the stock fell 3.75 percent in a day and cut through both moving averages at once. Today it sits about 10.6 percent below that weekly close. The golden cross three sessions earlier closed at 1,926 and has lost 11.9 percent since. On this tape, a weekly close in the high 1,800s hasn't been trend repair. It's been the launch point.

It's been the launch point for the prints too. All three of this year's down-gaps came off closes between 1,870 and about 1,923. Aggressive, one of your arguments for carrying half was that this print comes off a stock already marked down 15 percent, not off 1,900. That's fair at 1,697. But the rebuy only fires in the world where that cushion is gone and we're back at the prices the last three gaps started from. In that world, it adds a quarter of the position.

The trader's own sizing note says a 13 percent gap costs about 6.5 percent of a standard position at half weight and about 10 percent at 75. The whole plan was built to avoid the 10. This rule walks back into it in the run-up to the runoff, the FOMC and the print. It does so at a price still 9 percent under the weekly SuperTrend stop at 2,061.81. And if the second tranche filled at 1,835 on the way up, we'd be buying the same shares back 40-plus points higher. You said you wouldn't defend paying that whipsaw in the daily-close version. Moving it to a weekly close doesn't change the arithmetic. It just pushes the rebuy closer to the print.

So my position hasn't moved. A close above 1,875, daily or weekly, stops the trims, and nothing gets rebought until the numbers are out. If the trend is genuinely repairing, it'll still be repairing the morning after the print, and we'll be buying with the answer in hand.

Second, the second tranche. Aggressive, you keep calling 1,813 to 1,860 the best-odds level in the packet, about 3 to 1. Look at what that number measures. It's the reward-to-risk of a short opened there, if price gets there. It says nothing about the chance that price gets there. For a holder sitting on a limit, the chance of a fill is the whole question.

Here's what the tape says about that chance. The bottom of the band is 6.9 percent above Friday's close. The 1,835 where you're modelling the fill is 8.2 percent above. The biggest closing bounce the technical report records in this whole slide was 2.19 percent, from September 18^th to the 22^nd, and the latest was 0.94. You need a bounce three to four times larger than anything this decline has produced.

The neutral already did the math on what that's worth. On a tape with no drift, a bracket that makes about 8 percent and loses about 3 has to lose roughly three times in four to be a fair bet. That's what fair means. Your 2 points if it fills and three-quarters of a point if it doesn't is exactly that shape. Positive skew with zero expected value is a lottery ticket. And the report doesn't call this tape driftless. It calls the decline the path the weekly and daily trends favour.

You say the next three weeks aren't a coin flip because of the relief catalysts. But each catalyst has a second side, and you've only priced one of them. The prediction markets on the Brazil election were withheld, so nobody in this room knows the odds of the good outcome you're waiting for. On CPI, the evidence leans hot: August ran 0.4 percent month on month. Core PCE re-accelerated from 0.13 to 0.25. Oil is at 96 after a 16 percent one-day swing. This week's headline is that the Iran war is driving inflation higher, and not just through oil. A hot print is at least as live as a soft one.

Here's the line I'd most like you to defend. You told us MELI trades like a long-duration asset, among the names with the most to gain if the 10-year falls back under 5. Then it's among the names with the most to lose if the 10-year breaks its 5.29 high and real yields go through 2.93. That 5.29 is already about the highest since 2007. The macro report names CPI as the release that can do that. You said a scheduled data release isn't a regime break. For a long-duration stock, a CPI print that takes real yields to new highs is exactly a regime break. It just arrives on a schedule.

Now look at what we'd carry through it. In the no-bounce path, the first tranche goes by Friday the 9^th, the second keeps waiting, and the hedge isn't due until the 23^rd. On CPI morning we're at 75 percent of a standard position with no hedge. Our only protection is a trigger that checks the close. You both agreed closes don't protect against opens. You said the trigger and the hedge already buy the certainty a market fallback would. Through CPI, the hedge doesn't exist yet, and the trigger can be gapped through.

You've both conceded the expected value is roughly the same either way. When it is, the tiebreaker is variance. That isn't timidity. It's the mandate.

So here's a compromise that still gives you the band if the bounce actually shows up. Invert the neutral's dial. As written, it defaults to waiting and only covers one of the three ways Monday can go. Make the default the session before CPI. Extend the limit to the 23^rd only if the technical report's own relief trigger fires first: a close above 1,731.36, the top of the box, ideally with RSI back above 43.5.

Neutral, check it against your branches. If MELI lags a strong Brazil, we give the same answer you do. If MELI genuinely leads, it'll be through 1,731 and the trigger fires, so we give the same answer again. The only difference is the branch your dial doesn't cover: a flat or ugly Monday, then a stock that just drifts. That's exactly the branch where nobody should carry 75 percent unhedged into CPI.

Third, the hedge and the size of the core. Aggressive, I want to use your table, because I think it says the opposite of what you're claiming.

On a repeat of May's first day, your hedged half loses about 3.9 percent and my unhedged third loses 4.2. On the full May path, it's 5.2 against 5.8. So in the two disasters, the hedged half is ahead by three-tenths and six-tenths of a point. You conceded the third wins by one to two points on a February- or August-sized move, and by the whole premium if the print is flat. The only place the half wins clearly is the good print, 6.5 against 5. That isn't a safer position. It's a more bullish one with a protective label on it. That can be a legitimate choice, but it's a bet on the good print, and it should be argued as one, not as insurance.

And that table only holds if the hedge is struck near today's price. Your execution note quietly changes that. You said to buy the same strikes on the bounce because they cost less with MELI at 1,800. They cost less because they protect less. Put the stock at 1,835 when we buy the 1,600 to 1,450 spread, and run this year's three moves from there: February's 8 percent lands near 1,687. August's 4.8 lands near 1,747. May's 12.7 lands near 1,602, two dollars above the long strike.

All three pay nothing. If you set strikes as a percentage of the price, the percentage cost barely changes with the price level. So the only real saving from buying into strength is buying less insurance. The one genuine saving you mentioned, the first-round election premium coming out, I'll grant. Any purchase after Monday captures it.

So strike the spread off the price on the day we buy it, roughly 6 and 15 percent below, the way the neutral first specified it. That way the protection doesn't shrink just as we get back to the prices the last three gaps came from. Struck that way, and financed with the call if it needs to be, I'll live with half.

On the fallback, you're both at 40 and I'm at a third. On a May-sized first day, that's about 5.1 percent of a standard position against 4.2. Honestly, that isn't the hill I'd die on. I'll meet you at 40 if the financed spread won't fit, on two conditions. The pre-print rebuy to 75 comes out, and the hedge is struck off the price we actually pay. Removing the path that puts us at 75 percent into the print is worth far more than the fraction of a point I'm giving up here.

Fourth, the print itself. Both of your cases for carrying size lean on a reading of it that the data doesn't support.

Aggressive, you said expected outcomes don't gap, surprises do. Then look at the quarter you've both held up as proof that margins are steadying. In Q2, operating income was up 11.8 percent on Q1, operating margin barely moved, and opex fell 2.6 points as a share of revenue. If August 6^th was that report, as we've all been assuming, the market marked it down 4.8 percent on the day. That makes three apparent prints this year and three down gaps, including the one where things looked like they were stabilizing. There are no consensus estimates in this packet. What we do have is three straight data points saying the market's expectations have sat above the results.

And you can't run the regional argument both ways. You told us this selloff is regional, a real-yield and Latin American fintech de-rating rather than company-specific rot. I'll accept that. But then the 15 percent slide hasn't lowered the bar for MELI's own quarter at all. And regional here isn't generic risk-off. The selling is concentrated in Latin American lenders. The question the market is asking about Nu is whether credit quality can hold up while lending expands. MELI's Q3 release answers that same question for the first time.

Here's the part nobody has said out loud. The trader's plan has three exit doors after the print, not one: Operating margin under 6 has seven-tenths of a point of headroom. Gross margin under 40 has nine-tenths. Opex at or above 35.7 percent of revenue has about a point and a half, since Q2 ran at 34.2.

That third door was open as recently as Q1, when opex ran at about 36.8 percent of revenue. The trader's median estimate already has us standing in the first doorway. With two more doors, the odds of a forced exit start at even and only go up from there.

Neutral, you said two years of Q2-to-Q3 drops is a trend, not a season, because both years were mid-decline. Agreed. But so is this year, and on the line that matters most, the decline is getting steeper. From Q1 to Q2, gross margin fell 2.8 points this year against 1.1 last year. The flatter operating step you pointed to came entirely from opex falling 2.6 points of revenue, against 0.4 the year before. You can compress opex like that once. You can't do it every quarter while gross margin falls faster. And the rebuild test doesn't ask gross margin to stop falling. It asks it to rise above 40.9.

Aggressive, take the drags you say were already easing. Brazil's interbank rate has come down from 15 to about 14.06. That's a 6 percent cut in a funding benchmark that still sits around 14. Quarterly asset growth of 9 to 10 percent is slower than last year, but compounded it's still over 40 percent a year. The CECL drag eases relative to last year. It doesn't go away.

And you supplied the reason funding may get dearer, not cheaper. You read the $534 million drop in long-term liabilities, next to the $4.4 billion jump in current ones, as debt moving to within a year of maturity. Debt coming due gets refinanced at today's spreads. Latin American corporate spreads just widened 51 basis points in six sessions. That's the funding-cost drag pointing the wrong way, right into the outlook the market will actually trade.

Which brings me to the way back in.

On the 112, you said the add is self-limiting because it only fires at 35 times FY2027 earnings or less. But the estimate under that gate rises with a good quarter. Rerun the frozen-margin math after a 7.5 percent quarter, and the gate lands somewhere around 1,800 to 1,900. So the rule that's supposed to hold us at 100 would let us go overweight right up toward the zone the last three gaps came from.

On Q3 versus Q4, the second quarter was never about seasonality. The neutral named the real reason. This release is our first look at MELI's delinquencies and provisions. Under CECL, slower loan growth lifts margins mechanically even when credit is getting worse. One quarter of credit data can't tell a margin turn from a provisioning artifact. Two can start to. I won't go overweight a lender on one look at its loan book, in the same month the market is questioning Brazilian consumer credit.

On valuation, yes, 46 times trailing earnings is a multiple on depressed margins. But your 34 times assumes last year's 11.1 percent margin comes back. That's 4.4 points above where we are, when our own 7.5 percent test already requires breaking a two-year pattern. The last margin expansion started from a balance sheet freshly topped up by a $1.9 billion equity raise in early 2019. This time it would have to happen on a balance sheet where about 84 percent of liabilities are short-term and leverage has risen five quarters running.

The recovery case may well be right. If it is, it will take years, the way 2019 to 2023 did, and there'll be plenty left to own after a second clean quarter. We don't need the first leg of a multi-year recovery. We need to not be at size for the fourth gap.

On the current ratio, I've conceded the cap. But your own explanation for the drop, debt coming due within a year, is a refinancing risk, not a reassurance. So the cap at 75 should lift only if the filing shows two things. First, that the rise in current liabilities is customer funds backed by matching liquid or restricted assets. Second, that the debt coming due is covered. "Until the filing explains it" isn't a test until we say what explanation passes.

A few operational points, quickly.

The USD/BRL trigger can't run off the series we've been quoting. Our 5.19 comes from the Fed's weekly release, which runs a week behind; the pre-election week only shows up on Monday. If we wait for that series to print 5.24, we'll be acting on last week's market. The trigger has to run off the live spot rate.

On spreads, both of your summaries dropped the second half of the neutral's own rule. One close above 2.5 plus a MELI close under 1,668.44 should fire too. Regional credit breaking on the same day MELI breaks the box isn't noise.

On working the post-print exit over a session or two if we're hedged: the hedge is there to pay for the gap. It's not a license to hold a thesis our own rules say has failed. May is the warning. Three sessions after that gap the stock traded at 1,495, and the closes a week later were about 5 percent below the gap-day close. If you want time to work the order, make it two sessions, with the gap-day intraday low as the line and no extensions.

On other holdings, aggressive, you turned the neutral's point around. If MELI is the caller's only Latin American exposure, you said, the half is their whole stake in the 10-year falling under 5. A portfolio doesn't need a stake in every macro outcome. If it wants that one, a Brazilian lender heading into a runoff and an earnings print is a very noisy way to own it. Duration is the clean version.

So here's where I land. Keep the Sell, keep half as the target, and no short.

The first tranche goes on whichever side of the box breaks, or at market by Friday the 9^th.

The second tranche keeps its limit and its 1,646.73 trigger. It goes before CPI unless the report's relief trigger fires first, in which case it works to the 23^rd.

A close above 5.24 on the live USD/BRL rate fires on its own. Spreads need two closes above 2.5, or one plus a MELI close under 1,668.44.

A close above 1,875 stops the trims and does nothing else. No rebuild before the print.

The core gets the put spread, struck off the price on the day we buy it and financed with the call if needed. If that won't fit, the core goes to 40 percent, provided the rebuy is gone.

After the print, the exit rules are rules, with at most two sessions to work the order if we're hedged.

The rebuild to 100 needs the three tests, stable credit and the leverage gate. The current-ratio cap holds at 75 until the filing passes a stated test.

The step to 125 waits for a second quarter.

Aggressive, you said your version doesn't need the rally either, but it's there at size when the rally comes. The trouble is that it's also there at size when the gap comes. That's the version this year has shown us three times out of three. I'd rather pay a little for the answer than pay in full for a fourth gap. Conservative Analyst: Let me start with what I'm taking, because the last round moved this plan a long way and both of you earned it.

The rebuy is gone, and the neutral's case for killing it beat mine. Any close above 1,875 has already filled the 1,813 to 1,860 order on the way up, so the only real content in that rule was the buy. I'll also concede that one weekly close in September is thin evidence on its own, and that the 2019 raise isn't a fair comparison.

The state test is a better version of my CPI rule than the one I wrote, because it checks where the stock is, not where it's been. The neutral's arithmetic on the opex door is right too. Operating margin is gross margin minus opex, so that test only fires on its own once gross margin is back above about 41.7. Make it a watch item. Aggressive, your mirror rule on the call is fine with me. It means the call pays for less of the spread, so the 40 percent fallback fires a little more often, and I can live with that.

Aggressive, moving the hedge deadline to the close before CPI is the best idea you've put on the table, and I'm with you over the neutral's 23^rd. It closes the hole I was most worried about. What's left unhedged into CPI is the second tranche. That's a quarter of the position, carried only if MELI closes above 1,731 the day before. A CPI gap from there costs roughly a point to a point and a half of a standard position, with the trigger about five percent below. The price action earned that, so I'll carry it.

I'll also stop arguing the CPI forecast. You're right that breakevens barely moved. But that's why CPI matters for this stock: the shock is running through real yields, the channel that compresses long-duration multiples. With the hedge on before the release, neither of us has to win that argument.

Now the problem. Aggressive, you closed by saying the insurance is on before every event we can see. It's on until the print, and the plan has it expiring just after. Both rules you added last round, the gross-margin exception and the two-session rebuild to 100, put size on after it's gone. Your whole case for the half, ever since you drew that table, has been the hedge. Those two rules aren't hedged. Neutral, you said a plan like this breaks where two rules meet. This is that meeting point: the post-print exits and rebuilds run into a hedge that has already expired.

Start with the exception. Neutral, you called the gross-margin test the one most likely to fire, and you said it stays. The aggressive has written an escape hatch into it: a gross margin under 40 is an exit unless operating income is up year on year with stable credit.

Look at what "up year on year" actually measures. Last year's Q3 operating income was $724 million. With revenue growing near 50 percent, clearing that takes an operating margin of about 6.5 percent. At 40 percent growth it takes about 7. Q2 ran at 6.7. So this isn't a margin test. It's a revenue-growth test with a floor near today's margin. The faster the growth that has been coming at the margin's expense, the easier it is to pass.

A couple of rounds back, you conceded that the easy comparison against $724 million doesn't touch our rebuild tests. A number too weak to justify adding a share shouldn't be strong enough to cancel an exit. And if that headline helps the stock the way you expect, the two-session window gets us a better fill on the way out. That's what the window is for.

Your own example shows how thin the line is. Take gross margin at 39.8, opex at 33 percent and revenue of about $10.7 billion. Operating income then lands anywhere from about two million dollars short of last year's to about seven million over, depending on how you round. That's less than one percent either way, and it's the margin your rule uses to decide between selling half the position and keeping it.

The yardstick you used to call 39.8 an improvement is mostly the comparison base. Last year's gross margin fell 2.3 points from Q2 to Q3, from 45.6 to 43.3. So anything above about 38.6 scores as a narrower decline than Q2's 4.7. Gross margin could fall more than two full points from here, to a new series low, and your yardstick would call it no worse.

The trader set the exit as a level for a reason. For a business that now looks more like a lender than a retailer, the gross line is where funding costs and spread compression show up.

Then ask what kind of quarter makes the exception fire. Gross margin falls another point, and opex falls another 1.2 points of revenue on top of Q2's 2.6. Where does a second drop like that come from? Either it's cost cuts that can't be repeated, or it's the provision line. MELI's income statement has historically carried its provision for doubtful accounts inside operating expenses, below gross profit. Confirm that in the release. If it still holds, the quarter your exception rewards, with gross margin falling and opex falling faster, is exactly what it looks like when lower provisions prop up the operating line. That's the false signal the neutral warned us about: margin borrowed from reserves.

You've made the exception conditional on stable credit. But the exit decision gets made on the release, inside two sessions, with no extensions. The test that separates earned margin from borrowed margin is the reserve as a share of loans, and that's a 10-Q test. We all agreed on that when we put it in front of 112. What the release gives us is delinquency ratios. On a fast-growing book, those are flattered by loans too young to have gone bad. That's the oldest caveat in lender analysis.

So the exception would have us hold half the position, unhedged once the options expire, on a quarter where gross margin broke to a new low. That's the line the trader built this Sell around, and we'd be checking it against the weakest credit number we'll have. Neutral, you showed that this year's gap risk sat mostly in the bad-margin quarters. Gross margin under 40 is a bad-margin quarter, on the line that's been falling fastest.

Aggressive, you said that if I'm right, the exception never fires and costs nothing. The cost isn't in how often it fires. It's in what fires it. Strike it. Gross margin under 40 exits, as the neutral said.

If you want a foothold for the quarter that proves me wrong, size it like the ambiguous evidence it is. Take a quarter of a standard position, not half. Operating income up year on year, with delinquencies flat or lower in the release, cuts us to 25 instead of zero. The 10-Q's reserve test then decides whether that 25 stays. Yes, that quarter is unhedged too. But it's half the exposure your version carries, and it has a deadline: the 10-Q. The way back up runs through the rebuild tests like any other path. The price exits at 1,495 and the monthly 1,549.51 override everything.

Second, the rebuild to 100 within two sessions. Neutral, your reserve test is the best idea of the last round, and I think it's in the wrong place. You said it yourself: if the reserve share shrank, the margin was borrowed. If that's what the 10-Q shows, the step to 112 isn't the only mistake. The 7.5 percent pass that took us back to 100 was a false pass too. A test that can invalidate the rebuild belongs in front of the rebuild.

So here's what I'd sign. A clean release takes us to 75 within two sessions, with no waiting for a pullback. The last quarter of the position waits for the 10-Q. There, the reserve test and the current-ratio test, which already holds us at 75 until that filing, become a single checkpoint. One document decides every step above 75. That's one rule instead of two, and it closes the gap between a press-release pass and a filing that could undo it. Aggressive, you still get three-quarters of the position back inside two sessions. That captures most of whatever re-pricing the first clean quarter brings.

You called this hurrying out and dawdling back in, a bearish tilt nobody voted for. The trader voted for it. The decision on the table is a Sell, built on three down gaps out of three and a gross margin that's fallen five straight quarters. A plan built on that should need more evidence to add than to cut. One broken number is enough to say a thesis failed. One good quarter only says it might be turning. That isn't a tilt. It's the difference between disproving a thesis and confirming one.

"A clean print won't give us a pullback" has nothing behind it in this packet. All three gap days this year went down. There isn't one up-gap in the data to show how this stock trades after a clean print. The one recovery we can study, May's, retested near its lows about six weeks later.

Third, 112 on one quarter. Aggressive, your own argument undoes it. You said the first quarter that shows a turn is when the turn gets priced. If you're right, the stock rerates above 35 times the pre-print $48.5, roughly 1,697, and the gate holds us at 100. The add only fires in the world where you're wrong, where a clean quarter on a heavily watched stock goes unrewarded. When that happens, it usually means the market saw something in the release or the outlook that we haven't modelled. That's the world you want to go overweight in.

You said nobody answered the seasonal point. Here's the answer. The second quarter was never about margin seasonality, so Q3 being the harder margin test doesn't touch it. It's about credit seasoning.

The repair story you and the neutral both lean on is that loan growth is cooling, so the CECL drag eases. That isn't visible in the one line that tracks lending. Total assets slowed to 9 or 10 percent a quarter, which is still over 40 percent a year compounded. And that's all assets, including customer funds and currency effects. The line the fundamentals report reads as mostly interest income grew 56.7 percent in Q2. By my arithmetic, that's faster than the roughly 52 percent of a year earlier.

If the loan book is still growing that fast, the CECL drag hasn't eased and the delinquency ratios are flattered. If it's slowing, the ratios lose that cushion and the next quarter is the real test. Either way, one look is weak evidence.

Aggressive, your example of being at size while a turn is doubted is this summer. The stock rose thirty percent off the May low, and about three-quarters of the summer rally was handed back within a month, because the turn didn't come. Our job isn't to own the first leg of a recovery at maximum size. It's to still be here, with the capital intact, for the second.

If you both want 112 on Q3, add one condition: the 10-Q has to show loan growth slowing, so that a flat delinquency ratio actually means something. Otherwise 112 waits for Q4, and 125 comes after that.

Last, the meeting points, because the neutral is right that this is where plans like this break.

The hedge has to outlive the exit window. If the print comes on a Thursday night and the options expire Friday, the second session of our two-session window is unhedged, and the reason for the window is gone. Buy the first expiry that lands at least three sessions after the confirmed print.

If an accelerator fires, the hedge decision gets made that same session. Either buy it within budget at the percentage strikes, or cut the core to 40. Waiting for an up day during a regime break means paying more for volatility later.

Aggressive, the reset above 1,860 is a good rule, and it should be mandatory. But "the rally pays for it" sounds like the budget stretching. The one point covers everything we spend through the print, net of what the old spread sells for. If the reset breaches that, the reset still happens at the right strikes, on a core cut to 40. That cut happens at 1,860, the best price this plan will have sold at. The same applies if buying before CPI instead of the 23^rd pushes the original spread over budget. The budget holds, and the size moves.

Every deadline that says "by the 23^rd" should read "by the 23^rd or the session before the confirmed print, whichever comes first." If the print is late, as we're all assuming, that costs nothing. If it isn't, it keeps us from carrying 75 percent into earnings on a limit order. That's the neutral's own test: no size we didn't choose going into an event we could see coming.

Two quick ones. Aggressive, the regional slide raised the payoff for a good credit answer, and it raised the penalty for a bad one by just as much. Neutral, you're right that the steadying quarter got the mildest gap. But it still gapped down. Operating income up 11.8 percent sequentially with a flat margin wasn't enough to clear the bar, and we have no estimates to tell us the bar has moved.

So here's where I land. Keep the Sell, at half through the print, with no short. Before the print, keep everything we've agreed: the box for the first tranche, the state test and the 1,646.73 trigger for the second, the live real and the spread rules, and nothing bought back before the numbers.

The hedge goes on after Monday's reaction and before the CPI close, at percentage strikes. It costs no more than one point of a standard position all in and expires at least three sessions after the print. It resets above 1,860, and it's closed or cut along with the stock. If it won't fit, the core goes to 40.

After the print, operating margin under 6 exits and gross margin under 40 exits. At most, a year-on-year rise in operating income with clean credit in the release leaves a quarter of the position, not half, and the 10-Q decides whether it stays. A clean release takes us to 75 within two sessions, and the 10-Q decides 100 through the reserve and current-ratio tests together. 112 waits for Q4, unless the Q3 filing shows loan growth slowing alongside the reserve and delinquency tests. 125 always waits one more clean quarter beyond that.

Aggressive, you said your version is still a Sell; it just doesn't forget why we kept half. We kept half because the hedge protects it through the events we can see. Your version holds half unhedged through a broken gross margin. It goes back to full on a press release, before the filing that tells us whether the numbers were real. A plan that does that has forgotten why it was a Sell. Conservative Analyst: Last round for me too, so let me pay what I owe before I ask for anything.

Neutral, three of your hits land. My 25 percent foothold depended on release-day delinquency ratios, which I had just called the weakest credit number we'll get. A smaller size doesn't fix a test that can't tell earned margin from borrowed margin. I'll also drop the hedge-expiry argument as my reason for 25. The hedge was bought for the gap, and the trader's plan has always held half unhedged through an in-between quarter. And I shouldn't have leaned on the trader's vote. The trader voted for speed. So the case for needing more evidence to add than to cut has to rest on what the tests can actually tell us, and under CECL it does. Your reset arithmetic is right too. A mandatory reset that has to fit inside a single point never added up. I'll sign one reset on its own half point, with the core sized to fit.

Aggressive, you've earned some as well. The lagged delinquency ratio handles my seasoning worry better than a loan-growth gate, and I'll trade my condition for it. You're right that a falling provision line is a question, not a verdict, whenever the release gives us the data to answer it. After an accelerator fires, let the budget decide, as you said. At honest strikes after a break, the spread usually won't fit, so the budget sends us to 40 without anyone having to presume it. And pulling consensus on Monday is the best thing you added last round. Hold onto it, because I'm going to use it.

What's left is really one idea, and you both signed it last round, so I'll quote it back. Under CECL, the reserve test can only downgrade a good-looking quarter. It can never rescue a bad one. The neutral drew the right conclusion: evidence like that belongs in front of the adds, and it can't soften an exit. The reserve test is that kind of evidence. So is consensus, and so is the group test. Each of them can tell us to own less. None of them measures what would justify owning more. My last asks all come down to applying that principle everywhere it reaches. As written, the plan breaks it in three places.

The first, and the most expensive, is the gross-margin branch. Aggressive, under your rule a gross margin below 40 with operating income up puts us at 25. Then, if the reserve share and lagged delinquencies hold, we go back to half. Now take the case where the release carries the reserve data. We would sell a quarter of a standard position and buy it back within two sessions, and nobody would actually make that round trip. In practice the rule says: hold half through a broken gross margin, as long as operating income is up and the reserve held. That's the reserve test rescuing an exit, the one thing you had just agreed it can't do.

Look at what the reserve share can actually see in that quarter. It tells us whether the reserve kept pace with the book. It doesn't tell us whether it kept pace with the risk. For that, you check it against what the book is actually doing. Your lagged ratio is a good check, and I'm taking it. But it needs a partner, because write-offs and loan sales take bad loans out of the delinquency count. A lender that charges off faster, or sells its bad paper, can show flat delinquencies while losses rise. So net charge-offs, measured against the lagged book, go next to it.

Even with all three clean, the reserve share only clears the operating line. It shows the gain in operating income wasn't borrowed from reserves. It says nothing about why the gross line broke 40. The gross line is where funding costs, shipping subsidies and first-party mix show up, and the reserve test measures none of them. All of this assumes the provision line still sits below gross profit, which Monday's check confirms. If it has moved into cost of revenue, a gross margin under 40 is partly the loan book itself, and there's no exception left to argue about.

Then think about what a gross margin under 40 would mean in this particular quarter. Aggressive, you told us the Q3 books came from a better backdrop than the late-September tape. Q3 had falling Brazilian rates and calm regional credit for all but its last week. If the gross line breaks 40 with all that behind it, it broke with the wind at its back. Q4 starts with the 51-basis-point spread widening, and possibly with Brazil's central bank pausing after the Fed's hike. A break under 40 in Q3 looks like the start of something, not the floor.

On 2020 and 2021, you're right that gross and operating margin can move apart. They did. But look at where the gap came from. In 2019, operating expenses were about 55 percent of revenue. That left nearly 20 points of overhead and marketing to take out, on 73 and 78 percent growth. Today opex is 34 percent of revenue, and in every quarter since mid-2024 it has run between about 32 and 37. The 2020 playbook needed room that isn't there anymore. Every point of gross margin MELI loses now has to be made up inside that narrow band. And in both years we can see, opex rose from Q2 to Q3.

On the cliff, the half we carry through the neutral's in-between quarter isn't an endorsement. It's the size we already own, kept because no line broke. Holding what you have when nothing broke, and cutting when something did, isn't inconsistent. That's what a line is for, and if you move it, the cliff just moves with it. The trader put this one at 40, on the line that's been falling fastest.

You also say a monthly breach and this quarter shouldn't share a size. In one the market says the structure broke, and in the other the company says the opposite. But the company would also be telling us its gross margin fell year on year for a sixth straight quarter, to a new series low. The two cases share a status: a line the trader drew has broken, and we don't yet have the evidence for why. Twenty-five is the plan's size for "broken, not yet explained."

Your repair mechanism doesn't need this exception either. If the CECL drag eases because originations slow, that shows up in provisions, which sit below the gross line if they're where I think they are. If that repair comes with gross margin at 40 or better, every rule we've written lets it through, to half, 75 or 100. The cap only binds when your repair arrives alongside a new low in the line this Sell was built on.

So here's the branch I'll sign. Gross margin under 40 exits. The one exception is operating income up year on year on real operating leverage. That means one of two things: the rest of opex did the work, or the provision line did, and the reserve share, lagged delinquencies and charge-offs all show it wasn't borrowed.

"Operating income up" is a weak gate. You called it a growth test wearing a margin costume yourself. That's exactly why what it earns is 25 and not half, and 25 is the ceiling for this quarter. Credit data can confirm that 25 or take it away, but it can't raise it. If the release can't show us which kind of quarter it was, the 25 waits for the filing in cash rather than in stock, and comes back if the 10-Q confirms it. The road back to half runs through Q4's numbers. You've told us Q4 is the seasonally easier test, so if the turn is real, it'll pass.

The second place is 112. I'll take the lagged ratio in place of my loan-growth gate, with charge-offs beside it. Neutral, you took my loan-growth condition last round, so I owe you the reason for trading it away. The lagged ratio answers the question I was using loan growth to get at, and it does so without penalizing the strongest version of the quarter. That also settles the aggressive's charge that the plan wants it both ways. With the gate gone and the reserve share answering the provision question, we no longer demand slower lending in one place and punish it in another.

One caution stays. On revolving credit, losses keep building well past two quarters, so one look catches only the early part of the curve. That's the honest limit of a single quarter, and it's why 125 waits, as we've all agreed. And yes, a 7.5 quarter means the frozen-margin $48.5 understates earnings, so the true multiple at the gate is under 35. I don't dispute the arithmetic.

What nobody has put in front of 112 is the region. Aggressive, you built the add to fire when a clean quarter goes unrewarded because the whole group is being marked down. The neutral's group test checks that MELI held up against Nu or a Latin America fund. But a MELI that matches a group down 15 percent still passes that test. For a retailer, a regional markdown might be noise. For a lender with 84 percent of its liabilities short-term, and debt apparently moving inside a year, the regional tape is the funding channel.

In your second round, you told us a scheduled data release isn't a regime break, but the real breaking 5.24 is. We don't go overweight into a regime break. So the signals that speed up our selling should also block anything above normal weight. No 112 while the real is fixing above 5.24, or while LatAm spreads are above 2.5.

That gate will often be shut exactly when the price gate opens, and that's the point. A clean quarter the market won't pay for, in a region whose credit is breaking, is where being overweight a lender hurts most. The return to 100 isn't affected, because that's the trader's normal weight. The region only gates the bet on top of it. And give the group test at least the two-session window, so a 10-Q filed the same day doesn't reduce it to one day of noise.

You said a good answer separates MELI from the group. It does, in relative terms. It doesn't change what Nu's book does or what the region pays to borrow. Separation is relative. The firm's capital isn't.

That's also my answer to raising both stakes on an asymmetric shape. The shape is asymmetric in one band, for about a week. The spread pays between roughly 6 and 15 percent down, and it expires a few sessions after the print. Above minus six, the half takes the loss. Below minus fifteen, it takes the loss again. After expiry, the half is a plain long, and the overweight is never hedged at all. So for the one position that exists only because we're bullish, raising both stakes equally is a wash at best. And the credit question doesn't get settled in one print. Nu's version of it has been running since at least September.

The third place is consensus. Aggressive, you said a 7.5 that misses a consensus of 8 is a miss, not the tape, and the add shouldn't fire. Then it's a miss at 100 too. As written, the plan would buy back half a standard position within two sessions on a quarter you've just called a miss, and refuse only the twelve and a half points above it. Put consensus in front of every step above half. A clean release that misses consensus on operating margin goes to 75, and the 10-Q decides the rest. That's the same staging we already use when the release is missing data, and the filing is where we'd find whatever the market saw.

A few meeting points, quickly, because the neutral is right that this is where plans like this break.

First, the two-session rebuild to 100 needs a balance sheet on release day. The current-ratio and leverage gates can't pass on a release that doesn't print them. Without one, it's 75 and the filing. That goes on Monday's list.

Second, every rule we've written assumes the print comes after the FOMC, and the date isn't confirmed. If MELI reports early in the window, a hedge that expires three sessions after the print could roll off before the Fed decides on the 28^th. Make the expiry at least three sessions after the later of the two. If the print comes after the FOMC, as we've all assumed, that costs nothing.

Third, price rules outrank every fundamental branch. A close under 1,495 is a full exit, whatever the release said. A monthly close under 1,549.51 cuts to 25, whatever the release said, and cancels any pending add. This matters because the 112 price gate sits around 1,697. The add is built to fire on weakness, so the two rules can collide within a single month. On a lender whose book we've seen once, the tape is the only other witness we have.

Fourth, spell out the flat accounts. The trader's own invalidation rule took them to half where holders went to full. Keep that ratio after the print: a clean release takes a flat account to half, and the 10-Q decides the rest. Nobody should open a full position in two sessions on a press release.

So here's the version I'll sign. It's a Sell, with half held through the print, no short, and every step scaled to what you hold.

Everything before the print stands as we've all written it: the box for the first tranche; the band, the 1,646.73 trigger and the state test for the second; the fixing and spread accelerators; the earlier-of deadlines; nothing bought back before the numbers.

The hedge stands as agreed: percentage strikes, one point all in, one reset on its own half point, 40 if it won't fit, and it closes or shrinks with the stock. The only change is the expiry, which moves to at least three sessions after the later of the print and the FOMC.

After the print, price rules come first. Operating margin under 6 exits. Gross margin under 40 exits, except that real operating leverage with operating income up earns 25, which credit data can confirm or remove but never raise. A clean release goes to 100 within two sessions only if it carries the reserve data and a balance sheet and doesn't miss consensus. Otherwise it goes to 75 and the 10-Q decides. 112 needs: the credit tests, with charge-offs; the group test over at least two sessions; no consensus miss; the pre-print price gate; a region that isn't breaking. 125 waits one more clean quarter.

On Monday, confirm the print date, the CPI date and when the 10-Q lands. Check whether the release carries the loan book, the allowance and a balance sheet, and where the provision line sits. And pull consensus margins.

Aggressive, you said this plan loses small if the bear case is right and is at size, early, if it isn't. With these changes it still loses small if the bear case is right. If it isn't, we're back at full weight within days of a clean release, and overweight once the region stops breaking. That isn't late. Late would be waiting for two confirmations. This buys the first confirmation without buying the region's problem along with it.

The trader built this Sell on a gross margin that has fallen five quarters running, and on three gaps this year, all of them down. The one thing this plan must never do is hold size through the line it was built on, in the very quarter that line breaks. Keep the evidence that can only say "less" in front of every purchase, and the firm will still have its capital when the turn is real. Conservative Analyst: Aggressive, you took the last word, and I don't begrudge it. But you amended the neutral's handover after we'd both closed, so the plan on the table isn't the one I answered. I'll take your four amendments in order, then close a few meeting points nobody has closed. None of it touches Monday. The box, the fixing, the state test and the hedge timing stand as all three of us wrote them.

Debts first. You're right that I can't call Brazil's rate cut too small to help margins in round two and then big enough to make a gross-margin break ominous in round four. Strike the wind at Q3's back. The neutral had the honest version: the late-September spread widening is a fourth-quarter question. You're also right that an opex ratio near 33 is the bottom of 2025's range, not a new low, and that Q2 reversed a spike rather than squeezing anything. I'll drop "no room."

I'll also take these: Parity between the cash path and the stock path at the 10-Q. An account that waited in cash shouldn't end up smaller than one that waited in stock on the same evidence. Missing data staging us to 75 rather than disqualifying a release. That's what all three of us meant. Consensus as one line, operating margin, frozen the session before. The put spread on the 112 step. It's the first time anyone has asked the overweight to carry its own insurance, and it's the right instinct.

One concession is bigger than those. Last round I made 25 the ceiling for the gross-margin exception until February. The neutral found something better than my blanket cap. Credit data still can't raise that 25, but an explanation of the line that actually broke can. I'll take the lift to half at the 10-Q, so your four months is gone. What's left between us on that branch is narrower: whether the explanation can come from the release, and whether the 25 that comes back is insured.

Start with insurance, because you wrote the rule. In your second round you told me to insure the part that can hurt you and keep the part that can pay you, and you said cutting size is insurance paid for with upside. Last round you applied that to the overweight: twelve and a half points added after the print and held through February get their own put spread, or they wait.

The lifted 25 is the same kind of position: an add made on one quarter's evidence and held through the Q4 print. The difference is that the overweight follows a quarter that passed every test. This add follows a quarter that broke the line the trader built the Sell on, with gross margin at a new series low and down year on year for a sixth straight quarter. If the add on a clean quarter needs insurance, the add on a broken one needs it more.

So the lift carries its own spread through the Q4 print, with the same percentage strikes and the same call rule, within two percent of the stock it covers. That's half a point of a standard position. I'm not reviving hedge expiry as my reason for 25. I dropped that, and the first 25 stands unhedged. This is your rule for adds, applied to an add.

It isn't a veto in disguise, either. There's no implied vol in the packet. But at the neutral's high-thirties guess, a twenty-percent call over three or four months pays for far more of a spread than it did over five weeks, so the financed version should usually fit. If it fits, you have half. If it doesn't, the market is telling us what that 25 really costs to own, and it stays at 25.

Why insure it rather than trust it? Because the explanation tells us where the margin went, not whether it comes back. The fundamentals report says plainly that some of the decline may be permanent if competition is the cause. Shipping subsidies and first-party mix land in the same lines whether management chose them or competitors forced them. The 10-Q can locate the damage. It can't tell us the damage reverses.

I have two conditions on the explanation itself. First, "mainly from the commerce side" isn't a test. The neutral's fail condition is a real test, so make it the pass condition too: funding costs grew no faster than credit revenue.

Second, it has to be numbers. If the release prints the credit-revenue line, the funding-cost line and all three credit legs, act within two sessions, as you want. If what it prints is management's walk of where the margin went, that's a press release standing in for a filing, the neutral's own closing line, and we wait for the 10-Q. If charge-offs aren't in the release, as you've both been assuming, your own "all three legs" condition puts this at the filing anyway.

I don't need to win the cliff argument any more, but it proves too much. A 6.1 operating margin and a 5.9 are the same quarter give or take two-tenths of a point, yet one holds half and the other holds nothing. That's a steeper cliff than yours, and nobody has asked to smooth it, because a line you smooth stops being a line.

The quarter that proves the gross line wrong is already in the plan. Gross margin comes back over 40.9, and we go to 100. The exception quarter is the one where the gross line broke while the operating line improved. One quarter of those two lines coming apart is the front of the curve, by your own logic on why 125 waits.

Your second amendment, the pro-forma read in both directions, I'll take in principle. You built it the right way round: the margin does the work, and the reserve only gets subtracted.

But look at the exact branch you wrote. The reserve share fell, lagged delinquencies fell and charge-offs fell, all in one quarter. That's what better underwriting looks like, and a lender selling bad paper can produce the same pattern. Sell delinquent loans, and the delinquencies leave the book. The reserve that sat against them leaves too, so the coverage ratio drops. Sell written-off loans, and the proceeds come back as recoveries that shrink net charge-offs. No borrower got any better.

So I have two conditions there too. First, measure charge-offs before any recoveries from portfolio sales, everywhere "credit holds" appears, not just here. Second, the 10-Q has to show no material loan sales or transfers of receivables in the quarter, because that's where they'd show up, not in a release. That puts your branch at 75 on the release if the pro-forma margin clears 7.5, and the filing decides 100. You've already agreed it can't fund an add.

One more thing about that branch. It's a quarter in which management cut its lifetime loss rate at a September 30 balance-sheet date. Latin American spreads were widening fast, the real and the peso were sliding, and an election was days away. The pro-forma read fixes the margin, but it can't tell us whether that reserving call was right, and next quarter inherits it. So when we've had to strip a reserve release out to read the margin, the stripped number is also the one that faces consensus. A beat bought with the reserve isn't a beat.

You asked me to sign the neutral's charge-off arithmetic. It's right about the quarter and silent about the book. Under CECL, the reserve isn't a bill for loans that have already died. It's the lifetime loss on every loan still outstanding.

If charge-offs rise and the reserve share doesn't, management is telling us realized losses went up while expected losses on everything left didn't. Sometimes that's fine, because the loans being written off were reserved long ago. Sometimes it's a reserve behind the curve. The 7.5 paid for the first case. It hasn't paid for the second.

That second case is the forward signal you both say charge-offs carry. So I'll sign normal weight on a release without them, on one condition. The neutral's "charge-offs at the 10-Q can take us back to 75" becomes "will," executed in the session the filing posts. In a rulebook, "can" means "won't," because nobody voluntarily sells a quarter of a position a week after buying it. I made that point about your round trip in the gross-margin branch last round, and it cuts the same way here.

Same instinct on disclosure. Missing data stages to 75. But a credit metric that was in last quarter's materials and isn't in this one hasn't gone missing. It's been dropped, on our first look at MELI's credit this cycle, at a time when the market is asking every Brazilian lender exactly that question. Check Q2's release on Monday. If anything that was there disappears, there's no move on the release, and the filing decides.

Now the region gate. You want it to open as easily as it shuts. I'd put the burden of proof on the action, not on the waiting. Shutting means we wait, and by your own measure waiting a day costs a day. Opening means we buy. And nothing after the print sells for a regime break, because the accelerators were all pre-print.

The neutral called that spread series a hair trigger, which is why the sell rule needs two closes above 2.5. If one close is noise when it tells us to sell, it's noise when it tells us to buy. Spreads sat at 2.41 on October 1, nine basis points from the line, after an eighteen-basis-point day. A gate with the same line in both directions on that series will open and shut on consecutive sessions.

The fixing also watches one currency in a three-currency business. The peso fell 4.7 percent in three weeks against the real's 2, and Argentina isn't in the packet at all.

So one close shuts the gate, and it reopens after two consecutive sessions with both the fixing and spreads back inside the lines. That's one extra day, your price. It only lasts until February if the region stays broken, and then February is the right answer.

Then close the other side of that meeting point. The gate stops us buying an overweight in a broken region, but nothing takes the overweight off if the region breaks after we own it. You said it yourself: a lender with 84 percent of its liabilities short-term shouldn't run an overweight while its funding market is breaking.

Your spread covers minus six to minus fifteen, and a regime break is how you get past minus fifteen. September took this stock down fifteen and a half percent in a month without a print. May went seventeen percent below its pre-gap close within a week.

So a fixing above 5.24, or two spread closes above 2.5, takes the overweight off that session, along with its hedge. Normal weight rides. I'm not asking the trader's baseline to trade the region, only the bet on top of it.

There are two timing gaps on the overweight. Neutral, you made the add wait rather than die when the region is the only thing missing. Fine, but not into the next print. If the gate opens the week before February's numbers, a waiting add puts on size right in front of an event we can see coming, which your own test says this plan never does. We started cutting for this print about a month ahead of it, so use the same distance. Inside a month of the Q4 print, a waiting add lapses, and Q4 decides fresh.

The second gap: price rules outranking fundamentals has to cover the way back in, not just the way out. The 112 price gate sits around 1,697. It opens widest in exactly the world where October closes under 1,549.51, about a week before the print. The technical report says that close turns all three timeframes bearish and ends the long-term buying case for 1,546 to 1,600.

A monthly breach already cuts us to 25 and cancels any pending add. The lift from 25 to half is an add, so it goes too. After a breach, a clean release rebuilds to 75, the plan's holding pattern for evidence that hasn't arrived. Anything above that waits for a monthly close back above 1,549.51.

Two small mechanical points. First, the hedge expiry depends on a print date nobody has confirmed. If it's still unannounced at the hedge deadline, don't guess. This year's gaps on February 25, May 8 and August 6 point to early November, so buy the November monthly, which expires on the 20^th. That covers the FOMC and the whole plausible print window, with at least three sessions to spare.

Second, every "close under" trigger should execute in that day's closing auction, off a check just before the bell, not at the next open. Otherwise each closing trigger carries an overnight gap on top of the one we've already admitted it can't stop.

Aggressive, you said a plan in which every new number can only subtract can never be surprised upward. It can. The numbers built to say "more" still say it: gross margin over 40.9, operating margin of 7.5 or better, growth of 40, and the tape itself on re-rating day, which the half rides from the first tick. A clean release still takes us to 75 within two sessions, and to 100 when the release carries the evidence. Flat accounts still go to half, and 112 and 125 still come through their gates. None of my changes closes those paths. They check the evidence on the way through.

You also said none of your four amendments does anything if the bear case is right. That's true, and it's why they're the ones that need checking. Rules that only fire on good news fire exactly when we're most inclined to believe what we're reading. You said no number should be refused a job it can do. None of these is being refused. Each is being asked to show it's been checked before it does the job.

So here's what I'll sign. It's the neutral's handover, with your cash-path parity, missing-data staging, one-line consensus and the hedged 112 step. On top of that: The lift from 25 to half needs filed numbers showing funding costs grew no faster than credit revenue, all three credit legs, and its own spread through the Q4 print within half a point. Otherwise it stays at 25. Charge-offs are measured before portfolio-sale recoveries, everywhere. The pro-forma branch gets 75 on the release and 100 only after the 10-Q shows no material loan sales or transfers. The stripped margin is the one that faces consensus. Rising charge-offs at the 10-Q take us back to 75 in that session. A credit metric dropped since last quarter means no move on the release. The region gate shuts on one close and reopens on two. A regime break while we're overweight takes the overweight off. A waiting add lapses inside a month of the Q4 print. A monthly breach cancels the lift, caps a clean rebuild at 75 and holds everything above that until a monthly close back above 1,549.51. If the print date is unconfirmed at the deadline, the hedge runs to the November monthly. Closing triggers execute in the closing auction.

I know that's more lines in a rulebook that's already long, so write the whole thing down as one decision table before Monday's open. A rule nobody can find at ten to four isn't a rule. But every line I've added sits where two rules we already wrote meet and disagree, and the neutral is right that that's where plans like this break.

You closed by saying this plan must never stay small through the quarter that proves the line wrong. It won't: that quarter goes to 100. What it mustn't do is mistake the quarter that breaks the line for the one that proves it wrong. Nor should it hand out size on a reserve ratio before we've checked whether the bad loans were sold.

Every change here costs a day, a fraction of a point in premium, or a wait for a filing that's already on the calendar. That's a small price for making sure that when this plan adds, it's adding on evidence that's been checked, not evidence that's been presented. It's still a Sell, and when the turn is real, the firm's capital will still be there to buy it.

Neutral Analyst¶

Neutral Analyst: Both of you pre-wrote the neutral speech, and in both drafts I'm holding full weight because the stock is oversold. That isn't my position. RSI hasn't closed below 30 once in this slide. ATR has shrunk from 64 to 55 while price fell, and the weekly TD count is only 3 of 9. That's a grind, not a washout. Add five events in five weeks, on a stock that has gapped down three times this year on what look like earnings days, and carrying less is right. So I'm with the Sell, and roughly with half.

Where I part with you is what each of you is optimizing. The aggressive plan tries to maximize the average exit price. The conservative plan tries to beat the left tail by selling sooner. I think the job is to control the tails directly and let the average take care of itself, because on this tape the average is mostly noise.

Start with the number you keep trading. The aggressive seat says patience earns about 2.6 percent of a standard position if both tranches fill around 1,786. The conservative seat says that only happens if we get a rally first. True, and it goes further. On a tape with no edge, a limit order above the market doesn't raise your expected exit at all. It just swaps a better price on the paths that bounce for a worse one on the paths that don't.

The technical report rates a fresh short here at about 1 to 1 and says to wait for either a bounce or a confirmed break. That's about as close as a technical report gets to calling the next move a coin toss. So patience doesn't earn the 2.6 percent, and waiting isn't automatically a disaster either. What matters is how each plan handles the bad tail.

Take the first tranche. Waiting for 1,738 is worth about 0.6 percent of a standard position, as the conservative said. Selling on a breakdown at about 1,665 instead of today's price costs about half a percent. You've both spent a lot of airtime on half a percent, and the technical report already settles it. The October 1^st range, 1,668.44 to 1,731.36, is the near-term decision box, and a break out of either end is the next signal.

So sell the first tranche on whichever end breaks first. A trade into 1,731 to 1,745 sells the pop the aggressive seat wants. A daily close below 1,668.44 sells the breakdown that the report says the trend favors. If neither has happened by Friday the 9^th, sell at market. The conservative's deadline is right. What the plan never had was a downside trigger.

The second tranche is where the conservative overcorrects. The 1,813 to 1,860 band is the one place in this packet where the odds genuinely reward patience: about 3 to 1 for a trend-following seller, with the 20-day, the 200-day, the 50-day and the daily SuperTrend all stacked there. The likeliest catalysts for a move that far are a good election outcome and a tame CPI. With hike pricing already fading after a 29,000 payroll print, a soft CPI is exactly the kind of relief that lifts long-duration names. Forcing this tranche to market before CPI throws that chance away.

But CPI could just as easily run hot, with oil around $96 and August core PCE picking up again. The conservative is right that the plan as written lets us drift lower into it with nothing underneath. So put something underneath: a daily close below 1,646.73, the lower Bollinger band, sells the second tranche at market.

Now patience has a cap. Short of a gap, the worst case is selling about 3 percent below today, roughly three-quarters of a percent of a standard position. The gain if the band fills is about 2 percent. I won't call that free money. On a pure coin-flip tape it's about breakeven. But a small, capped bet on the bounce this setup is ripe for is very different from the open-ended wait in the original plan.

That trigger has two side effects. First, the 1,600 clause can never fire, because you can't be at or below 1,600 on the 23^rd without closing below 1,646.73 along the way. Strike it. The aggressive seat's real concern was not dumping stock into the 1,546 to 1,600 long-term buying zone. That's still honored, because we carry half the position through that zone. That half is our long-term buyer.

Second, turn the outperformance pause into a deadline dial. The conservative is right that a pause contradicts selling the pop, since a 2 to 3 percent Monday bounce would trip it on day one. But relative strength still carries information. Nothing in the news explains MELI's weakness on company grounds. It's trading like part of a Latin American fintech selloff, with Nu getting hit and LatAm spreads out 51 basis points in six sessions.

That corrects both of you. Aggressive, the selling isn't purely stock-specific. Conservative, a regional relief rally can be sharp, and the macro report flags exactly that squeeze risk. So watch Monday: If the real and Brazilian stocks rally and MELI can't hold a gain, that's MELI-specific weakness. The second tranche's market deadline moves up to the session before CPI. If MELI leads, the limit keeps working to the 23^rd. Either way, unless the trend genuinely repairs, every path reaches half before the runoff.

On the macro accelerator, I'd split it. The conservative is right that requiring both signals means acting late, and that our 5.19 on the real is a September 25^th number. Monday's Fed release fills in the pre-election week, so check that first. But LatAm spreads are 9 basis points from 2.5 percent after moving 18 in a single session. Firing on spreads alone is a hair trigger on a noisy series. A USD/BRL close above 5.24 breaks the August-September range and is the cleanest single read on a fiscally ugly result, so let that fire on its own. Spreads alone need a second close above 2.5, or one close plus a MELI close below 1,668.44.

On the upside invalidation, the conservative has the better argument, with one adjustment. Rebuilding to 100 percent on a single daily close above 1,875 means paying for the answer in advance at full size. That's exactly what the aggressive seat says this plan refuses to do. Selling at 1,835 and buying back above 1,875 is less than one ATR of whipsaw, and the stock is down 11.9 percent since the September 8^th golden cross.

So a daily close above 1,875 stops the trims. A weekly close above it lets us buy back one tranche, to 75 percent. Full weight waits for the numbers, and flat accounts stay flat until the print. You don't buy ahead of a print whose median outcome sits right on your exit line.

Now the print, because that's where the real money is.

Aggressive, most of your tailwinds don't touch the tests you care about. The easy comparison against $724 million is a year-over-year dollar comparison. None of the rebuild tests are year-over-year dollars. They're margin levels: gross margin above 40.9 and operating margin at 7.5 or better. Currency translation mostly scales revenue and costs together, so it helps the growth test, which is the easy one at 49.8 percent.

And Q3 closed on September 30^th. It's in the books. The rate cuts and the stronger real already did whatever they were going to do. What's still live is how the market reads the quarter and the Q4 outlook. That's where the late-September slide in the real and the peso, and the spread widening, show up. Those are headwinds.

Conservative, your seasonal math is harsher than the data. You took last year's 2.4 and 3.8 point drops, which came off a 12 to 14 percent base, and applied them to a 6.7 percent base. Scale them proportionally and Q3 lands around 4.9 to 5.4 percent. That's still under the 6 percent exit line, so your conclusion survives, but your magnitude doesn't.

More to the point, two years is a trend, not a season, and both of those years were in the middle of a margin decline. This year shows things those years didn't: Operating margin went from 6.9 to 6.7 between Q1 and Q2, a flatter step than last year's 12.9 to 12.2. Operating expenses fell 2.6 points as a share of revenue in a single quarter. The fundamentals report spells out a mechanical route to repair. Under CECL, the accounting rule that books expected loan losses when a loan is made, fast loan growth pulls provisions forward. Quarterly asset growth has already slowed to about 9 to 10 percent this year, from 16 to 19 percent last year. If loan growth is cooling, that drag eases.

So yes, the rebuild branch is probably the least likely of the three. But it isn't negligible, and it's the reason we keep half instead of a third.

That cuts both ways, though, and it's the aggressive plan's real blind spot. If margins improve because provisions fall as loan growth slows, that is not the same as credit getting better. A margin pass with rising delinquencies is a false signal. The Q3 release is the first time any of us will see MELI's own delinquency and provision numbers. The rebuild to 100 needs those to be stable, not just the three headline tests and the leverage gate. And 125 percent on one quarter, in a lender whose loan book we've never seen, is too much. That waits for a second confirming quarter, as the conservative says.

Where I'd soften the conservative is the current ratio. You're right it could slip under 1.10x on report day even with good margins. But on a balance sheet that's 85 percent liabilities and built like a lender's, the current ratio is a blunt instrument. The direction matters, so don't ignore it. But don't let it veto a return to normal weight on an otherwise clean quarter. Let it cap the rebuild at 75 percent and block anything above 100.

On valuation, you're both quoting bookends. Thirty-five times frozen-margin 2027 earnings assumes the margin slide stops, which is the open question. Forty-six times trailing earnings assumes no growth from a company growing revenue 50 percent. Somewhere in between, the stock is roughly a wash against a 2.88 percent real yield. That makes valuation neither a reason to dump it nor a reason to commit to overweight in advance.

What valuation does tell you is that MELI trades like a long-duration asset. The macro report says that if the 10-year drops back under 5 percent, MELI is among the names with the most to gain. That's a reason to keep a real core. It's also a reason to protect it, because a hot CPI cuts the other way.

Which brings me to the hedge, where I think you're both arguing without evidence. Aggressive, you say buying protection without seeing its price is how you overpay. The fix for that is to look at the price, not to skip the hedge. Conservative, you lean on equity volatility looking cheap relative to credit, but that's the VIX, an index.

The only MELI options data point in the whole packet is a StockTwits post about January 2028 $3,000 calls at roughly $5,000 a contract, which the poster calls insanely expensive. By my rough math that implies volatility in the high 30s, about the same as what this stock's own ATR says it actually moves. The sticker price is big, but nothing here says MELI options are mispriced. The near-dated ones will carry an election and earnings premium, so set a budget.

By the 23^rd, with the print date confirmed, price a put spread through the print on the core. Strikes would be roughly 6 percent and 15 percent below the stock price, which is the conservative's 1,600 to 1,450 at today's price. The hedge belongs on the core, not in place of the second tranche, because that sale is the best-odds trade we have.

I'd pay up to about 1 percent of a standard position for it, which is about 2 percent of the stock it protects. That's less than half the 2.5 percent whipsaw the aggressive seat called a small, defined cost. If the plain spread doesn't fit the budget, sell a call near 2,060 to help pay for it. That's the weekly SuperTrend stop and the September rejection high, above anything MELI has closed at since the February gap. The cap only binds on a blowout we'd be happy to have.

If even that version doesn't fit, cut the core to about 40 percent, not a third. At 40, a full repeat of May costs about 5 percent of a standard position, which is what a plain 3-ATR gap costs at half. That's the survivability line the technical report draws, and it leaves enough on to matter if the print is good.

The hedge also fixes something you both raised and neither solved. Conservative, you're right that every tripwire is a close, and closes don't protect you from opens. The spread does. With it on, the post-print exit doesn't have to be a market order into the open. We can take a session or two to get out, with the gap-day low as a hard line.

May says don't dawdle. The stock fell about another 5 percent in the week after that gap. The 30 percent run the aggressive seat cites only got going after a retest to a 1,583 close nearly six weeks later. August says don't panic. The stock was back above the pre-gap close in three sessions. The hedge means we don't have to bet on which one we get. If we're unhedged, the hard rules stand as written.

One thing neither of you mentioned: we don't know what else the caller owns. This week MELI traded as part of a Latin American fintech group, with Nu, the region's funds and LatAm credit all moving together. If you also hold Nu or a Latin America fund, count it toward the same bet when you size the core.

So here's the adjustment: Keep the Sell and the half-weight target through the print, with no short. Confirm the print date Monday, since the hedge expiry and every pre-print rule depend on it. Sell the first tranche on whichever side of the 1,668 to 1,731 box breaks first, and at market by Friday the 9^th if neither does. Keep the second tranche's 1,813 to 1,860 limit. Sell it at market on a daily close below 1,646.73. Its deadline is the 23^rd, pulled forward to the session before CPI if MELI lags a strong Brazil market on Monday. Strike the 1,600 clause and the pause. A USD/BRL close above 5.24 accelerates the trims on its own. Spreads need a second close above 2.5. A daily close above 1,875 stops the trims. A weekly close above it allows a rebuild to 75 percent. Full weight waits for the numbers. Hedge the core within about 1 percent of a standard position, funded with a 2,060 call if needed, or go to 40 percent. After the print, the exit rules stand, worked over a session or two if we're hedged. Rebuild to 100 on the three tests plus stable credit metrics and the leverage gate. A current ratio under 1.10x caps the rebuild at 75. The step to 125 waits for a second quarter.

The conservative says their version protects us whether or not we get a rally. It does, but it pays for that in three ways. It sells the best-odds tranche at market right before one of the likeliest catalysts. It cuts the core to a third when a hedge might carry half. And it lets one current-ratio reading block the way back in. The aggressive version keeps all the upside, but only if the rally shows up first.

This version doesn't need to know which way Monday goes. The box decides the first tranche, a trigger caps the second, the hedge covers the gap that closing-price rules can't, and the door back in stays open if the margin question gets a good answer. Neutral Analyst: Neutral Analyst: Before we argue about what's left, look at how much is settled. All three of us now agree on the following:

The Sell, at half weight, with no short. The first tranche goes on whichever end of the 1,668 to 1,731 box breaks first, with a Friday deadline. A close under 1,646.73 caps the wait on the second tranche. The 1,600 clause and the pause are gone. The real can fire the trims on its own. The core gets a put spread, with 40 percent as the fallback. Credit metrics sit inside the rebuild tests.

What's left is how much we hold going into three events we can see coming: CPI, the print, and our first look at the loan book. Each open point is worth a point or two of a standard position. What matters more is that the pieces fit together. A plan with this many rules rarely breaks in the middle. It breaks where two rules meet. So most of what I have is about those meeting points.

I'll start with one I have to give back. The weekly-close rebuy to 75 was my idea, and I'm withdrawing it. Conservative, your conclusion is right, but I'd rest it on different evidence. One weekly close in September, when the stock was rolling off the top of its range, tells us little about a reversal after a completed TD 9. And the fact that this year's gaps started from 1,870 to 1,923 mostly tells us where the stock was trading, not that the level is cursed.

The rebuy goes because of your arithmetic. It's the last rule that adds size before the print, and it only fires once the 15 percent cushion the aggressive leaned on is gone. At 75 percent, a May-sized gap costs about ten points instead of six and a half. The whole plan exists to avoid that ten.

There's also a mechanical point neither of you made. Any price that closes above 1,875 has passed through the 1,813 to 1,860 order on the way up. A resting sell limit fills even if the stock gaps straight through it. So "a close above 1,875 stops the trims" does almost nothing. The only real decision in that rule was the rebuy. Aggressive, you opened by saying this plan refuses to pay for the answer in advance at full size. The rebuy was the last place it still did. If the trend really is repairing, it will still be repairing the morning after the print, and we can pay up then with the answer in hand.

On the second tranche, the conservative improved my rule and then left the same kind of gap in a different scenario. You're right that mine defaulted to waiting. A flat Monday followed by a slow drift would have carried 75 percent into CPI on hope, and flipping the default fixes that.

But in your version, the relief trigger only has to fire once. Picture a close at 1,745 on Tuesday that fades back to 1,680 by the day before CPI. Your rule keeps the limit working to the 23^rd, so we go into CPI at 75 percent on a bounce that has already failed.

So test where the stock is, not where it's been. At the close of the session before CPI, if MELI is above 1,731.36, the top of the box, the limit keeps working to the 23^rd. If it isn't, the tranche sells at that close. The 1,646.73 trigger stays live the whole time. This also replaces the Monday rule I proposed last round, so it's one rule instead of two.

Aggressive, that keeps your 1,813 to 1,860 target alive in the only scenario where your odds mean anything. Three to one is what a seller earns if price reaches 1,835. From here, that needs a bounce three or four times bigger than anything this slide has produced. Two points gained against three-quarters of a point lost tells us the payoffs, not the odds. Lopsided payoffs aren't an edge. With no trend either way, that setup is worth about zero, and the technical report says the trend is down. A bounce that's still intact the day before CPI is the one piece of evidence that actually improves those odds.

Conservative, in that scenario we do carry 75 percent through CPI, with about five percent of room above the trigger. I'll accept that, because it's the only scenario where the bounce has actually shown up.

On CPI itself, you're each leaning on the side you need. The headline number will probably run warm, because oil spent most of September well above August levels. But the market trades core inflation, and that's a real coin flip after August's pickup in core PCE and a 29,000 payroll print. Conservative, you're right that a scheduled release can break the regime for a stock valued on distant earnings. Aggressive, you're right that a scheduled release is one we can plan for. Together those say the same thing: set our size the day before CPI, not on CPI morning.

On the hedge, conservative, you're right about the strikes. Set them off the price on the day we buy, roughly 6 and 15 percent below. Aggressive, you're half right about timing. Buying on a strong day helps, because implied volatility usually falls when the stock rises. And the first-round election premium comes out after Monday either way. But fixed strikes costing less after a bounce isn't a saving. It just buys less insurance.

So the hedge looks like this: Buy after Monday's election reaction, on an up day if we get one, and no later than the 23^rd. Use percentage strikes, roughly 6 and 15 percent below the price that day. Expire just after the print, once the date is confirmed.

Aggressive, I'd push you harder on the financing. You said that when puts get expensive, calls do too, so selling a call covers the cost more often. That's only partly true. At today's price, a call 21 percent out of the money that expires just after the print is cheap at almost any volatility. By my rough math, it covers a fifth to a third of the spread's cost. If the stock bounces to 1,800 first, the same 2,060 call pays more. But that's only because it now caps us 14 percent up instead of 21. And when fear rises, puts usually get more expensive faster than calls. So plan around what the spread costs on its own, and treat the call as a discount, not a way to pay for it.

Here's the rule I most want written down. If the real spread doesn't fit the one-percent budget, we don't make it fit by moving the strikes lower. A spread that starts 12 percent below the stock fits any budget and would have paid on almost none of this year's gaps. That hedge is for show. If the real one doesn't fit, the core goes to 40. Since the rebuy is gone and the strikes move with the price, that also meets both of the conservative's conditions for 40.

Conservative, you read the aggressive's table correctly. The hedged half is a more bullish position than an unhedged third, not a safer one. It roughly ties in the disasters, wins on a good print, and loses on the mild gaps and on a flat result. Aggressive, you should argue it on exactly those terms.

I'd still choose the hedged half. The half exists for the case where margins turn. If a May-sized loss is no worse than with a third, that's a fair price for holding more when the answer is good. But the conservative's point has teeth. Two of this year's three gaps, February and August, were the mild kind where the third wins. That's why the one-percent budget is a hard limit.

One thing nobody has said: the hedge has to move with the core. Suppose an exit rule fires and we sell the stock but leave the spread on. Then we're holding puts on stock we don't own, which is a short, and the plan says no short. If we sold the call to pay for it, we'd also be short a 2,060 call with no stock behind it. So any exit closes the whole structure the same day. If the monthly rule cuts the core to 25, the hedge is cut in proportion.

On the window after the print, I'm with the conservative: two sessions, the gap-day intraday low as the line, no extensions, and only if we're hedged. The exit decision is made on the release. The window only exists to get a better fill.

Now the print. Conservative, your three exit tests aren't three separate chances to fail. Operating margin is gross margin minus operating expenses. So the opex test can only fire by itself if gross margin climbs above about 41.7. Below that, the operating-margin test has already fired. That means the only case the opex test adds is a quarter where gross margin climbs most of a point off its low. That quarter answers the main bear question in our favor, and the rule as written would sell us out of it. Make opex something we watch, not an exit.

The gross-margin test is different, and it's the one most likely to fire. If Q3 repeats either of the last two years' moves from Q2, gross margin lands at 40.2 or 38.6. That's close to a coin flip on its own, and it stays.

Aggressive, "expected outcomes don't gap" is too strong, but there's something real in it. If those gap days were the earnings prints, as we've all assumed, the reactions tracked the news: The biggest gap came on the worst quarter. In May, operating income was down 20 percent and margin fell six points. The stock dropped 12.7 percent and kept falling. The smallest gap came on the quarter that steadied. August fell 4.8 percent and was back above its pre-gap close in three sessions.

Conservative, that tempers "three for three." The one quarter that showed stabilization got the mildest and shortest reaction of the year.

So the gap risk isn't spread evenly. It sits mostly in the bad-margin scenario, the same one where our exits fire. What none of us knows is where expectations are now. The packet has no consensus estimates. We can't tell from here whether September's slide lowered the bar for MELI's own numbers or just repriced the region. That's the strongest case for the hedge, and why I don't treat it as optional.

You're both using the regional argument, and the conservative has the sharper version. The selling is concentrated in Latin American lenders. The question the market is asking of Nu is whether credit holds up while lending grows. MELI's release answers that same question for the first time. So the print is the moment MELI either separates from that group or confirms it belongs there. That's why credit has to sit inside every rebuild test, not next to them.

On funding, you're both reaching. Aggressive, only part of Brazil's 95-basis-point rate cut is new between Q2 and Q3, maybe half. On any reasonable guess about MELI's funding base, that's worth a few tenths of a point of margin at most. That's not the jump the 7.5 test needs. The slowdown in asset growth matters more. The CECL provisioning drag responds to whether loan growth is speeding up or slowing down, and our tests measure exactly that kind of change.

Conservative, the jump in Latin American credit spreads came in the last week of September. That makes it a fourth-quarter question. It only hurts if the debt coming due is in dollars. If it's local funding priced off Brazil's interbank rate, the rate cuts help instead. We don't know which, and the 10-Q will tell us.

That's why your test for lifting the current-ratio cap is the right one. The cap at 75 lifts only if the filing shows both of these: The jump in current liabilities is mostly customer funds, matched by cash, investments or restricted assets. Debt maturing within twelve months is covered by unrestricted cash and investments.

If either fails, the cap holds until Q4.

On going overweight, aggressive, your seasonality point is good, and the conservative set it aside rather than answering it. A 7.5 percent margin in the quarter that fell from Q2 two years running is stronger evidence than a 7.5 in Q4.

Conservative, your credit point is the stronger one, but one quarter can answer more of it than you allow. If margin improved because loan-loss provisions fell, look at the loan-loss reserve as a share of the loan book. If that share held, slower loan growth lifted the margin honestly. If it shrank, the margin was borrowed from reserves.

So the step to 112 waits for the 10-Q, not the press release. It needs that reserve share flat or higher, and delinquencies flat or lower.

Conservative, you also caught that the 35x price gate doesn't limit itself as written. A good quarter raises the earnings estimate, and the gate rises with it. Fix that by setting the first step's gate on the pre-print estimate of $48.5. That puts the gate right around today's price. We'd only go overweight if a clean quarter goes unrewarded, which is the aggressive's own case for adding. Now the rule enforces it. The last step to 125 waits for Q4.

I wouldn't spend much more time on this, though. Leverage has been rising about a tenth of a turn a quarter. At this year's pace, it reaches the 6x gate in about a year. So an overweight here has an expiry date, unless loan growth keeps slowing. That happens to be the same thing that would lift margins.

Two quick points on valuation and other holdings.

Aggressive, "you only need last year's margin back" means 4.4 points of margin. Your mid-60s earnings scenario is a bull case, not a base case. Conservative, the 2019 equity raise isn't a fair comparison. Back then, $1.9 billion was more than five times the equity it went into. Today the business earns about that much in a year. The constraint now isn't capital. It's that assets keep growing faster than equity.

On other holdings, the reason to keep the core is the franchise and the chance of a margin turn. It shouldn't be the portfolio's bet on the 10-year yield. If the caller wants that bet, Treasuries are the cleaner way to own it. Any Nu or Latin America fund exposure should count toward the core.

Two last things to make the triggers usable. The real trigger should use a defined live rate, either the Brazilian central bank's daily fixing or a set New York close, not the Fed's weekly series. And conservative, thank you for restoring the second half of my spread rule, which I left out of my own summary: two closes above 2.5, or one plus a MELI close under 1,668.44.

So here's where I land. Keep the Sell, with half as the target through the print and no short. If you hold less than a full standard position, scale every step to what you hold. If you're already at or below half, skip the trims, but the hedge and the post-print rules still apply to what you carry. Flat accounts stay flat until the numbers are out.

Before the print: The first tranche goes on whichever end of the box breaks first, or at market by Friday the 9^th. The second tranche keeps its 1,813 to 1,860 limit and its 1,646.73 trigger. It keeps working past CPI only if MELI closes above 1,731.36 the day before CPI. Otherwise it sells at that close. A USD/BRL close above 5.24, on a live rate, speeds up the trims on its own. Credit spreads speed them up on two closes above 2.5, or one plus a MELI close under 1,668.44. A close above 1,875 buys nothing back before the print.

The hedge: A put spread about 6 and 15 percent below the price on the day we buy it. Bought after Monday and by the 23^rd, expiring just after the confirmed print. Within about one percent of a standard position, with a call near 2,060 as a discount if needed. No swapping in cheaper, lower strikes. If it won't fit, the core goes to 40. It closes with any exit and shrinks with any cut.

After the print: Exit on operating margin under 6 or gross margin under 40. Opex is something we watch, not an exit. The price rules stand: a monthly close under 1,549.51 cuts to 25, and a close under 1,495 exits. If hedged, take up to two sessions to sell, with the gap-day low as the line. Go back to 100 on the three tests, stable credit and the leverage gate. If the current ratio is under 1.10, cap at 75 until the 10-Q passes the test. Go to 112 only after the 10-Q shows the reserve share held and delinquencies flat or lower, with the price inside 35 times the pre-print estimate. The step to 125 waits for Q4.

Between you, you've built most of a good plan. The test I'd hold every remaining rule to is simple. There should be no scenario where we carry size we didn't choose into an event we could see coming. This version waits only while the price action justifies waiting. It insures the half we keep against a gap that no closing-price rule can catch. And it lets the release, not any of our convictions, decide when we buy back in. Neutral Analyst: We're close enough now that what's left comes down to a handful of scenarios, so let me bank what's settled first.

The hedge goes on before CPI, with the deadline at the close of the session before the release. Aggressive, that's better than my 23^rd, and I'll take it. I'm also signing the rest: the state test; nothing bought back before the print; percentage strikes, with no lower puts and no closer calls; the hedge closing and shrinking with the stock; two sessions to exit, with the gap-day low as the line; the central bank's daily fixing for the real; both halves of the spread rule.

Aggressive, one small correction on the second tranche. From a close just above 1,731, it's roughly a coin flip whether we reach the bottom of the band before the trigger. It's a bit worse for the 1,835 you model, and the technical report calls the trend down. "Even odds or better" oversells it. That's fine, because the state test was never meant to create an edge. It stops us carrying 75 percent into CPI on hope, and it does that.

What's left is mostly what happens after the print, plus one budget rule that doesn't add up. Most of these last disputes turn on facts we can look up Monday, not on how bullish or bearish either of you feels. So alongside the print date and the CPI date, Monday's list needs three more items: When does the 10-Q land relative to the release? Does the release carry the loan book and the loss allowance, as many lenders' earnings materials do? Where does the provision for doubtful accounts sit on the income statement? Conservative, you said it has historically sat inside operating expenses. If that holds, it settles most of the gross-margin argument.

So start there. Aggressive, I'll grant your narrow logic. Operating margin is gross margin minus opex. So the gross-margin exit only fires on its own when gross margin is under 40 and operating margin is still above 6. That means opex has to come in under 34 percent of revenue, against 34.2 in Q2. It has to come in lower still if operating income is going to beat last year's $724 million.

Now look at what opex did from Q2 to Q3 in the data we have: In 2024, it rose from 32.3 to 35.4 percent of revenue. In 2025, it went from 33.4 to 33.5. So it didn't fall in either year.

Your exception needs it to drop roughly another point, on top of Q2's 2.6-point drop, in the quarter where it rose both times. That can happen. But if provisions sit inside opex, the likeliest way it happens is lower provisions. That's the borrowed margin all three of us agreed shouldn't count as a pass.

You said the exception costs nothing if the conservative is right and fires on the proof if he's wrong. That's backwards. When it fires, the likeliest cause is the bad one.

Conservative, your diagnosis is right, but your foothold has a hole in it. You called release-day delinquency ratios the weakest credit number we'll have, flattered by loans too young to go bad. Then you made the 25 percent foothold conditional on exactly that number. A smaller size doesn't fix a test that can't tell earned margin from borrowed margin.

Here's a test the release can actually answer, if the provision line is broken out. Take opex apart. If provisions fell as a share of revenue and account for most of the drop, the operating income gain was borrowed. The exit stands in full. If the rest of opex did the work, with provisions flat or up as a share of revenue, that's real operating leverage. Then we keep 25 and let the 10-Q's reserve test decide whether it stays.

Why 25 and not half? Conservative, it's not because the hedge has expired, and I'd drop that framing. The trader's plan already holds half unhedged after the print on any in-between quarter. Say operating margin comes in at 6.5 with gross margin at 40.3. Nobody has objected to holding half there. The hedge was bought for the gap, not for every week after it.

The reason for 25 is different. This case sits below the line the trader built the Sell around, on a result that runs against the seasonal pattern. A quarter of a position fits that, and it's a size the plan already uses for a monthly-close breach.

Aggressive, this version still keeps you in the quarter you described: gross margin down, real operating leverage, profits growing again. It only takes you out of the one where a lower provision did the work.

Next, the rebuild. Conservative, you're right that the reserve test is in the wrong place, and since it's my test, I should be the one to say so. If the 10-Q shows the reserve share shrank, the 7.5 percent pass was a false pass. Then the step to 100 was the mistake, not just the step to 112.

But don't lean on the trader's vote to defend this. As written, the trader's plan rebuilds to 100 on the three tests and adds toward 125 on the same quarter. The trader voted for speed. Your asymmetry has to stand on its own logic, and fortunately it does.

Under CECL, the reserve test can only downgrade a good-looking quarter. It can't rescue a bad one. If margins miss and the reserve share rose, expected loss rates went up, which is bad news on its own. If margins miss and the share held, the miss came from somewhere else, and it's still a miss. So the test belongs in front of the adds and changes nothing about the exits. Aggressive, that isn't a bearish tilt nobody voted for. It's simply what the test can tell us.

Where I'd push back on the conservative is the cost of staging, which depends on a fact neither of you has. If the release carries the loan book and the allowance, the 10-Q adds little on this question. In that case, run the reserve test on the release. If the release is clean, the reserve test passes and the current ratio is at or above 1.10, go to 100 within two sessions, as the aggressive wants.

If the release doesn't carry the data, a clean release takes us to 75 within two sessions. The 10-Q then decides everything above that in one checkpoint, with reserve and current ratio together, as the conservative proposed.

Either way, the test sits in front of the rebuild. The only thing that changes is how long we wait for it. The filing calendar sets that, not either of your temperaments.

On whether a clean print gives us a pullback, neither of you has evidence. All three gaps this year went down, so there's no up-gap to study. What the chart does say is that a rally from around 1,700 runs into the 20-day, the 200-day, the 50-day and the daily SuperTrend between 1,813 and 1,860. That's the same band we've been selling into. I wouldn't bank on a pullback, and I wouldn't bank on a straight line through that band either.

On 112, the conservative's best point stands. If the first clean quarter gets priced, the gate holds us at 100, so the add only fires when a clean quarter goes unrewarded.

But conservative, "unrewarded means the market saw something we haven't modelled" is only one explanation. You endorsed the other one yourself: the selling is concentrated in Latin American lenders, driven by real yields and regional credit. A clean MELI quarter can go unrewarded because the whole group is being marked down.

We can tell those two apart. Compare MELI with Nu, or a broad Latin America fund, from the pre-print close through the 10-Q. If MELI held up at least as well as the group, the problem is the tape. The aggressive's case for adding is then at its strongest. If MELI lagged the group, the market saw something in the release, and we stay at 100. The sentiment report suggests the same test for Monday's election reaction. Lagging a strong region means MELI-specific weakness.

I'll also take your loan-growth condition, and give something back with it. In my first round, I pointed to total assets slowing to 9 or 10 percent a quarter as a sign that loan growth was cooling. You're right that the credit-revenue line grew 56.7 percent in Q2, faster than the roughly 52 percent a year earlier. Those are dollar figures with currency effects nobody here can strip out, so they don't prove the loan book is speeding up either. We simply don't know, which is exactly why the 10-Q should have to show it.

So 112 on Q3 needs all of the following: reserve coverage held in the 10-Q; delinquencies flat or lower; the loan book growing more slowly than the quarter before; MELI at least matching the group over that window; a price at or below 35 times the pre-print $48.5. Miss any of those and 112 waits for Q4. 125 comes one clean quarter after 112, whichever quarter that turns out to be.

Now the hedge, where two of your rules collide.

Conservative, you want two things at once: a mandatory reset above 1,860, and one point all-in through the print, with the core cut to 40 if the reset breaches it. Those can't both hold if the first purchase uses most of the point. On the numbers we've all been using, it will.

After a rally, the new spread sits much closer to the money than the old one does by then. So re-striking always costs more than the old spread sells for. Cutting the core to 40 shrinks the overrun but doesn't remove it. Read literally, your rule means no reset at any size we'd actually want to hold.

Aggressive, "the rally pays for it" is the budget quietly stretching, and preventing that is the whole point of a budget.

So decide it now. Allow one reset, with its own half-point allowance, and size the core to whatever we can re-strike within that.

Here's the rough math, and it is rough, since we have no implied-vol data. Re-striking a full half costs something like three-quarters of a point. So half a point supports a core in the high 30s, call it 40. The conservative gets his size, with arithmetic that works.

Half a point is roughly a tenth of what the core will have gained by the time MELI closes above 1,860. Total protection spend stays under the 2.5-point whipsaw the aggressive once called a small, defined cost.

And don't roll the call on a reset. If we sold one at 2,060, buying it back after a ten percent rally is expensive. The cap was set relative to the price we bought at. It sits at the weekly SuperTrend stop and the September rejection high, and a print that clears it is a blowout we'd be glad to have.

If the reset cuts the core, the matching share of the call has to be bought back, since a call with no stock behind it is a short. That buyback counts against the half point.

The rest of the conservative's mechanics I'd take as written: The first expiry is at least three sessions after the print, so the two-session window is actually covered. Every "by the 23^rd" reads "by the 23^rd or the session before the confirmed print, whichever comes first." If an accelerator fires, the hedge decision is made that same session.

I'd add one thing to that last rule. In a regime break, implied volatility will have jumped, so the 40 percent fallback will usually be the honest answer. Don't chase protection after the break.

And if Monday's check puts CPI on or before Friday the 9^th, the first tranche's deadline moves to the session before CPI as well.

So here's where I land. Keep the Sell, with half through the print and no short. Scale every step to what you hold. If you're already at or below half, skip the trims but follow the hedge and the post-print rules. Flat accounts stay flat until the numbers are out.

On Monday, confirm: the print date; the CPI date; when the 10-Q lands; whether the release carries the loan book and allowance; where the provision line sits.

Before the print, everything we've agreed stands. That means the box for the first tranche, the state test and the 1,646.73 trigger for the second, the live fixing and the spread rules, and nothing bought back. Every deadline that says the 23^rd becomes the earlier of the 23^rd and the session before the print.

The hedge: It goes on after Monday's reaction and by the close before CPI, at percentage strikes, within about a point of a standard position. It expires at least three sessions after the print and closes or shrinks with the stock. One reset above 1,860 gets its own half point, with the core sized to fit and the call left where it is. If the first spread won't fit, the core goes to 40. If an accelerator fires, the hedge gets decided that session.

After the print: Operating margin under 6 exits. Gross margin under 40 exits too, unless operating income is up year on year and the opex decline didn't come from provisions. In that case we hold 25, and the reserve test decides whether it stays. A clean release that carries the reserve data, with the current ratio at or above 1.10, goes to 100 within two sessions. Without that data, a clean release goes to 75, and the 10-Q decides the rest. 112 needs the 10-Q's credit tests, a slowing loan book, MELI at least matching the Latin American group, and the pre-print price gate. Otherwise it waits for Q4. 125 waits one clean quarter beyond 112.

You two have spent this round arguing over how much to trust a press release. My answer is as much as it can actually tell us, and no more. Where the release carries the evidence, act on it within two sessions. Where it doesn't, wait for the filing that does. Neutral Analyst: Last word from this chair, so I'll spend it on what's still open. The Sell, the half, no short, everything before the print and nearly all of the hedge are settled, and I'm not reopening any of it. What's left is how size comes back after the release. That comes down to four disputes, plus two places where rules collide that nobody has closed.

First, a debt. Aggressive, you caught me in a real contradiction. My opex decomposition would have exited the honest version of the provision story, where originations slow and the reserve share holds. My own reserve test passes that quarter. You're right, and the conservative has already folded the fix into his version. A falling provision line now tells us which question to ask on release day. It doesn't answer it.

Now the gross-margin branch. It's the most expensive thing left, and I think you're each half right.

Conservative, you called holding half on a clean reserve test "the reserve test rescuing an exit." That isn't what happens in that branch. What rescues the quarter is operating income growing. The reserve test only checks that the growth wasn't borrowed. But your conclusion survives the correction, because a test that can only say "less" can't be what lifts 25 to half.

Aggressive, that's why credit alone doesn't get you back to half. The reserve share tells us whether the operating line borrowed from reserves. It says nothing about why the gross line broke, and the trader built this Sell on the gross line.

Where I part with the conservative is the road back. Q4's numbers arrive in February, and the aggressive's cliff is real. Take the in-between quarter: operating margin 6.5 on a gross margin of 40.3. Operating income is about 696 million, down about 4 percent, and we hold half. Now take the exception quarter: gross margin 39.8 with opex near 33. To qualify it has to clear last year's 724 million, and by the conservative's own math it does so by a few million. Under his rule it sits at 25 until February. Those are nearly the same quarter. One has half a point less gross margin and most of a point less opex.

Conservative, you named what 25 is for: "broken, not yet explained." So let an explanation lift it, and make it an explanation of the line that actually broke. The gross line carries three things: first-party mix, shipping subsidies and funding costs. The first two are choices management made to buy growth, and management can reverse them. That's the aggressive's 2020 story. Funding costs are how the region gets into MELI. Q4 opens with LatAm spreads 51 basis points wider, debt apparently moving inside a year, and a Brazilian central bank that may pause after the Fed's hike. That's the conservative's "start of something."

The 10-Q's revenue and cost detail should show which one did it. If the drop came mainly from the commerce side and credit holds, the quarter goes back to half, the same size as the in-between quarter it nearly matches. If funding costs grew faster than credit revenue, or the filing can't tell us, it stays unexplained and stays at 25 until Q4. Anything above half still needs gross margin over 40.9, like every other path. That doesn't move the trader's line. It gives a quarter that broke the line a way to show why.

Neither of you gets to name the cause in advance, because you've both overstated your evidence.

Conservative, "with the wind at its back" oversells Q3. Only part of the 95-basis-point cut landed in the quarter, worth tenths of a point of margin. The stronger real and peso scale revenue and costs together.

Aggressive, the conservative is right that 2020 had nearly twenty points of opex to give back, and that room is gone. But the exception doesn't need it. It needs opex at about 33 percent of revenue, the low end of where it ran through 2025. It has to get there in a quarter where opex was flat at best coming off Q2 in both prior years. That's unusual, not unprecedented.

On release day I'll take the conservative's mechanics. If the rest of opex did the work, the quarter earns 25 on the release. If the provision line did it, the quarter earns 25 only if the release shows the reserve share and lagged delinquencies holding. Otherwise it waits in cash, and comes back if the 10-Q confirms it. When the evidence for an exception is missing, the trader's rule applies. If Monday's check puts provisions inside cost of revenue, the conservative is right that there's no exception left to argue about. Gross margin under 40 exits.

Second, charge-offs. Conservative, you're right that a lender that writes off faster can show flat delinquencies while losses rise, so charge-offs belong next to the lagged ratio. Your trade of the loan-growth gate for that ratio also settles the charge that we wanted slower lending in one place and punished it in another. So let's define "credit holds" once and use it everywhere: the reserve share held or higher; lagged delinquencies flat or lower; net charge-offs, against the lagged book, flat or lower.

But I wouldn't let missing charge-offs block a return to 100 when the release has the other two. Under CECL, every dollar charged off has to be replaced through the provision before the reserve can hold its share. So if the reserve share held and operating margin still cleared 7.5, any rise in charge-offs is already paid for in the number we're reading.

What charge-offs add is direction: whether next quarter's losses are building. That's a reason to keep them in front of 112, which is a bet on next quarter. It's also a reason to let them take us back from 100 to 75 when the 10-Q shows them. It isn't a reason to hold back normal weight on a quarter that has already paid for its losses.

The same principle reaches one place nobody has looked, and this time it cuts the conservative's way. As written, a failed reserve test only blocks adds. But if the reserve share fell while lagged delinquencies were flat or rising, the margin we're reading was borrowed. Then the 6 percent exit should read the margin MELI would have printed with the reserve held at last quarter's share. If that's under 6, it's an exit, whatever the headline said. If delinquencies fell along with the reserve, the credit earned that release. It still can't fund an add, but it isn't an exit. Aggressive, that's your "one number as the judge everywhere," taken at its word. It judges in both directions.

Third, the region. Conservative, the gate on 112 is right. About 84 percent of MELI's liabilities are short-term, and a lender like that shouldn't run an unhedged overweight while its funding market is breaking. A group test can't see that when the whole group falls together.

But be honest about the cost. With the price gate pinned near 1,697, your gate will often be shut exactly when the add would fire, so on Q3 the add may simply never happen. I'd make it wait rather than die. If the region settles before Q4 and every other condition still holds that day, it goes. Aggressive, if the regional fear reverses the way you expect, the half we held and the 100 we rebuilt ride it. Missing the last twelve and a half points is the cheapest mistake this plan can make.

Then follow your own logic one more step, conservative, because you stopped at 112. Before the print, a fixing above 5.24 is a regime break that sends us to 50 at any price. After a clean print, the plan as written would buy back to full weight within two sessions in that same regime. Those two rules collide.

Use the staging we already have: while the region is breaking, nothing gets bought above 75, and the last quarter waits for it to settle. For a gate on buying, one fixing above 5.24 or one spread close above 2.5 is enough. A noisy close costs us a day, not a fill at any price.

Fourth, consensus. Conservative, you're right, and it's the aggressive's own logic: a 7.5 that misses a consensus of 8 is a miss at 100 too. A miss on operating margin, measured against the consensus we pull before the print, means 75 within two sessions, and the 10-Q decides the rest. That makes "75 and the filing" this plan's single holding pattern for evidence that hasn't arrived.

Pull consensus for one more reason. If it sits at or below our 6 percent line, an exit can land on a beat. That doesn't change the exit. The decision gets made on the release, and the two-session window only buys a better fill.

The rest of the conservative's mechanics I'd sign as written: The hedge expires at least three sessions after the later of the print and the FOMC. The group test runs at least two sessions. Price rules outrank every fundamental branch, and a monthly breach cancels any pending add. Flat accounts go to half on a clean release, and the 10-Q decides the rest. I'd add one thing: the hedge deadline follows the earlier-of rule like everything else. It's the close before CPI or the close before the print, whichever comes first.

On the asymmetry argument, you're both right about different weeks. The shape is asymmetric through the gap, which is where this year's damage happened. After expiry it's a plain long. That's why everything after the print is sized by evidence rather than by the hedge, which is what all of the above does.

So here's the plan as I'd hand it to the trader. Sell, hold half through the print, no short, and scale every step to what you hold. If you're already at or below half, skip the trims and run the hedge and the post-print rules. Flat accounts stay flat until the release.

On Monday: Confirm the print, CPI and 10-Q dates. Check whether the release carries the loan book, the allowance and a balance sheet, and where the provision line sits. Pull consensus Q3 margins.

Before the print, everything stands as all three of us signed it: the box for the first tranche; the band, the 1,646.73 trigger and the state test for the second; the fixing and spread accelerators; the earlier-of deadlines; nothing bought back.

The hedge: A put spread about 6 and 15 percent below the price on the day we buy. Bought after Monday's reaction, and by the earlier of the close before CPI and the close before the print. One point all in, expiring at least three sessions after the later of the print and the FOMC. Any call at 2,060 or 20 percent up, whichever is higher. One reset above 1,860 on its own half point. If it won't fit, the core goes to 40. It closes and shrinks with the stock.

After the print, price rules come first. A close under 1,495 exits. A monthly close under 1,549.51 cuts to 25 and cancels any pending add.

The margin rules: Operating margin under 6 exits. If the reserve share fell while lagged delinquencies didn't, read that margin with the reserve held at last quarter's share. Opex is a watch item. Gross margin under 40 exits, unless provisions sit below gross profit and operating income is up year on year. In that case it's 25 at most on the release, or cash if provisions did the work and the release can't show credit. At the 10-Q, failing credit takes that 25 to zero. Passing credit with a commerce-side explanation lifts it to half. Anything else holds 25 until Q4.

The rebuild: A clean release means gross margin over 40.9, operating margin at 7.5 or better, growth of 40 or more, and credit holding. It goes to 100 within two sessions if four things hold. The release shows the reserve share and lagged delinquencies. The balance sheet passes, with a current ratio of 1.10 or better and leverage under 6x. Operating margin doesn't miss consensus. The region isn't breaking. Otherwise it goes to 75 within two sessions. The last quarter waits for whatever held it back: the 10-Q for missing data or a consensus miss, a settled region for a break. Charge-offs at the 10-Q can take us back to 75. A current ratio under 1.10 holds us at 75 until the filing passes the two-part test.

Above normal weight: 112 needs credit holding with charge-offs, MELI matching its group over at least two sessions, no consensus miss, a price within 35 times the pre-print 48.5, and a region that isn't breaking. If the region is the only thing missing, it waits. 125 needs one more clean quarter after that.

Between the two of you, this has been argued down to a quarter of one position for a couple of weeks at a time. That's what a finished plan looks like. The test I've held every rule to in this round is that no number gets a job it can't do. Credit can't explain a gross margin. A press release can't stand in for a filing. A falling price can't, on its own, tell us the market is wrong. Give each number the job it can actually do. Then this plan sells into the weakness it can see, insures the gap it can't, and buys back only as fast as the evidence arrives. Neutral Analyst: I said my last turn was the last word from this chair. Since then the aggressive amended my handover and the conservative amended the amendments, so the plan on the table now belongs to nobody. Let me try to make it everybody's, and then argue that we stop.

Start with perspective. Everything that happens in the next two weeks is settled: the box, the band, the state test, the fixing and the hedge before CPI. That's where most of the probability sits. What's still open is a handful of post-print branches. Most of them are one chance in five or less, and each is worth a fraction of a point. Most of this plan's upside isn't in those branches anyway. It's in the half that rides a good print from the first tick, with no conditions attached. The adds are the garnish.

So the biggest risk left isn't any branch we're arguing about. It's the rulebook itself: around forty conditional lines, run by a desk at ten to four on the worst day of the quarter. Both of your last turns created new collisions, each for good reasons. Let me close them.

The first collision would actually cost money. Aggressive, you want the region gate to reopen on the first session the fixing and spreads are back inside the lines. Conservative, you want a regime break to take the overweight off. Each rule makes sense alone. Put them together on a spread series sitting at 2.41, nine basis points under the line after an eighteen-basis-point day, and you've built a churn machine. It buys the overweight on a quiet day, sells it two closes later, and buys it back on the next dip, rebuying its hedge every time.

Aggressive, that's where your symmetry argument breaks. The two errors don't cost the same. A gate that shuts too easily costs a day of waiting. A gate that opens too easily, next to a rule that sells, costs a round trip. When two errors carry different costs, their thresholds should differ. That's ordinary handling of a noisy signal, not a bearish tilt. So I'm with the conservative: one close shuts the gate, and two consecutive sessions back inside reopen it. Your worry that one noisy close costs us until February doesn't apply to that version. It costs a day once the region settles.

I'd add the cheapest rule in the plan. Once a regime break takes the overweight off, it stays off until the next print decides fresh. One strike per quarter. Aggressive, you signed my line that missing the last twelve and a half points is the cheapest mistake this plan can make. This is that mistake, made on purpose, to avoid a churn we can already see.

Conservative, one piece of your gate argument doesn't hold. You said the fixing watches one currency in a three-currency business. That's true of the fixing, but the gate has two legs. The spread leg is a regional index that covers Mexican issuers among others, which is why both legs are there. Argentina is a gap in the packet, and no rule we write today fixes a missing data series.

Second, the hedges on the adds. You both now agree that adds carry insurance into the Q4 print, the aggressive for the step to 112 and the conservative for the lift from 25 to half. I agree with the principle. You've both timed the purchase wrong.

Aggressive, you said to price the 112 hedge on the day the add fires, after the print has taken the event premium out. It won't have. Any option that runs through the Q4 print carries Q4's event premium whenever you buy it. Buying in November only adds three months of time decay on days the price rules and the regime rule already police.

Look at how this year's damage actually arrived. All three big gaps landed on what look like print days. September's fifteen percent slide was a grind, with the ATR shrinking from 64 to 55 as the price fell, which is exactly what closing triggers are built to catch. Hedges for prints, closing rules for grinds. That's what this stock has shown us.

Conservative, your version has the same timing problem plus one more. You said the financed spread should usually fit over three or four months, and on my rough math you're right. There's no implied vol in the packet, but in the high thirties a 6-to-15 percent put spread over four months costs roughly three percent of the stock, and the twenty-percent call brings back about two.

Ask why that call is worth two-thirds of the spread. A twenty percent rally in three months is a live outcome for this stock: the summer ran twenty-seven percent on closes in ten weeks. So the financed version isn't cheap insurance. It's a collar that sells the lifted quarter's upside over exactly the months a turn would get priced, on the one tranche that exists only for the upside.

It also contradicts your own argument. After the exception quarter and the lift, we're at half, the size we carried into Q3. We hedged that whole half into Q3 because the gross line was falling and every gap this year had been down. Going into Q4, after gross margin broke 40 for the first time in the series, your rule hedges half of that half and leaves the other quarter bare. If the broken quarter is the dangerous one, and I think you're right that it's worse than a clean one, then the whole position going into the next print needs the treatment.

That exposes a hole none of us has closed. Take the plain in-between quarter, operating margin 6.5 on gross margin of 40.3. We hold half through it and nobody objects, because the hedge was bought for the gap, not for the weeks after it. I stand by that. But the weeks after it end in another gap.

As written, this plan carries an unhedged half into the Q4 print after a quarter that never answered the margin question. That's the exact trade we spent this whole debate refusing to make into Q3. And before anyone calls Q4 the seasonally easy quarter, February's minus eight looks like it was a Q4 print.

So replace both custom hedges with one checkpoint a month before every print, the same lead we gave ourselves this time: No new adds inside that month, which is the conservative's lapse rule. Anything above normal weight gets a percentage spread inside its budget by the session before the print, or it comes off. If the last quarter didn't pass all three tests with credit holding, everything we carry gets this quarter's treatment: a spread within two percent of the stock it covers, or a cut by a fifth, which is what the 40 percent fallback does today. If the last quarter was clean, normal weight rides into the print as normal weight always does.

Aggressive, that gives you the 112 step and the lift with no hedge attached at purchase and no three-month cap on either. In a clean quarter, the branch you've been defending, it costs you nothing. Conservative, it gives you more protection at the event, on the whole position instead of a slice, for less premium. Your regime rule covers the months in between, which is what you built it for. And it's one rule instead of two.

Third, the credit tests. Conservative, you're right that a lender selling bad paper can make the reserve share, delinquencies and net charge-offs all fall in one quarter without a single borrower improving. But your test, no material loan sales or transfers of receivables, may be impossible to pass for reasons unrelated to credit. Brazilian lenders commonly fund loan books by moving receivables into dedicated funds, and none of us knows how MELI's funding is set up. If those transfers are routine, your test fails every quarter and silently vetoes the branch.

Test for what actually worries you instead: No sales of delinquent or charged-off portfolios. No jump in the pace of transfers compared with prior quarters. If the filing doesn't split recoveries by source, use gross charge-offs, which recoveries can't flatter. The sales test covers the rest.

Keep the remainder of that branch as you wrote it: 75 on the release, the filing decides 100, and the stripped margin is the one measured against consensus.

On charge-offs at the 10-Q, I'll take "will" over "can". You're right that discretion in a rulebook usually means inaction. But "rising" needs a definition, or it fires on normal seasoning: a fast-growing book shows more charge-offs as its loans age, and consumer credit has seasons. So rising should mean the charge-off rate against the lagged book is above both the prior quarter and the same quarter last year. Above both is deterioration; above one is noise.

I'd sign the dropped-metric rule as written, defined narrowly. If a credit metric was in Q2's release and isn't in Q3's, there's no move on the release, and the filing decides.

Two corrections for the aggressive, because both bear on the overweight. You said nothing this year went past minus fifteen, and the part outside the band is the part that healed. That's true of the day-one gaps but not of the path. May's pre-gap close was 1,870. Three sessions after the gap it traded at 1,495, down twenty percent, and its lowest close a week later was down seventeen. That went through the lower strike while a spread like ours would still have been alive. The band covers the gap, not the follow-through. That's why the two-session window keeps the gap-day low as a hard line, and why the overweight needs the regime rule as well as a spread.

And "the best-priced purchase this plan will ever make" oversells it. At a 7.5 percent margin, the frozen-margin 48.5 scales to roughly 54. That puts the gate price at about 31 times earnings, an earnings yield around 3.2 percent against 2.88 on TIPS. For a levered lender in a region whose credit spreads just widened fifty basis points, that's fair value, not a bargain. That's the honest case for 112: a twelve-and-a-half-point step behind five gates, not a conviction add.

Now the mechanics. The conservative is right on each of these in principle, but the details will bite.

Closing auctions, yes. But the closing cross stops taking market-on-close orders about ten minutes before the bell, so every close-based rule really reads the ten-to-four price. Write that down as the convention for the state test as well as the triggers, so nobody argues afterwards about which price governed. If a sell line is within a couple of dollars at the check, treat it as hit. A near miss on a sell trigger costs almost nothing either way.

The spread rules can't execute in the closing auction at all. The Latin American spread is an end-of-day index, so a spread close doesn't exist at ten to four. In this packet it arrived even later: the macro report written on the 3^rd had the yield curve and the NASDAQ for October 2^nd, but its last spread print was October 1^st.

So anything keyed to spreads acts at the first check after we actually know the number. The combined rule counts a MELI close under 1,668.44 on either the spread's date or the day we learn it. The central bank's fixing comes out in the early afternoon in Brasília, before the New York close, so fixing rules can act the same day. And the November monthly as the default expiry is agreed.

One thing none of us has said matters precisely because we don't know the caller's size. One MELI option covers a hundred shares, about 170,000 dollars of stock at today's price. If your core is under a hundred shares, you can't buy even one spread without being net short the difference, and this plan has no short. So: Small holders take the 40 percent fallback directly. Larger holders round contracts down, never up, and cut the uncovered remainder by a fifth. The same applies to any call sold against the core.

If you already own Nu or a Latin American fund, count it toward the core, and don't recycle trim proceeds into either. That just rebuys the bet we're selling.

Last, the conservative's decision table. I endorse it, and I'd add the one thing any table needs, an order of precedence. Price rules first, then regime rules, then fundamental exits, then staging, then adds. One tie-break covers everything else: when two separate rules point to different sizes in the same session, the smaller size executes, and the larger has to re-earn it on its own trigger.

I checked that against every conflict we've written explicitly, and each time it gives the answer we already chose. The fixing beats the state test, price beats a clean release, and the gate beats the staging rule. It adds no new behavior. It just means nobody has to work it out at ten to four.

Then freeze it. From here, any new rule has to replace an old one. Every rule added in the last three rounds made sense on its own, and I've spent half this turn on collisions between sensible rules. That's what happens when a rulebook only grows.

So here's the plan, scaled to whatever you hold. It's a Sell: half through the print, and no short. Flat accounts stay flat until the release, then go to half on a clean one. If you're already at or below half, skip the trims and follow the rest.

On Monday, confirm the print, CPI and 10-Q dates. Check whether the release carries the loan book, the allowance, charge-offs, a balance sheet, and a revenue and cost split. Find out where the provision line sits, and what Q2's release disclosed, so we can tell missing data from dropped data. Pull consensus operating margin and freeze it the session before the print.

Before the print: The first tranche sells on a trade into 1,731 to 1,745 or a close under 1,668.44. Otherwise it sells at market by Friday the 9^th, or the session before CPI if that comes first. The second tranche rests at 1,813 to 1,860 and sells on a close under 1,646.73. It keeps working past CPI only if MELI is above 1,731.36 at the check the session before. It's done by the earlier of the 23^rd and the session before the print. A fixing above 5.24 accelerates the trims the same day. Spreads accelerate them at the first check after two closes above 2.5, or one close above 2.5 plus a MELI close under 1,668.44. Nothing gets bought back before the numbers.

The hedge: A put spread about 6 and 15 percent below the price on the day we buy. Bought after Monday's reaction, on an up day if we get one, by the earlier of the close before CPI and the close before the print. A point of a standard position all in. Expiring at least three sessions after the later of the print and the FOMC, with the November monthly as the default. Any call goes at 2,060 or 20 percent up, whichever is higher. One reset above 1,860 gets its own half point. It closes and shrinks with the stock. If it won't fit, or your core is too small for whole contracts, go to 40.

After the print, price rules come first. Operating margin under 6 exits. Read it pro forma if the reserve share fell while lagged delinquencies didn't. Gross margin under 40 exits, unless provisions sit below gross profit and operating income is up year on year on real operating leverage. That earns 25 at most. Filed numbers showing funding costs grew no faster than credit revenue, with credit holding on all three legs, lift it to half. Failing credit takes it to zero. A clean release goes to 100 within two sessions if it carries the reserve data and a balance sheet, meets consensus, and the gate is open. Otherwise it goes to 75, and the filing or a settled region decides the rest. A pro-forma pass earns 75 on the release and 100 once the filing shows no bad-loan sales. Rising charge-offs at the filing take 100 back to 75 that session. A current ratio under 1.10 holds us at 75 until the filing passes the two-part test. A monthly breach cancels any pending lift or add, and caps a clean rebuild at 75 until a monthly close back above 1,549.51.

Above normal weight, 112 needs all of the following: The reserve share held. Lagged delinquencies and charge-offs flat or lower. MELI matching its group over at least two sessions. No consensus miss. The price within 35 times the pre-print 48.5. An open gate. A regime break takes it off for the quarter. 125 waits for one more clean quarter.

And a month before every print, the checkpoint runs: no new adds, the overweight hedged or off, and if the last quarter wasn't clean, everything hedged within budget or cut by a fifth.

If all of that is more machinery than your account can run, it boils down to three things. Sell half, into the bounce or on the breakdown. Insure or shrink what's left before every print. And let the release and the filing decide how much comes back.

You two have argued this down to whether a quarter of a position moves in November or in February. Settle it the way this stock has actually behaved. Insure the prints, because that's where the gaps were. Police the grinds with closing rules, because that's how September came. And let each document move only as much size as it can vouch for. That keeps the upside the aggressive kept half for and the capital the conservative is protecting, and someone who wasn't in this room can still run it.

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Underweight

Executive Summary

Cut MELI to about half of a standard allocation through the Q3 print, and hedge what's left or cut it further. Don't exit and don't short. The trader's SELL ticket is how this Underweight gets executed: it is a trim, not an exit.

Over the next four to seven weeks the bear case is stronger: - Gross margin is still falling, and the decline is getting faster. - Seasonality puts the likely Q3 operating margin right on our 6.0% exit line. - All three 2026 prints gapped down. - Today's first-round vote, CPI, the Oct 25 runoff and the Oct 27–28 FOMC all likely land before the numbers.

But selling all of a 50%-growth franchise at 1,696.56, about 6% above its long-term support zone, is the worst-priced trade available. All three risk analysts ended at half weight with no short. I'm adopting their consolidated plan, with the rulings set out in the thesis.

How to act. Sizes are percentages of a standard MELI allocation. I don't know your holdings, so scale every step to what you own.

Tranche 1 (full weight to ~75%).
Sell on a trade into 1,731–1,745, or on a close below 1,668.44, whichever comes first.
If neither happens, sell at market by Fri Oct 9, or the session before CPI if that is earlier.
Tranche 2 (~75% to ~50%).
Rest a limit order at 1,813–1,860. Sell at market on a close below 1,646.73.
Keep the order working past CPI only if MELI closes above 1,731.36 the session before CPI. Otherwise sell at that close.
Finish by Oct 23 or the session before the print, whichever comes first.
Accelerators.
A Brazilian central bank USD/BRL fixing above 5.24 takes you straight to ~50% that session, at any price.
LatAm corporate spreads do the same after two closes above 2.5%, or one such close plus a MELI close below 1,668.44.
No buybacks before the print. A close above ~1,875 will already have filled tranche 2, and it does not trigger a rebuild.
Hedge the remaining stake.
Buy a put spread with strikes ~6% and ~15% below that day's price.
Buy it after Monday's election reaction, on an up day if possible. Do it no later than the close before CPI or before the print, whichever comes first.
Spend no more than ~1% of a standard position all-in. Expiry should be at least three sessions after the later of the print and the FOMC; the default is the November monthly.
If you sell a call to pay for it, strike it at 2,060 or 20% above the price, whichever is higher.
Never lower the put strikes or bring the call closer to make it fit the budget. If it won't fit, or your core is under 100 shares (one contract), cut to ~40% instead. Larger holders round contracts down and cut the uncovered remainder by a fifth.
Reset the strikes once if MELI closes above 1,860 before the print, with its own budget of half a point.
The hedge closes or shrinks whenever the stock position does, so you are never net short.
Already at or below half: no trims and no adds, but follow the hedge and post-print rules.
Flat accounts: stay flat until the release. A clean release takes you to half, and the 10-Q decides the rest.
Related holdings: count Nu or LatAm-fund holdings toward the MELI core, and don't recycle trim proceeds into them.
After the print. Price rules come first.
A daily close below 1,495 means exit. A monthly close below 1,549.51 means cut to ~25%.
Operating margin below 6.0%, or gross margin below 40%, means exit. There is one narrow exception, described in the thesis.
A clean quarter means gross margin above 40.9%, operating margin of at least 7.5%, revenue growth of at least 40%, and credit holding.
On a clean quarter, go back to 100% within two sessions if all of these hold: the release shows reserve data and a balance sheet, it doesn't miss consensus operating margin, and the FX/spread gate is open. Otherwise go to 75% and let the 10-Q decide the rest.
Anything in between: hold ~50% and add nothing.
Monday checklist.
The first-round election result.
The Q3 print, CPI and 10-Q dates.
Consensus Q3 operating margin, frozen the session before the print.
Whether the release will carry the loan book, the allowance, charge-offs, a balance sheet and the segment split.
Where the provision line sits on the income statement.

Investment Thesis

What decided it: the bear case wins this window.

The gross margin the Sell rests on is still falling.
Q2 gross margin was 40.9%, the lowest in the dataset. It is down year on year for the fifth straight quarter.
The 4.67-point year-on-year drop was the steepest yet. It accounts for 4.67 of the 5.43-point fall in operating margin.
From Q1 to Q2, gross margin fell 2.8 points, against 1.1 points a year earlier.
Q2's apparent operating floor came from opex reversing Q1's spike, from 36.8% to 34.2% of revenue. It was not gross-margin repair.
The next print is a seasonal low, and this stock gaps on prints.
Operating margin fell from Q2 to Q3 in 2024 (14.3% to 10.5%) and in 2025 (12.2% to 9.8%). Scaled to today's 6.7%, that points to about 4.9–5.4%.
The bull's own scenario grid puts the median at 6.0%, our exit line.
All three earnings-type gaps this year were down: −8.05%, −12.70% and −4.82%. That includes August's, which apparently followed the quarter that steadied.
May's gap opened about 3.3 ATR below the prior close, beyond any closing stop. A −13% gap costs about 6.5% of a standard position at half weight, and about 13% at full weight.
The valuation leaves no margin of safety.
About 35x frozen-margin FY2027 EPS (~$48.5) is a 2.86% earnings yield, against 2.88% on 10-year TIPS.
On trailing EPS of $36.77, the multiple is 46x.
Any excess return depends on a margin recovery that Q3 is only beginning to test.
The balance sheet is drifting toward our limits.
Liabilities/equity is 5.56x after five straight increases. The current ratio is 1.12x, a series low. Cash covers about 10% of current liabilities.
Credit-type revenue is about 30.6% of the total and grew 56.7%, the fastest-growing line. The packet has no delinquency, provision or charge-off data at all.
LatAm spreads widened 51bp in six sessions, and Nu, the closest Brazilian peer, is under pressure.
The tape and the calendar point the same way.
The weekly and daily SuperTrend are both down. MELI has closed below a falling 200-day average 14 sessions in a row.
The Sept 8 golden cross is down 11.9% since. MACD is −50.37, below its signal line, and OBV is at a 90-session low.
There has been no capitulation. RSI never closed below 30, and ATR shrank from 64 to 55 during the grind lower.
A death cross is estimated around Oct 21, before the print.

Why not Sell. - The franchise is intact. - Revenue growth has accelerated for four straight quarters, to 49.8% on $35.2B of trailing revenue. - ROE is 27.5%, with no dilution and book value up 37%. - Operating plus investing cash flow was $1.58B in 1H26, against $0.88B a year earlier. - Even with margins frozen, FY2027 EPS still grows about 30%. - The price is near support. - MELI is about 6% above the 1,546–1,600 zone. There the monthly SuperTrend, still pointing up with its stop at 1,549.51, lines up with the March, May and June lows. - RSI is 33.5 and the daily TD 9 count is complete. A short here has only about 1:1 reward to risk. - The selling looks regional, not company-specific. The slide tracks the real, LatAm credit and Nu. It can reverse if the 10-year yield drops back below 5%. - Nobody in the debate argued for zero.

How I ruled on the debate. The analysts disagreed about execution, not direction.

The conservative analyst was right about the downside paths.
The original plan only reached 50% if MELI bounced first. In a steady decline neither limit order filled. The 1,600 clause would have left 75% sitting next to the monthly support line going into a gap.
The fixes are the 1,668.44 trigger on the near-term trading range, the 1,646.73 trigger, the pre-CPI price check and the "whichever comes first" deadlines.
The 1,600 clause and the pause-on-outperformance rule are struck.
So is any pre-print rebuy above 1,875, so the trader's 1,875 stop no longer triggers a rebuild. A close there would already have filled the 1,813–1,860 order. The rule's only effect was buying back near the 1,870–1,923 closes that this year's gaps started from.
The aggressive analyst was right to keep half, insured.
A hedged half roughly ties an unhedged third in a May-type gap (about −3.9% vs −4.2% of a standard position). It wins on a good print (+6.5% vs +5%).
A hedge removes only the downside variance. Selling removes the upside too.
The hedge goes on before CPI, not by the 23^rd.
The neutral analyst was right about what this position is.
When reward and risk are about even, limit orders above the market change which paths you take, not the expected exit price. The trims are about controlling variance into events, not about getting a better price.
The hedged half is a more bullish position than a third, not a safer one. That is why the ~1% budget is a hard cap and 40% is the fallback.

Rulings on the open points.

Rules apply in this order: price rules, then FX/credit regime rules, then fundamental exits, then staging, then adds. If two rules conflict in the same session, the smaller size wins. The rulebook is now frozen: any new rule must replace an old one.

The gross-margin exception.
Gross margin below 40% with operating income up year on year earns at most 25%. That only applies if the gain comes from real operating leverage and provisions sit below gross profit.
The 25% rises to 50% only on printed numbers, in the release or the 10-Q, showing funding costs grew no faster than credit revenue and credit is holding.
"Operating income up" is a growth test, and the Sell was built on gross margin.
What "credit holding" means.
The reserve held its share of the loan book.
Delinquencies and net charge-offs, measured against the loan book from one to two quarters earlier, were flat or lower. Use gross charge-offs if recoveries aren't split by source.
If the reserve share fell while delinquencies didn't, apply the 6% and 7.5% tests to the margin restated with the reserve at Q2's share.
If the reserve share fell while delinquencies and charge-offs fell too, a pass on the restated margin earns 75%. It stays there until the 10-Q shows no sales of bad or written-off loans and no jump in receivable transfers. The restated margin is the one compared with consensus.
10-Q follow-through.
A lagged charge-off rate above both the prior quarter and last year's Q3 takes 100% back to 75% that session.
A current ratio below 1.10x caps the rebuild at 75% until the 10-Q shows two things. The new current liabilities must be customer funds matched by liquid or restricted assets, and debt due within a year must be covered by unrestricted cash and investments.
Liabilities/equity of 6.0x or higher blocks adds. Either breach combined with worsening credit means exit.
The region gate.
One fixing above 5.24, or one spread close above 2.5%, blocks anything above 75%.
The gate reopens after two consecutive sessions back inside both lines.
If the region breaks while you are overweight, the overweight comes off for the rest of the quarter.
Overweight (~112%). All of the following must hold:
The 10-Q passes the credit tests.
MELI at least matched Nu or a LatAm fund from the pre-print close through the 10-Q.
No miss against consensus.
The price is at or below 35x the pre-print $48.5, about 1,697.
The region gate is open.

At a 7.5% margin that price is about 31x the rescaled EPS. That is fair value, not a bargain, so treat it as a small step. If it hasn't fired by a month before the Q4 print, it lapses. 125% waits for another clean quarter. A month before each later print, anything above normal weight, or held after a quarter that wasn't clean, gets hedged within budget or cut by a fifth. - Mechanics. - Triggers based on closes are checked about 10 minutes before the bell. - Spread triggers act at the first check after the data is published. - FX uses the central bank's daily fixing, not the stale 5.19 weekly reading.

What would change the rating. - Up. A clean Q3 returns MELI to normal weight, which is a Hold. If the 10-Q conditions above are met, a modest Overweight follows. Nothing before the print upgrades the call, including a close above 1,875. - Down to Sell. Any one of these: - operating margin below 6.0%, using the restated margin where required; - gross margin below 40% outside the narrow exception; - a daily close below 1,495; - worsening credit together with a current ratio below 1.10x or leverage of 6.0x. - Macro. A fixing above 5.24, or spreads through 2.5%, speeds up the cut without changing the rating. The main relief path is the 10-year back below 5% plus a clean print. That is the case the half we keep is for.

Price target: scenario-weighted valuation (method 1).

I start from frozen-margin FY2027 EPS of about $48.5, which assumes Q2's 6.7% operating margin. I scale that EPS to each Q3 scenario in the fundamentals report. That is reasonable because the share count is flat at about 50.7M and net income tracks operating income. I then apply the 35x multiple the debate anchored on.

Q3 scenario	Op. margin	FY2027 EPS	× 35	Weight
At or below the exit line (bull's median)	6.0%	~$43.4	~1,520	50%
Margin holds at Q2 level	6.7%	~$48.5	~1,697	30%
Recovery (the least likely scenario)	7.5%	~$54.3	~1,900	20%
Weighted value			~1,649, rounded to 1,650

The weights come from the debate. The median outcome sits on the exit line, and all three analysts called the rebuild the least likely scenario. Using 6.0% for the low scenario is generous to MELI, since the seasonal pattern points to 4.9–5.4%. Moving 10 points of weight between the low and recovery scenarios shifts the result by about ±$38.

Cross-checks: - 1,650 is 2.7% below the current close. - It sits at the lower Bollinger band (1,646.73), just under the Oct 1 low (1,668.44). Those are the technical report's first breakdown targets, and both are above the 1,546–1,600 support zone. - It equals 34x frozen-margin FY2027 EPS, a 2.94% earnings yield, roughly what TIPS pay. That fits a market that won't pay for a recovery it hasn't seen yet.

The target is an expected value, not a predicted path. A May-sized gap from here would reach about 1,481, and a clean print could test 1,813–1,900. Use the execution levels above for orders. The 4–7 week horizon runs through the Q3 print, the 10-Q and the November-monthly hedge expiry.

Data gaps. The packet has no confirmed Q3 date, no consensus estimates, no credit-quality data, no implied volatility, no first-round result and no insider data, and the FX reading is stale. These keep confidence at Medium.

Current Price: 1696.56 USD (latest verified close, Friday 2026-10-02)

Price Target: 1650 USD

Confidence: Medium

Time Horizon: 4-7 weeks

Trading Analysis Report: MELI¶

I. Analyst Team Reports¶

Market Analyst¶

MELI (MercadoLibre, Inc.): technical analysis report¶

Summary¶

1. Indicators chosen (8) and why¶

2. Data check¶

3. Price structure and context¶

4. Moving averages¶

5. SuperTrend: the timeframes point bearish¶

6. Momentum¶

7. Volatility¶

8. Volume and OBV¶

9. TD Sequential setup¶

10. Key levels¶

11. Scenarios and triggers¶

12. Event risk¶

13. What the data supports (the trade decision is left to the other agent)¶

Key points at a glance¶

Sentiment Analyst¶

1. Source-by-source breakdown¶

2. Cross-source alignments and divergences¶

3. Dominant narrative themes¶

4. Catalysts and risks¶

5. Key sentiment signals¶

News Analyst¶

MELI (MercadoLibre, Inc.): news and macro research report¶

1. Bottom line¶

2. MELI-specific news flow¶

3. Global macro¶

3.1 Geopolitics and oil: the Iran war is re-escalating¶

3.2 US inflation: firm, not runaway¶

3.3 The Fed has turned to hiking¶

3.4 The bond selloff is a real-rate shock¶

3.5 US labor and growth: low hiring, low firing, slowing¶

3.6 Credit stress is growing while equity volatility stays calm¶

3.7 The dollar is up and Latin American currencies are under pressure¶

3.8 Latin American interest rates are easing¶

4. How this reaches MELI¶

5. Catalyst calendar¶

6. Scenarios and levels to watch¶

7. Data gaps¶

8. Summary table¶

Fundamentals Analyst¶

MELI (MercadoLibre, Inc.): Fundamental Analysis Report¶

1. Summary¶

2. Data limits and method (read first)¶

3. Company profile¶

4. Income statement: quarterly trend¶

5. Financial history: annual¶

6. Balance sheet¶

7. Cash flow¶

8. Returns, per-share figures and valuation inputs¶

9. Insider activity¶

10. Catalysts and what to watch¶

11. Bull vs bear case¶

12. Key metrics summary¶

II. Research Team Decision¶

Bull Researcher¶

The disconnect this debate turns on¶

1. Growth is accelerating, at $35 billion of scale¶

2. Margins: the bear's best card, and why I'd rather own it than fear it¶

3. Balance sheet and cash: I'll concede the right things¶

4. So why is the stock falling? Rates, region and an election, not the business¶

5. The chart: I'll grant the trend, but I'll take the location¶

How I'd own it, and what proves me wrong¶

1. "We've never seen a gross-margin trough." We have. It was 2021.¶

2. The CECL test: you graded it on the wrong line¶

3. Your Q3 pattern rests on two years with two different causes¶

4. Valuation: fixing my table, and showing what yours assumes¶

5. Credit, the balance sheet and "pick one framing"¶

6. "It's not rates": then it's region and election, two-thirds of my thesis¶

7. Timing: we agree on the next move¶

Revised plan¶

Closing¶

1. You asked me to name a line that stopped. Here are five.¶

2. Drop the analogy: "no recovery" is already in the price¶

3. My weights, since you asked¶

4. The September selloff came after the market had absorbed Q2¶

5. Balance sheet, reinvested capital and Nu¶